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Abstract 
The immune system comprises highly sophisticated networks of cells and 
signalling molecules which function in concert to protect the body against 
pathogens. Within this system a role for the extra-cellular microenvironment as 
a crucial mediator of immune responses is becoming increasingly apparent. 
Conventional in vitro cultures lack physiologically relevant extra-cellular cues, 
such as extracellular matrix (ECM) and shear flow. Tissue engineering can be 
used to simulate features of the natural microenvironment for the development 
of biologically relevant platforms. It is anticipated that this will enable the 
study of the influence of the extra-cellular environment on immune responses. 
This thesis describes the development and characterisation of tissue-engineered 
platforms for immune cell culture which incorporate the ECM and shear flow. 
This work goes on to apply these platforms for the study of the effect of the 
extra-cellular environment on dendritic cells and their interactions with T cells 
in the context of immunological stimulation. 
The ECM defines the three-dimensional architecture of the natural 
microenvironment. It provides structural support and also promotes cell 
motility in tissues. This is important for the function of the immune system as 
it directs the organisation and interactions of immune cells which ultimately 
contributes to the modulation of immune responses. 
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Candidate synthetic and natural biomaterials were assessed for their suitability 
to provide an in vitro extracellular matrix (ECM) platform for human immune 
cell culture. The suitability of these materials to provide an artificial ECM 
platform was based on the viability, resting immune state and immune 
competence of the cells. 
The synthetic biomaterials tested were a thermo-responsive colloidal gel and 
electrospun PET and PLGA scaffolds coated with a thermo-responsive 
polymer. An important finding from the work done with the colloidal gel was 
that the human dendritic cells, which were incorporated into the gel at the 
beginning of the experiment, could not be separated from the material for flow 
cytometric analysis. Therefore, characterisation of the colloidal gel for immune 
cell culture could not be completed. Regarding the characterisation of the 
electrospun PET and PLGA scaffolds, although they did not significantly 
impair cell viability of dendritic cells they were found to induce cell 
maturation. As a result, none of the synthetic biomaterials were found to be a 
suitable ECM surrogate. 
A semi-natural biomaterial, gelatin methacryloyl (GelMA) hydrogel, was 
included in the investigation. The results from the characterisation of GelMA 
for human immune cell culture indicated that the hydrogel induced a pro-
inflammatory immune response due to the profile of secreted cytokines. Based 
on this, GelMA was also discounted as an appropriate material for the 
development of the ECM platform. 
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The final ECM candidate was a collagen hydrogel, which is a naturally-derived 
biomaterial. The collagen hydrogel was shown to support immune cell survival 
and human dendritic cells maintained an immature phenotype in culture. In 
addition, typical responses to immunological stimuli by human dendritic cells 
and T cells were observed in collagen hydrogel cultures. This work 
demonstrated that out of the biomaterials which were characterised, the 
collagen hydrogel was the most suitable biomaterial for the development of the 
ECM platform. 
The influence of the collagen hydrogel ECM platform on antigen-specific 
immune responses was investigated in the context of autologous human 
dendritic cell and T cell co-cultures stimulated with the model antigen 
Mycobacterium tuberculosis purified protein derivative, also referred to as 
PPD. The results from these experiments indicated that the presence of the 
collagen hydrogel increased the sensitivity and specificity of the immune 
response, compared to conventional tissue culture conditions. 
An attempt was made at utilising the ECM platform to investigate immune 
responses to chemical sensitisers to address the requirement for in vitro 
alternatives to replace current animal testing methods. In this work, innate and 
adaptive immune responses to sensitisers were detected using the ECM 
platform. However, the reproducibility of these experiments was low due to 
large donor variation. Therefore the effect of the ECM platform on immune 
responses to sensitisers could not be evaluated. This difficulty likely reflects 
the complexity of the molecular and cellular mechanisms which lead to the 
acquisition of chemical sensitisation. 
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Shear flow is a type of physiological stress to which immune cells are exposed 
in vivo due to the movement of blood and lymph fluid. Recent studies have 
implicated flow as an immunologically relevant stimulus, capable of inducing 
changes in the expression of receptors and chemokines involved in regulating 
immune cell migration, and activating immune receptor signalling. 
A fluidic cell culture platform was developed to recapitulate the effect of shear 
flow. Two different prototypes were constructed, one of which was taken 
forward and characterised for immune cell culture applications. 
The fluidic platform taken forward had a paper-based cell culture scaffold 
which was coated with collagen hydrogel. The scaffold was found to induce 
maturation of human dendritic cells which was attributed to the possibility of 
incomplete coverage of the scaffold by the collagen hydrogel. The viability of 
dendritic cells was slightly impaired by flow, however not significantly. 
Interestingly, when exposed to shear flow, dendritic cells maintained a less 
mature phenotype compared to their static counterparts. 
Antigen-specific immune responses were studied on the fluidic platform by 
setting up co-cultures comprising PPD-stimulated autologous human dendritic 
cells and T cells. Typical T cell activation was observed on the platform and 
the sensitivity and specificity of immune responses was found to be greater 
under flow conditions, compared with static cultures. 
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In conclusion, this thesis demonstrates the value of developing biomimetic 
platforms for studying the influence of the extra-cellular environment on 
immune responses. 
Finally, the ability to mimic extra-cellular cues to which cells are exposed in 
vivo has the potential to generate more realistic immune responses in the lab. 
This presents huge opportunities for advancing understanding in immunology. 
It also has implications for methods used in research, drug discovery and safety 
testing, where currently only animals provide a representative system for the 
study of immune reactions. It is anticipated that enhancing the physiological 
relevance of in vitro cell culture will ultimately contribute to the reduction of 
animals used in research and testing. 
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Chapter 1 
Introduction 
1.1. Considering how the microenvironment 
influences immunity 
Dendritic cells (DCs) are strategically positioned at the interface of the innate 
and adaptive immune systems (Steinman, 1991). They patrol peripheral tissues, 
such as, the skin, gut, lung and genito-urinary tract, which are common routes 
for the entry of pathogens into the body (Caux et al., 1995, Austyn, 1996). 
DCs actively scavenge both host and pathogen-derived material from their 
local environment. They migrate from sites of inflammation to secondary 
lymphoid organs, via the lymphatic system. This mechanism enables the 
delivery of peripheral antigen to naïve T cells, which are restricted to lymphoid 
tissues. Induction of adaptive immunity depends on efficient T cell activation, 
which requires antigen-specific recognition in conjunction with co-stimulatory 
factors produced by DCs (Cella et al., 1997b, Hart, 1997). 
In vivo, DCs interact with the extracellular matrix (ECM), within a 3D 
environment (Garcia-Nieto et al., 2010, Gunzer et al., 2004). In addition, they 
are likely to be subject to physical stimuli, for example, shear flow (Previtera, 
2014, Swartz et al., 2008).  
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The profound influence of the extra-cellular environment on the biological 
function of DCs, and the outcome of interactions between DCs and T cells, is 
becoming apparent based on findings from recent studies. However, most of 
the current understanding of DC biology comes from in vitro cultures, which 
are performed in the absence of extra-cellular cues. 
Assays which comprise DCs are valuable tools in areas of research, drug 
development and safety testing. The requirement and usage of in vitro assays is 
increasing due to restrictions on animal testing methods. However, these 
methods are currently limited by their lack of biological relevance.  
Enhancing the biological relevance of immune cell assays is anticipated to 
provide a more realistic representation of immune responses and thus more 
accurately predict the immunological outcomes of drug and chemical exposure 
in humans. 
Tissue engineering enables recapitulation of features and functions of natural 
tissues through the combination of cells and scaffolds and appropriate 
biological, chemical or physical signals. Thus, tissue engineering technologies 
can be used to address the simplistic, artificial nature of conventional 
immunological assays by simulating certain aspects of the in vivo 
microenvironment (Pampaloni et al., 2007). 
1.2. Introducing Dendritic Cells 
Dendritic cells were identified by Ralph Steinman and Zanvil Cohn in the late 
1970s. They have since been proven to be highly specialised antigen presenting 
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cells (APCs), due to their dedicated role in the induction of specific adaptive 
immunity against foreign antigen (Steinman, 1991). Broadly speaking, DCs 
reside within peripheral tissues and upon recognition of ‘danger’ signals they 
are capable of directing the induction of the adaptive immune system.  
As illustrated in Figure 1, DCs originate from a common progenitor in the bone 
marrow. A major distinction in the DC family can be made between classical 
and plasmacytoid DCs (pDCs). Although they have similar origins, pDCs 
differ in that they predominately partition to the blood and lymphoid tissues. 
pDCs are responsive to virus-derived stimuli, and as a result, produce large 
amounts of IFN-γ. Following viral stimulation, pDCs differentiate, thereby 
acquiring a mature phenotype which allows them to activate specific T cells 
effectively (Liu, 2005, Reizis et al., 2011). 
Classical DCs describe the cells discovered by Steinman and include all DCs, 
apart from pDCs. For the purposes of this thesis, further discussions relate only 
to the function of classical DCs. 
There are several developmentally and functionally distinct subsets of DCs. In 
the last fifteen years, the scope of DC diversity, and the biological significance 
of this, has become apparent (Merad et al., 2013). The different DC subsets 
arise through complex developmental programmes determined by cytokine 
signalling and transcriptional control. Depending on the subset, DCs reside 
throughout the body in lymphoid and non-lymphoid tissues. 
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One DC subset which is set apart from the rest is the epidermal Langerhans 
cells. These cells reside in the epidermal layer of the skin and represent 3-5% 
of epidermal cells. They are unlike other DC subsets as they have to capacity to 
self-renew. Langerhans cells have distinct characteristics, including the 
presence of Birbeck granules, and expression of cluster of differentiation (CD) 
1a and langerin (Ginhoux and Merad, 2010). 
During times of tissue injury and infection, it is likely that tissue-resident DCs, 
such as Langerhans cells, become depleted. Therefore monocytes can be 
recruited to sites of inflammation and subsequently differentiate to become 
monocyte-derived DCs (moDCs) (Leon and Ardavin, 2008). 
The study of DCs in vitro has been facilitated by the ability to isolate 
monocytes. DCs are commonly generated through the culture of monocytes in 
the presence of interleukin (IL)-4 and granulocyte macrophage colony-
stimulating factor (GM-CSF), which leads to the differentiation of monocyte-
derived DCs (moDCs). moDCs have comparable phenotypic and functional 
characteristics to their in vivo counterparts (Sallusto and Lanzavecchia, 1994, 
Horlock et al., 2007). 
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Figure 1. Dendritic cell development. 
Dendritic cells originate from common bone marrow precursors, named lymphoid-primed 
multipotent progenitors. The existence of intermediate precursors is controversial, it has been 
suggested that a macrophage and DC precursor, which differentiates into a common DC 
precursor may exist. Classical DC (cDC) progenitors can be distinguished from pre-
plasmacytoid DCs (pDCs). cDC progenitors give rise to subsets of cDCs. Pre-pDCs are 
restricted to pDC differentiation. Monocytes arise from common monocyte progenitors and can 
differentiate in response to inflammatory signals from the environment into monocyte-derived 
DCs ((Schraml and Reis e Sousa, 2015, Poltorak and Schraml, 2015). 
The Role of Dendritic Cells in Immunity 
DCs provide a mechanism for the transport of peripheral antigens to naïve T 
cells for the induction of adaptive immune responses. This is important as 
naïve T cells are restricted to lymphoid tissues. DCs do not have a passive role 
in this process, they direct appropriate immune responses depending on the 
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immunological context of the tissue from which they originate (Flores-Romo, 
2001). 
The plasticity of the phenotype and function of DCs contributes to their 
specialised role as APCs for the modulation of adaptive immunity 
(Lanzavecchia and Sallusto, 2001). In the steady-state, DCs are classed as 
‘immature’. These cells can be identified based on their high endocytic 
activity, which allows efficient antigen sampling, and absence, or low-level 
expression of cell-surface co-stimulatory molecules and inflammatory 
cytokines (Lutz and Schuler, 2002, Banchereau et al., 2000). 
Pathogen Recognition 
DC maturation can be induced as a result of exposure to microbes (bacteria, 
fungi, viruses and parasites), certain chemicals, or tissue injury. Activation of 
DCs in response to these stimuli occurs through pattern recognition receptors 
(PRRs). These receptors are expressed by APCs to ensure the rapid activation 
of protective pathways of the innate immune system in response to potential 
pathogens and tissue damage (Gordon, 2002). 
Several different groups have been identified which make up the PRR family, 
including Toll-like receptors (TLRs), nucleotide binding and oligomerization 
domain (NOD)-like receptors (NLRs) and RIG-I-like receptors (RLRs) (Jeong 
and Lee, 2011).  
The recognition of microbial products by PRRs is based on conserved 
molecular structures, such as lipids, lipoproteins, lipopolysaccharide, 
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glycoproteins and nucleic acids. Together, these ligands are known as 
pathogen-associated molecular patterns (PAMPs) (Akira et al., 2006).  
PRRs also sense host-derived products which are generated as a result of tissue 
damage, for example, adenosine triphosphate (ATP), low molecular weight 
(LMW) extracellular matrix fragments and reactive oxygen species (ROS). 
These ligands are collectively termed damage-associated molecular patterns 
(DAMPs) (Beg, 2002). 
Engagement of PPRs by PAMPs or DAMPs activates signal transduction 
pathways which involve adaptor molecules, kinases and transcription factors. 
This leads to the expression of a multitude of pro-inflammatory cytokines, 
chemokines and cell-surface molecules which are essential for instructing the 
immediate innate response and, crucially, the elicitation of adaptive immunity 
(Mogensen, 2009, Takeuchi and Akira, 2010). 
Antigen Presentation 
As DCs mature, their antigen capture function is lost. Instead, their ability to 
present antigen is enhanced (Banchereau et al., 2000). As a rule, for the 
elicitation of adaptive immune responses, DCs present antigen to T cells bound 
to major histocompatibility complex (MHC) molecules (Guermonprez et al., 
2002). 
There are two classes of MHC molecule. Antigens presented via MHC class-I 
molecules usually derive from the cytosol, this mechanism of activation 
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principally targets intracellular infection or malignant cells by direct cell killing 
(Théry and Amigorena, 2001, Germain, 1994). 
Antigens obtained though endocytic pathways are presented in association with 
MHC class-II molecules (ten Broeke et al., 2013). When DCs mature, transfer 
of peptide-loaded MCH-II to the cell membrane is increased. This leads to an 
accumulation of MHC-II on the cell surface, thus enhancing antigen 
presentation for the successful activation of naïve T cells (Cella et al., 1997a, 
de Saint-Vis et al.). 
Migration 
Increased expression of the chemokine receptor CCR7 promotes DC migration 
to lymphoid organs. Cell migration is directed by gradients of the chemokines 
CCL21 and CCL19, which are expressed by the lymphatic endothelium. 
Co-stimulation 
Mature DCs also express high levels of cell-surface co-stimulatory molecules, 
CD80, CD83, CD86 and CD40, and inflammatory cytokines, TNF-α and IL-
12, which are essential for T cell activation (Flores-Romo, 2001). 
DC maturation depends on the extent of the inflammatory response in the 
native tissue. DCs which are not fully mature lack the full complement of co-
stimulatory molecules, and are therefore unable to activate T cells efficiently. 
Semi-mature DCs are associated with the maintenance of peripheral tolerance 
through the induction of regulatory T cells, T cell anergy or apoptosis (Moser, 
2003). 
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Dendritic Cells in Contact Allergy 
Inappropriate induction of adaptive immunity by non-pathogenic or host-
derived products can result in devastating pathology, such as allergy or 
autoimmune disease. This is exemplified by the development of a severe 
allergic condition, known as allergic contact dermatitis (ACD), which occurs as 
a result of repeated skin contact with certain organic chemicals, or metal ions. 
ACD, or contact hypersensitivity (CHS), is typical of a delayed type IV 
hypersensitivity response. As depicted in Figure 2, this develops via a well-
defined series of events. The first time the sensitiser comes into contact with 
the skin, the induction phase is initiated, this culminates in the acquisition of 
specific immune sensitisation. Subsequent exposures to the same sensitising 
agent elicit cell-mediated immune responses, resulting in severe dermatological 
inflammation at the site of contact (Vocanson et al., 2009). 
The development of ACD depends on the relay of immunogenic sensitiser-
modified peptides from the skin, to T cells residing within draining lymph 
nodes, by dendritic cells. An appreciation of the mechanisms involved is useful 
in order to understand the role of DCs in this complex immunopathology. 
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Figure 2. Development of Contact Hypersensitivity. 
Induction phase: 1) Sensitiser penetration of the stratum corneum. 2) Activation of stress and 
innate immune responses in the skin. 3) Peptide haptenisation by sensitiser. 4) Dendritic cell 
activation and sensitiser-modified peptide processing. 5) Dendritic cell migration and T cell 
activation within lymph nodes. Elicitation phase: 6) Repeated chemical exposure. 7) Rapid T 
cell-mediated response directed to skin, resulting in severe inflammation and eczematous 
lesions. (Vocanson et al., 2009). 
Key Tissues and Events in the Induction of Contact 
Hypersensitivity 
The skin 
The skin is the first hurdle for chemical sensitisers to overcome in the 
induction of CHS. The outer protective keratinous layer, the stratum corneum, 
provides a physical barrier to entry of environmental pathogens into the body 
(Menon et al., 2012). Genomic profiling studies have linked weakness in the 
skin barrier function with increased susceptibility to allergic disease, such as 
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ACD (Schnuch et al., 2011, Thyssen et al., 2013). However, the low molecular 
weight of haptens, less than 500 Daltons (Da), generally facilitates their 
penetration despite the integrity of the skin (Bos and Meinardi, 2000). 
The epidermis is largely populated by keratinocytes and resident epidermal 
dendritic cells, known as Langerhans cells. Separated by the basement 
membrane is the dermis, which is home to subsets of dermal DCs. As the first 
cells to encounter environmental insults, keratinocytes are key players in initial 
stress and innate immune responses to sensitisers, for example, through the 
expression of antioxidant response genes, production of pro-inflammatory 
cytokines and recruitment of immune cells (van der Veen, 2011).  
Keratinocytes produce metabolically active enzymes, such as cytochrome P450 
isoenzymes. The metabolic activity of keratinocytes converts certain inert 
chemicals into reactive species able to haptenate peptides. Sensitisers which 
require activation via enzymatic processes are also referred to as pro-haptens 
(Gelardi et al., 2001). 
Formation of sensitiser-modified peptide 
A crucial aspect of CHS reactions is the specificity of the immune response 
towards the sensitising agent.  
Due to the low molecular weight (LMW) and polarity of chemical sensitisers, 
they cannot elicit an immune response unless associated with a carrier 
molecule, usually a peptide. In the field of Immunology, such agents are 
classed as haptens (half antigens) (Martin, 2004). 
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Haptenisation, which was first postulated by Landsteiner and Jacobs in 1935, 
describes the hapten-peptide reaction which gives rise to an immunologically 
recognisable complex. It is widely accepted that the interaction between 
sensitiser and host peptide is the principle mechanism by which immunogenic 
products are formed (Aptula et al., 2007). The generation of sensitiser-specific 
determinants is fundamental to immune sensitisation. 
Activation of Innate Immunity 
The inherently reactive nature of chemical sensitisers causes them to act as 
adjuvants through the oxidative damage and cell stress they cause in the skin. 
This results in the production of DAMPs, which activate the innate immune 
system by acting as ligands for PRRs (Kaplan et al., 2012, Sloane et al., 2010). 
Two groups of PRRs, Toll-like receptors (TLR) and NOD-like receptors 
(NLR) have been implicated in the progression of sensitisation (Martin et al., 
2008, Watanabe et al., 2008). Current research is beginning to elucidate the 
mechanisms by which sensitiser-induced DAMP production activates innate 
immunity. TLR activation by LMW hyaluronic acid (HA) has been 
demonstrated to occur as a consequence of sensitiser-dependent ROS 
production (Esser et al., 2012). Also, nickel ions (Ni
2+
), which are well-known 
contact sensitisers, are able to directly bind TLR4 in humans to activate the 
innate immune system. This mechanism could not be identified using animal 
models, as murine TLR4 lacks two histidine residues which define the binding 
site for Ni
2+
 in the human receptor (Schmidt et al., 2010). 
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Oxidative stress experienced by the skin-resident cells, DCs and keratinocytes, 
caused by the application of contact sensitisers is evident by the up-regulation 
of antioxidant response genes (van der Veen, 2011). The central players in the 
oxidative stress response are the members of the nuclear factor-κB (NF-κB) 
family of transcription factors (Morgan and Liu, 2011).  
NF-κB proteins exist as homo- or heterodimers which bind a 10-base pair κB 
site within a promoter/enhancer sequence for a specific gene. Within the 
cytoplasm, NF-κB dimers form a complex with Inhibitor of κB (IκB) proteins; 
IκB proteins inhibit the transcriptional activity of NF-κB by blocking the DNA 
binding site. Upon stimulation of pro-inflammatory receptors, IκB is 
phosphorylated by IκB kinase (IKK) which targets it for proteasomal 
degradation. As a result, the NF-κB dimer is released and translocates to the 
nucleus where it regulates the expression of its associated genes (Hayden and 
Ghosh, 2008, Vallabhapurapu and Karin, 2009). 
In the context of excessive ROS, caused by contact sensitiser exposure, NF-κB 
modulates the amount of ROS by inducing the expression of antioxidant genes. 
This ultimately reduces the ROS concentration and promotes cell survival 
(Morgan and Liu, 2011). 
An additional mechanism for the transcriptional regulation of antioxidant genes 
is the Keap1-Nrf2 pathway; under steady state conditions, Keap1 (Kelch-like 
ECH-associated protein) complexes with Nrf2 (nuclear factor erythroid 2–
related factor 2). Oxidative stress causes Nrf2 to dissociate and translocate to 
the nucleus, where it acts as a transcription factor for genes with antioxidant 
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response elements (ARE) in their promoter (Natsch, 2010, Natsch and Emter, 
2008). 
Activation of the innate immune system causes inflammation of the affected 
tissue and induction of dendritic cell maturation. The inflammatory setting 
experienced by DCs in the local tissue environment is important in determining 
the extent of the T cell response (Tuschl et al., 2000, Reiser and Schneeberger, 
1996). 
Induction of Specific Immunity 
Dendritic cells are the link to the elicitation of the sensitiser-specific cell 
response. They present skin-derived haptenated peptides to naïve T cells within 
draining lymph nodes (LNs) (Vocanson et al., 2009, Xu et al., 1996). There is 
evidence for the contribution of several DC subsets in the development of 
ACD. Untangling their roles is complex and made difficult by the limitations 
of experimental models of DC depletion. However, it is likely that both skin-
resident DCs, such as Langerhans cells, and peripherally-recruited moDCs play 
a role in T cell priming (Vocanson et al., 2009, Honda et al., 2010, 
Noordegraaf et al., 2010). 
CHS is governed by a cell-mediated adaptive immune response, which means 
T cells have a key role in determining the pathology of this condition. 
Therefore, T cell priming by DCs in the LN is arguably one of the most 
important events in the induction of chemical sensitisation. Recognition of 
cognate antigen through the antigen presenting function of DCs results in T cell 
activation and clonal expansion. 
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Sensitiser-primed T cells subsequently migrate from LNs and circulate 
peripheral and lymphoid tissues. Upon re-exposure to the sensitiser, effector T 
cells exert a cytotoxic response at the site of chemical contact. This reaction 
constitutes the elicitation phase, which presents as severe dermatological 
inflammation (Vocanson et al., 2009). 
1.3. Lymph Nodes are Specialised to 
Choreograph Interactions Between 
Dendritic Cells and T Cells 
Secondary lymphoid organs, including lymph nodes (LNs), are essential for the 
orchestration of adaptive immunity. They provide sites for the coordination of 
immune cells, antigen and inflammatory signals. This increases the efficiency 
of immune responses, as lymphocytes do not have to navigate the entire 
periphery to encounter their antigen. 
Lymph nodes contain a wealth of information with regards to the 
immunological status of peripheral tissues. Following exposure to pathogen or 
chemical sensitiser, lymph fluid brings antigen-loaded DCs, free antigen and 
inflammatory cytokines, to LNs via the lymphatic system (Randolph et al., 
2005). Lymph fluid is transported to LNs by afferent vessels and then driven 
through sinuses which extend through the organ. It is subsequently drained by 
the efferent vessel. 
The circulatory system is closely associated with LNs, which provides a point 
for naïve T cell entry. As an artery penetrates the LN, it differentiates into a 
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high endothelial vessel (HEV). The squamous endothelium and expression of 
specific cell-surface markers promotes the migration of lymphocytes from the 
blood into the LN through a defined multi-step adhesion cascade (von Andrian 
and Mempel, 2003). In this process, lymphocytes initially become loosely 
tethered to the wall of the HEV through L-selectin and the endothelial-
expressed L-selectin ligand, PNAD. They roll slowly until integrin leukocyte 
function-associated antigen 1 (LFA 1) interacts with intercellular adhesion 
molecules (ICAM) 1 and 2 to mediate their arrest. This is dependent on 
integrin activation by the constitutively expressed endothelial CC-chemokine 
ligand 21 (CCL21) binding CC-chemokine receptor 7 (CCR7) on T cells. 
Subsequently, T cells are able to transmigrate through the wall of the HEV into 
the LN. 
Lymph nodes have three functionally distinct compartments reflected by the 
cellular constituents of each, as illustrated in Figure 3 (Willard-Mack, 2006). 
The cortex is largely populated by B cells and follicular DCs providing a well-
adapted environment for the mediation of humoral immunity. The paracortex, 
or ‘T cell zone’, located beneath the cortex, is populated by T cells and DCs 
and is the centre for T cell priming. The medulla is understood to be a zone for 
plasma cell proliferation and differentiation, thereby contributing to antibody 
production (Harry L. Ioachim, 2009). 
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Figure 3. The Lymph Node. 
The lymph node structure is well-adapted to its function in facilitating efficient immune 
responses. Schematic re-annotated and adapted from Janeway’s Immunobiology 7th Ed. 
(Murphy et al., 2008) 
The architectural features of the paracortex create an ideal microenvironment 
for T cell priming. The ECM of the paracortex is a 3-dimensional (3D) network 
of collagen fibres. This is covered by T cell zone fibroblastic reticular cells 
(TRCs) which express ligands, such as fibronectin and podoplanin (gp38), to 
direct the migration of T cells and DCs (Stranford and Ruddle, 2012, Gretz et 
al., 1997). 
Homing of naïve T cells and DCs to the paracortical area is crucially mediated 
by the TRC- expressed chemokines, CCL21 and CCL19, for which DCs and T 
cells express the receptor, CCR7. 
The TRC-lined collagen fibres are proposed to have an internal space, called a 
conduit. This provides a structure for the selective movement of lymph fluid 
carrying DCs and soluble factors from the sinuses into the paracortex. 
Therefore, TRCs do not only provide structural support, but also direct cellular 
organisation and interactions within the paracortex. 
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The paracortex can be broken down into functional units, named paracortical 
cords, depicted in Figure 4  (Gretz et al., 1997). These microchannel structures 
can be visualised as a set of spiralling, incomplete rings centred on an HEV. T 
cells move out from the HEV, following corridors formed by collagen fibres. 
The corridors have a diameter of 10-25μm and are densely packed with T cells 
and immobilised DCs. 
 
Figure 4. The Paracortical Cord. 
Cross-section of the paracortical cord. Centred on an HEV, T lymphocytes move across the 
perivenular channel, then through spiralling corridors lined with TRCs, where interactions with 
DCs occur. DCs and soluble factors from the sinus are transported into the paracortex via 
conduits. (Katakai et al., 2004, Gretz et al., 1997) 
1.4. Extra-cellular Influences on Dendritic Cells 
In vitro study of DC biology has provided valuable insights into their role as 
professional APCs in terms of DC responses to pathogen extracts, chemical 
sensitisers and interactions with T cells. However, the limitations of such 
studies are becoming increasingly apparent due to the artificial nature of 
conventional in vitro cell culture. 
In vivo, the surrounding environmental conditions can significantly influence 
DC function. Factors including, the extracellular matrix (ECM), 3D 
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environment and mechanical stimuli can have profound effects on DC survival, 
maturation and capability to elicit T cell activation (Garcia-Nieto et al., 2010, 
Gunzer et al., 2004, Lewis et al., 2013, Miteva et al., 2010, Swartz et al., 2008). 
Recent research is beginning to elucidate the influence of ECM components on 
phenotypic and functional characteristics of DCs in vitro. Garcia-Nieto et al. 
showed that moDCs cultured in the presence of the ECM components, laminin 
or fibronectin, maintained a more immature cell phenotype, including 
enhanced endocytic activity, compared to a bovine serum albumin control. This 
work went on to demonstrate that moDCs were responsive to immunological 
stimulation and able to induce T cell activation with high efficiency in the 
presence of ECM (Garcia-Nieto et al., 2010). 
The influence of the highly abundant ECM protein, collagen, on DC 
maturation has been the subject of in vitro investigation. However, the results 
from the work in this area are conflicting. In a recent study, human collagen 
types I and II were shown to provide an activating signal to DCs as ligands for 
the FcRgamma-associated receptor, osteoclast-associated receptor (OSCAR). 
Collagen-induced DC maturation was demonstrated by increased production of 
inflammatory cytokines, up-regulation of maturation markers and efficient 
elicitation of T cell proliferation (Schultz et al., 2015). In contrast, it had 
previously been demonstrated that type I collagen from porcine, bovine and 
human sources did not induce DC maturation, based on cell-surface expression 
of maturation markers and TNF-α secretion (Bayrak et al., 2013). This may 
illustrate the variability in the immunogenicity between different sources of 
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collagen depending on method of purification, species of origin and collagen 
type. 
The DC-ECM interaction is crucial for their capacity to migrate to LNs. The 
integrins (VLA-4 and VLA-5) were identified for the adhesion of DCs to the 
ECM component, fibronectin, and are likely to be involved in the complex 
molecular mechanisms of DC trafficking in vivo (D'Amico et al., 1998). 
The 3D structural framework formed by the ECM in the LN is important in 
DC-T cell interactions. It provides a network which promotes T cell crawling, 
allowing dynamic antigen presentation which is likely to be more 
representative of the events leading to T cell activation in vivo (Gunzer et al., 
2000). T cells are likely to experience cues from the ECM, simultaneously to 
those from DCs, which contribute to their activation. 
In addition to the cues imparted by the ECM, other extracellular biophysical 
factors have been found to impact DC function and APC-induced T cell 
activation (Lewis et al., 2013, Tomei et al., 2009, Li et al., 2010, Previtera, 
2014). Physiological stress induced by shear flow is particularly relevant, since 
DCs are exposed to the effects of flow as they travel in the lymphatics and by 
slow interstitial flow through non-lymphoid and lymphoid tissues. In vivo, flow 
promotes DC migration towards the lymphatics through changes in the 
expression of adhesion molecules on the lymphatic endothelium and it also 
likely physically directs DC movement towards LNs (Swartz et al., 2008). 
Finally, Li et al. demonstrated that shear flow triggered the activation of T cells 
bound to artificial APCs (Li et al., 2010). 
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1.5. Applying Tissue Engineering to Safety 
Testing 
Animal models and in vitro cell-based assays are currently the most widely 
used and well-recognised methods for safety testing in industry. 
Animal models provide a physiologically relevant system to assess multiple 
safety parameters, such as toxicity, reproductive toxicity, carcinogenicity and 
hypersensitivity. Despite this, they are sometimes limited in terms of 
translation to humans due to fundamental biological differences. This was 
demonstrated by the 2006 TeGenero clinical trial, where the administration of 
TGN1412, a CD28 superagonist monoclonal antibody, caused a life-
threatening ‘cytokine storm’ in human volunteers (Goodyear, 2006). Pre-
clinical data, generated from non-human primate (NHP) models, failed to 
predict this (Stebbings et al., 2009). Differences in the pattern of expression of 
the target molecule on effector cells of the immune systems of the two species 
accounted for the disastrous translation from NHP to humans in this trial 
(Eastwood et al., 2010). 
In vitro immune cell assays are useful tools for research and safety testing 
since they: 
1. Use cells derived from human tissues, therefore issues relating to translation 
of animal to human immunology can be overcome. 
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2. Provide a defined environment to enable the study of specific biological 
pathways. 
3. Are amenable to high throughput screening, allowing thousands of 
pathogen\allergen extracts, drugs or chemicals to be assessed, saving time and 
costs compared to animal testing. 
The simplicity of such assays is not always an advantage since they cannot 
capture the complexity of biological mechanisms and extra-cellular factors that 
occur in whole tissues. In vitro monolayer, or two-dimensional (2D), culture 
often results in cells losing their native tissue phenotype and therefore do not 
have the same functionality as in vivo counterparts, which limits them for 
certain applications (Gomez-Lechon et al., 1998). 
An emerging solution to reconcile the limitations associated with the artificial 
nature of conventional in vitro cell culture methods lies in tissue engineering. 
Tissue engineering aims to recapitulate the structure and function of living 
tissues. The field has made significant advances, with the main focus being on 
clinical applications to replace, repair or enhance damaged tissues. 
It has been recognised that artificial tissues with biological function also have a 
place outside of the clinic. This has already been demonstrated through the 
development of a range of artificial tissue models including skin, liver and 
lungs, with potential applications in drug and chemical safety testing 
(Kandarova et al., 2005, Chang et al., 2010, Harrington et al., 2014). 
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Increasing attention is being given to the development of artificial tissue 
models which simulate immunological events, such as lymph nodes (Cupedo et 
al., 2012). Progress has been relatively slow in this area, perhaps due to the 
complexity of the immune system. However, studies have been published to 
demonstrate proof of concept of artificial immune-competent systems. 
Giese et al. described an approach for the construction of an artificial lymph 
node (aLN) model. It was centred on a 3D matrix-assisted culture of DCs in a 
bioreactor system which was perfused with lymphocytes (Giese et al., 2006). 
The immunological capabilities of the model were investigated by antigenic 
stimulation with human cytomegalovirus lysate and a commercially available 
Hepatitis A vaccine, HavrixTM (GSK) (Giese et al., 2010). The longevity and 
immune reactivity of the model was supported by the evaluation of cytokine 
production, including IL-2, IL-4, IL-5, IL-6, IL-10, IL-1β, interferon-gamma 
(IFN-γ) and tumour necrosis factor-alpha (TNF-α). 
Methods for Predicting Chemical Sensitisation 
Allergic conditions which manifest as a result of exposure to chemical products 
is a growing public health concern. Repeated skin contact with certain organic 
chemicals, or metal ions, can lead to the development of a severe allergic 
condition, known as allergic contact dermatitis (ACD). 
A recent epidemiological review estimated the prevalence of chemical contact 
allergy to be around 20% for Western European and North American 
populations (Thyssen et al., 2007). The occurrence of ACD is not significantly 
affected by age, genetic background or geographical location, thus it affects a 
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wide range of individuals, including young children. In the work place, ACD 
accounts for 70-90% of reported occupational skin disease. It carries a heavy 
financial burden in terms of loss of productivity and medical costs (Peiser et 
al., 2012). 
ACD is highly distressing for patients and treatment is only symptomatic. It 
can also be debilitating, since avoidance of the chemical involved is the only 
option for preventing reoccurrence of the condition. This may require drastic 
changes to occupation and lifestyle. Therefore, methods to predict the potential 
of chemicals to induce sensitisation are essential to prevent the occurrence of 
adverse immune reactions. 
Animal Safety Testing – The ‘gold standard’ 
Historically, the principle chemical safety tests recognised by regulatory bodies 
for the prediction of sensitisation have been based on animal models. The first 
test methods approved in the Organisation for Economic Co-operation and 
Development (OECD) guidelines for the evaluation of chemical sensitisation 
included the guinea pig maximisation test (GPMT) and Buehler’s occluded 
patch test (Botham et al., 1991). In these tests, animals are subject to an initial 
chemical exposure. After 10-14 days, they are re-challenged and quantification 
of sensitisation is based on the resultant skin reaction. 
In the last decade, the murine local lymph node assay (LLNA) has taken 
precedence over the guinea pig tests (GPTs). The LLNA was accepted as the 
first standalone test for the prediction of chemical sensitisation following 
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evaluation by the Interagency Coordinating Committee on the Validation of 
Alternative Methods (ICCVAM). 
In contrast to the GPTs, the LLNA assesses immune activation during the 
induction phase of sensitisation at a cellular level. This is done by measuring 
the magnitude of T cell proliferation in the LN following chemical exposure. 
Briefly, the chemical is applied behind the ears of the mice. Five days later, 
mice are injected with a radioactive tracer which labels proliferating T cells. 
The mice are euthanized and LNs are excised to harvest the LN-resident cells. 
The magnitude of the proliferative T cell response is measured by the level of 
radioactivity detected (Kimber et al., 2002). 
The LLNA also has the capability to establish a chemical’s sensitising potency. 
This is the dose which produces a certain level of response sufficient for the 
acquisition of skin sensitisation. The potency value commonly derived from 
the LLNA is the EC3, this is the concentration required to cause a 3-fold 
increase in T cell proliferation compared to un-treated animals (Kimber et al., 
2002). This feature gives the LLNA added value over GPTs and current non-
animal alternatives. 
At the time of implementation, the LLNA fulfilled regulatory, animal welfare 
and scientific requirements more satisfactorily than the GPT methods. 
Although the LLNA is sufficient for the assessment of the safety of most 
chemicals, there remain some discrepancies. The occurrence of false-positives 
to the non-sensitising irritant sodium lauryl sulphate (SLS) and the failure to 
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detect responses to Ni
2+
, a prevalent human contact allergen, limits the 
reliability of the assay (Kimber et al., 2002). 
Routine use of the LLNA in industry continues to raise ethical concerns 
regarding the welfare of animals used in research. This is in accordance with 
the long-running 3Rs campaign; advocating the Replacement, Reduction and 
Refinement of animals in research for the improvement of animal welfare 
(Mehling et al., 2012). 
Recent legislation has also put pressure on finding alternatives to animals for 
chemical safety testing. For instance, the 7th Amendment to the European 
Union Cosmetics Directive recently banned the testing of cosmetic products on 
animals. Also, testing for human hazardous effects of chemicals, produced or 
imported within the European Union at quantities greater than 1 ton per year, is 
now required according to the Registration, Evaluation, Authorisation and 
Restriction of Chemicals (REACH) guidelines. 
Animal models have proved to be useful tools for chemical safety testing and 
given some insight into the molecular and cellular basis of CHS. However, in 
the light of the ethical, scientific and regulatory limitations associated with 
animal testing, validated non-animal tests for the identification of chemical 
sensitisers are now highly sought after. 
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Non-Animal Alternatives: State of the Art 
A wealth of funding has been put into research and development of alternative 
tests (Aeby et al., 2010). Some of the key methods currently being developed 
to replace animal testing are summarised in Table 1. 
For the development of alternative methods, the immunological mechanisms 
involved in the development of CHS have been put into an adverse outcome 
pathway (AOP) framework (OECD, 2012). Assessing the performance of a 
chemical at each step in the AOP is important for determining sensitising 
potential using non-animal methods. 
The main requirements of alternative tests are the reliability and accuracy of 
predicting chemical sensitisation in humans. This includes ascertaining the 
relative sensitising potency of a chemical to allow the classification of 
sensitisers into strong, moderate and weak categories. This is likely to become 
a critical aspect of the modern risk assessment for the characterisation of 
sensitisers, according to an amendment in the regulations for the Globally 
Harmonized System of Classification and Labelling (GHS). 
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Table 1. Summary of Alternative Methods for the Prediction of Chemical Sensitisation. 
Method Summary 
 
Step in the development of CHS 
(refer to Figure 2 in this chapter) 
In vitro cell assays 
Keratinocytes  KeratinoSens 
 
Up-regulation of anti-oxidant response genes. 
(Andreas et al., 2011) 
Stress & innate immune responses 
 
NCTC 2544 IL-18 test 
 
Increase in IL-18 production. (Corsini et al., 2013) 
Dendritic Cells  human-Cell Line Activation Test (h-CLAT) \ monocyte-derived DCs 
(PBMDC) 
 
Up-regulation of CD86 or CD54 expression. 
(Nukada et al., 2012, Tuschl et al., 2000) 
 
Genomic Allergen Rapid Detection (GARD) 
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Transcriptional profiling MUTZ-3 metabolic, cell cycling and oxidative 
stress responses.(Albrekt et al., 2014) 
Dendritic cell - keratinocyte co-culture 
 
Up-regulation of DC markers CD86 and CD54. 
(Cao et al., 2012) 
Artificial skin  Sens-IS 
 
Keratinocyte activation. (Cottrez, 2011) 
 
3D artificial skin with DC co-culture. 
 
DC migration, CD86\CD54 expression and cytokine production. (Uchino 
et al., 2009, Chau et al., 2013) 
T cells  Human T cell priming assay. 
 
T cell proliferation and IFN-γ production. (Richter et al., 2012) 
 
 
Specific immune response 
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Chemistry 
Cell-free Direct Peptide Reactivity Assay (DPRA)\ Peroxidase Peptide Reactivity Assay 
(PPRA) 
Peptide depletion. (Gerberick et al., 2004, Gerberick et al., 2009) 
 
 
Chemical reactivity 
Computational modelling 
Cell-free Quantitative-Structure Activity Relationship models 
Databases of chemical information and data generated from in vivo 
sensitisation models.  
(Golla et al., 2009). 
 
Expert Systems 
Correlation of chemical structure with peptide haptenation associated with 
sensitisation.  
(Patlewicz et al., 2007) 
 
Chemical reactivity\biological activity 
relationship 
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In vitro cell assays 
Keratinocytes 
Induction of oxidative stress response gene expression by sensitisers, through 
the Keap1-Nrf2-ARE regulatory pathway, has been exploited to develop a 
keratinocyte reporter cell line. Natsch et al. generated an assay using the human 
keratinocyte cell line, HaCaT, with the stable insertion of a luciferase reporter 
construct under the transcriptional control of the ARE-element of a sensitiser-
inducible human gene. Evaluation of luciferase expression and cytotoxicity is 
performed to assess sensitisation potential. This tool is more widely known as 
the KeratinoSens assay (Natsch and Emter, 2008). An inter-laboratory study to 
test the ability of the KeratinoSens assay to predict skin sensitisers indicated a 
high level of reproducibility, accurate for 26 out of the 28 chemicals tested 
(Andreas et al., 2011). 
The up-regulation of IL-18, associated with exposure to sensitisers, has been 
utilised in a keratinocyte assay by Corsini et al. The keratinocyte cell line, 
NCTC2544, showed a specific, dose-dependent increase in intracellular IL-18 
to skin sensitising chemicals, in comparison to respiratory sensitisers and non-
sensitisers (Corsini et al., 2009). 
Dendritic Cells 
DCs have a central role in sensitiser-specific T cell activation. Therefore, they 
have been the focus in the development of many assays for the identification of 
sensitisers. 
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The induction of DC maturation by sensitisers provides a useful target for the 
development of alternative tests. The human cell line activation test (h-CLAT) 
was developed using a human monocytic leukemia cell line, THP-1. The 
expression of DC maturation markers, CD86 and CD54, are measured 
following exposure to the test substance. Evaluation of the h-CLAT for 
predicting chemical sensitisers highlighted the promise of this test, as it was 
found to have an accuracy of 84% against the LLNA (Nukada et al., 2012). 
In addition to the DC-like cell line assays, there is also a PBMDC (peripheral 
blood mononuclear DC) assay. Here, sensitisers can be identified based on the 
increased expression of CD86 (Reuter et al., 2011) 
A genomic biomarker signature of 200 genes for the human myeloid leukemia-
derived cell line, MUTZ-3, has recently been described for the identification of 
sensitisers. The Genomic Allergen Rapid Detection (GARD) assay revealed 
changes in the regulation of pathways associated with cell cycle, oxidative 
stress, metabolism and biosynthesis which correlated with sensitiser treatment 
(Albrekt et al., 2014, Johansson et al., 2013). 
The biological relevance of co-culturing DCs with keratinocytes has also been 
considered. The metabolic capacity of keratinocytes is likely to give such 
assays an advantage, particularly for the detection of pro-haptens. Co-cultures 
have shown potential for increased sensitivity over mono-cultures for 
identifying contact sensitisers based on markers of DC maturation (Wanner and 
Schreiner, 2008, Cao et al., 2012). 
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Dendritic cell-T cell co-culture 
The sensitiser-specific T cell response holds great value for the development of 
in vitro tests which predict sensitisation, since it ultimately determines the 
elicitation of ACD (Kimber et al., 2012). This is reflected in the LLNA, where 
the proliferative T cell response accurately predicts sensitisation. 
This aspect of sensitisation is vastly outweighed by the focus on innate 
responses to sensitisers. However, the importance of the sensitiser-specific DC-
T cell interaction is gaining more appreciation. This is evident from the focus 
on the development of the Human T cell priming assay (hTCPA), a co-culture 
of naïve T cells, sensitiser-pulsed monocyte derived DCs (moDC) and a feeder 
cell line with the addition of co-stimulatory signals (Richter et al., 2012). 
Successful T cell priming is measured by flow cytometry to determine 
sensitiser-specific T cell frequency and cytokine production. 
Artificial Skin 
The surface area of the skin exposed to the sensitising chemical, rather than the 
absolute concentration applied, appears to be the more important factor in 
determining sensitisation (Kimber et al., 2001). Conventional in vitro cell 
assays do not have the capacity to measure this element of skin sensitisation. 
This has been addressed through the construction of 3D human epidermal 
tissue models. The Sens-IS method exposes a 3D artificial epidermal tissue 
(EpiSkin) to test substances to address cytotoxicity and activation of 
keratinocytes based on the induction of antioxidant gene expression (Cottrez, 
2011). 
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Other models have the advantage of the incorporation of DCs. An immune-
competent 3D human skin model was developed by Chau et al. which was 
shown to be responsive to the strong sensitiser 2,4-Dinitrochlorobenzene 
(DNCB), based on DC movement towards the bottom layer of the construct 
(Chau et al., 2013). Another artificial 3D skin construct (VG-KDF-Skin) 
showed evidence of sensitiser-specific up-regulation of CD86 expression and 
cytokine release by DCs (Uchino et al., 2009). 
Cell-Free Methods 
Chemical Reactivity Assays 
Contact allergens, or haptens, have unique properties which allow them to react 
with peptides to produce immunogenic epitopes. As a result, there has been 
interest in measuring this interaction for the prediction of sensitisation. This led 
to the development of the direct peptide reactivity assay (DPRA), and the 
peroxidase peptide reactivity assay (PPRA) (Gerberick et al., 2004, Gerberick 
et al., 2009). Both measure chemical reactivity based on the depletion of 
synthetic model peptides containing a lysine or cysteine residue. However, the 
PPRA may be better at predicting pro and pre-haptens due to the incubation 
step with horseradish peroxidase, or hydrogen peroxide. 
Computer Modelling 
Finally, computational models have been developed, including Quantitative 
Structure Activity Relationship (QSAR) models, and expert systems to identify 
sensitising chemicals. These methods integrate sensitisation data from animal 
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models and sensitiser chemistry with algorithms to predict the reactivity and 
biological activity of a chemical entity in vivo (Golla et al., 2009). 
Perspective on Alternative Methods 
Alternative methods necessitate the breakdown of the complex process of skin 
sensitisation into isolated components. Taking these steps out of context in an 
experimental setting is not necessarily predictive of a chemical’s sensitising 
potential. Therefore no single alternative method can be used as a standalone 
test for predicting sensitisation. This has resulted in the development of 
integrated test strategies (ITS), whereby panels of alternative tests are 
implemented to cover the spectrum of events which lead to sensitisation 
(Sharma et al., 2011). 
Promising progress has been made in the field, with the h-CLAT and DPRA 
being entered into pre-validation studies by the European Centre for the 
Validation of Alternative Methods (ECVAM). However, the majority of 
alternative tests currently focus on the immediate stress and innate cell 
responses to sensitisers. Looking forward, a validated assay which indicates 
sensitisation based on the outcome of DC-T cell interactions is required to 
complete the picture in ITS. 
The artificial nature of alternative methods cannot be overlooked. The skin 
tissue models overcome this to some extent by the co-culture of multiple cell 
types in a 3D setting. However, conventional in vitro methods make it difficult 
to capture the complexity of the in vivo conditions during sensitisation. 
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The application of tissue engineered constructs, such as artificial skin and 
aLNs, to model immune cell responses shows great promise. The development 
of tools for the prediction of sensitisation is one area which could benefit from 
such an approach. It is anticipated that a biologically relevant in vitro platform 
for DCs and DC-T cell co-cultures would produce more realistic cell responses 
to sensitisers, thus enhancing the accuracy in predicting sensitisation. This 
system would also have potential applications in, but not limited to, 
immunology research, vaccine development and drug discovery. 
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1.6. Thesis plan 
The overall aim of the research presented in this thesis was to investigate the 
influence of the extra-cellular environment on human immune cells. 
Biomimetic platforms were used to simulate biologically relevant features of 
the in vivo microenvironment, including ECM and shear flow. The immune 
response generated on these platforms was compared to that elicited under 
conventional cell culture conditions.   
Chapter 2 describes the characterisation of synthetic and naturally-derived 
biomaterials to develop an ECM platform for immune cell culture. Chapter 3 
describes the construction of fluidic systems and characterisation of a fluidic 
platform for immune cell culture. Chapters 4 and 5 examine the application of 
the ECM and fluidic platforms for investigating the influence of the extra-
cellular environment on specific immune responses. An overview of the aims 
for each chapter is given here and these are reiterated at the start of each 
chapter. 
The aim of the work described in Chapter 2 was to investigate how human 
immune cells interacted with the candidate biomaterials including a colloidal 
gel, electrospun scaffolds, GelMA and collagen hydrogels. This was done by 
assessing immune cell viability, phenotype and response to immunological 
stimuli when cultured in the presence of the biomaterials.  
In Chapter 3, the aim of the work was to develop a fluidic cell culture 
platform in order to investigate the effect of shear flow on immune responses. 
This was achieved by first developing a robust fluidic system. Then, the fluidic 
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platform was utilised to characterise the effect of shear flow on immune cells 
based on human dendritic cell viability, maturation and response to 
immunological stimulation. 
The aim of Chapter 4 was to investigate the influence of the extracellular 
environment on antigen-specific dendritic cell interactions with T cells by 
using the ECM and fluidic platforms previously characterised in Chapters 2 
and 3 of this thesis. This was done by comparing the antigen-specific T cell 
response induced on the biomimetic platforms with that generated under 
conventional cell culture conditions. 
The aim of the work described in Chapter 5 was to study the effect of the 
ECM on immune responses to chemical sensitisers. Using the ECM platform, 
dendritic cell maturation and T cell activation in response to chemical 
sensitisers was compared with a conventional cell culture method. 
Chapter 6 summarises the results of the research conducted and provides a 
conclusion for this thesis. 
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Chapter 2 
Characterisation of the Immune-
Compatibility of Biomaterials 
2.1. Introduction 
Chapter Overview 
Biomaterials can be distinguished from other materials in terms of their ability 
to ‘exist in contact with tissues of the body without causing an unacceptable 
degree of harm…’ (Williams, 2008). 
The field of biomaterials has advanced significantly in the last 50 years. This 
has made a great contribution to tissue engineering in terms of allowing the 
fabrication of increasingly complex constructs for transplantation in vivo, in 
addition to research and safety testing in vitro (Place et al., 2009, Cosson et al., 
2015). 
It is recognised that when cultured as a monolayer, i.e. in two-dimensions (2D), 
cells often lose their native tissue phenotype. This limits traditional biological 
assays in terms of their physiological relevance. For example, in hepatocyte 
drug toxicity assays, monolayer cultures rapidly become undifferentiated and 
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lose their drug metabolising activity. This impairs the predictive power of the 
assay, thus many drug candidates fail (Gomez-Lechon et al., 1998). 
In vivo, cells reside within a densely populated, extracellular matrix (ECM). 
This three-dimensional (3D) network provides cellular, biochemical and 
mechanical cues which direct cell functions, such as apoptosis, differentiation 
and migration (Kleinman et al., 2003). Tissue engineers use biomaterials to 
recapitulate the natural microenvironment in order to maintain physiologically 
relevant cell differentiation and function in vitro (Pampaloni et al., 2007). 
Biomaterials may consist of natural or synthetic material, or combinations of 
both. The inherent nature of the biomaterial, along with the fabrication method 
and further (chemical) modifications, determines its suitability for applications 
in tissue engineering.  
Biomaterial selection depends on the requirements of the bioengineered 
construct. Factors including mechanical strength, degradability, micro-, or 
nano-architecture and biological activity influence the choice of biomaterial 
(Lee et al., 2014, Chan and Leong, 2008, Dhandayuthapani, 2011, Kohane and 
Langer, 2008). 
Assessment of biomaterial ‘biocompatibility’ is usually based on the cellular 
response, including cell viability, phenotype and function. Crucially, the cell-
biomaterial interaction can vary between cell types and tissue locations. 
Therefore, the biocompatibility of biomaterials should be characterised on an 
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individual basis, in terms of the tissue-specific application and desired outcome 
(Williams, 2014). 
This chapter describes the work carried out to characterise, in vitro, the 
suitability of biomaterials for the development of an ECM-supported platform 
for immune cell culture. The candidates for testing were: 
Synthetic 
1. Thermo-responsive particle gel. 
2. PET and PLGA thermo-responsive electrospun scaffolds. 
Semi-Natural 
Gelatin methacryloyl (GelMA) hydrogel. 
Natural 
Collagen hydrogel. 
Immune Responses to Biomaterials 
The importance of understanding how immune cells interact with a biomaterial 
was highlighted over 20 years ago by Remes (Remes and Williams, 1992). 
However, this has only been fully appreciated in the last few years with the 
increasing use of biomaterials for in vivo applications (Johnson et al., 2007). 
Many biomaterials have been extensively studied using well-established cells 
lines and thus termed ‘biocompatible’. However, comprehensive study 
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regarding their interaction with and impact on cells of the immune system is a 
relatively recent focus.  
The foreign body reaction is a well-known physiological phenomenon. It 
describes the natural propensity of immune cells to mount responses against 
foreign bodies, which extends to biomaterials. Briefly, upon recognition of 
foreign material, cells of the immune system, namely monocytes, become 
activated in order to attempt to eradicate it by phagocytosis (Anderson et al., 
2008, Ekdahl et al., 2011). Production of cytokines, including tumour necrosis 
factor (TNF)-α, IL-1β, IL-6 and IL-8 (Gretzer et al., 2003), by activated cells 
are characteristic of this response and mediate inflammation and wound 
healing in vivo (Chang et al., 2008). 
Certain biomaterials have been shown to have profound effects in terms of 
modulating the immune system (Silva et al., 2015, Yoshida and Babensee, 
2004). These properties can be harnessed in areas such as vaccine delivery, 
autoimmune disease and cancer therapeutics to direct appropriate immune 
responses (Swartz et al., 2012). In the development of vaccines, for example, 
adjuvant effects of certain biomaterials can be used to enhance the induction of 
adaptive immune responses, thereby potentially increasing the level of 
protection offered by the vaccine (Lewis et al., 2014). 
On the other hand, for applications where the purpose of the biomaterial is to 
contribute to the biological physiological relevance of the construct, it is not 
desirable for the material to directly affect the immunological status of the 
system, for example when investigating antigen-specific immune responses. 
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Therefore thorough characterisation of biomaterials for specific applications in 
immunology is important. 
Biomaterials for Tissue Engineering 
Synthetic Polymers 
Advances in polymer chemistry have sparked a huge increase in the use of 
synthetic polymeric biomaterials in tissue engineering. Synthetic polymers are 
non-biological materials which can be designed to have properties which make 
them potentially suitable for cell culture (Guo and Ma, 2014, Bajaj et al., 
2014). The advantage of such materials is that they may be functionalised to 
promote cell interactions, for example by the incorporation of ECM-mimic 
peptides (Zhu, 2010). Also, their physical and chemical properties, e.g. 
degradability and stiffness, can be tailored to a specific application (Guo and 
Ma, 2014). Since synthetic polymers generally have well-defined constituents, 
issues related to batch-to-batch variability and immunogenicity are greatly 
reduced (Bajaj et al., 2014, El-Sherbiny and Yacoub, 2013, Hughes et al., 
2010). 
The development of stimuli-responsive synthetic polymers offers further 
flexibility to tissue engineers. Changes in pH, temperature, light and other 
biochemical stimuli can be used to modulate the material properties, e.g. 
hydrophobicity\hydrophilicity, degradability (Hoffman, 2013, Huang et al., 
2011). Such properties are useful for in situ biomaterial assembly and non-
enzymatic cell passage (Al Ghanami et al., 2010, Takahashi et al., 2012). 
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In this work, two formats of synthetic biomaterial were employed, these being 
a particulate gel and electrospun fibrous scaffolds. Both of these types of 
material had thermo-responsive properties which were exploited to enhance 
cell recovery for analysis and downstream applications. 
Thermo-responsive particulate gel 
A new family of thermo-responsive particulate gels are showing promise in the 
field of tissue engineering. These materials have been demonstrated to form 
gels reversibly near human body temperature (37°C), have a porous 3D matrix 
structure and support multiple rounds of cell passage (Wang et al., 2009).  
This technology combines a thermo-responsive polymer, poly(polyethylene 
glycol methacrylate) (usually denoted as PEGMA or pPEGMA), with 
polycaprolactone (PCL) or poly(lactide-glycolide) (PLGA) micro-particles, 
which have hydrophobic surface properties. The structures of these 
components are depicted in Figure 5.  
 
Figure 5. Structures of thermo-responsive pPEGMA (a) and PCL particles (b). 
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A temperature-responsive particulate dispersion is generated by mixing 
pPEGMA and PCL particles. Upon mixing, the thermo-responsive polymer is 
adsorbed onto the surface of the particles, illustrated in Figure 6. At 
temperatures below 37°C, the pPEGMA chains are strongly hydrated and 
extend in aqueous solution to provide a steric barrier to particle aggregation, 
giving rise to a free-flowing suspension. When the temperature is increased to 
37°C, the pPEGMA chains dehydrate and collapse to self-associating globule 
this increases the hydrophobicity of each particle, leading to inter-particle 
aggregation and entrapment of cells within the 3D matrix (Al Ghanami et al., 
2010). 
 
Figure 6. Schematic illustration of temperature-responsive particulate gel matrix 
formation. 
PCL particles and pPEGMA are mixed to generate a colloidal dispersion. Below 37°C 
PEGMA chains are extended causing repulsive interactions between particles. Above 37°C 
PEGMA chains collapse and particles aggregate. Cells are dispersed in a free-flowing particle 
suspension below 37°C.  An increase in temperature, above 37°C, causes particles to form a 
gel which encapsulates the cells within the 3D matrix. 
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Thermo-responsive electrospun scaffolds 
Electrospinning is a popular technique for generating biomaterials for tissue 
culture (Sill and von Recum, 2008). It is applicable to a range of natural and 
synthetic polymers. Electrospun scaffolds are composed of micro-, or nano-
meter sized fibres, which form a mesh-like structure reflective of the 
architecture of some natural tissues (Agarwal et al., 2008). 
Electrospinning can be performed under ambient conditions. Briefly, the 
electrospinning rig comprises 1) a high voltage power supply, 2) a syringe and 
needle, and 3) a grounded collector plate. A high voltage is applied to the 
needle containing the polymer solution (which has been prepared using an 
appropriate solvent). The repulsive forces within the polymer solution 
overcome the surface tension resulting in the expulsion of a jet of polymer 
solution from the needle tip. The charged solution is attracted to the grounded 
collector plate. A whipping motion caused by the instability of the polymer 
stream dries the polymer fibres and creates a fibrous mesh which is deposited 
on the collector plate (Sill and von Recum, 2008).  
For this work, polymers were used which are regulated by the Food and Drug 
Administration (FDA) and regarded as safe, namely, polyethylene terephthalate 
(PET) and poly(lactic-co-glycolic acid) (PLGA). The molecular structures for 
these polymers are shown in Figure 7. It is important to note that PLGA 
degrades over time, the stability and therefore the degradation rate of PLGA 
depends of the ratio of glycol to lactic acid used (Shin et al., 2006). In this 
work, a fresh batch of electrospun PLGA was used in each experiment and was 
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only required to support cell cultures for a maximum of 6 days, therefore 
characterisation of degradation was not necessary. 
 
Figure 7. Molecular structure of A) poly (lactic-co-glycolic acid) (x = number of lactic acid 
units and y = number of glycolic acid units), and B) poly (ethylene terephthalate) (PET), (n = 
the number of repeating units in the PET polymer). Credit for illustration to Afnan Aladdad, 
PhD. 
PET or PLGA were co-spun with the thermo-responsive polymer PEGMA to 
achieve thermo-sensitive electrospun scaffolds. The molecular structure for 
polyPEGMA188 used in this work is depicted in Figure 8. 
 
Figure 8. Molecular structure of Poly (PEGMA188). Credit for schematic to Afnan 
Aladdad, PhD. 
As shown in Figure 9, the PEGMA chains collapse at body temperature and the 
hydrophobicity of the collapsed polymer structure allows protein adsorption 
onto the surface of the fibres. This in turn provides a matrix which facilitates 
cell adhesion.  Upon cooling, the polymer chains open up, causing repulsive 
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forces between the fibres in a hydrated environment, thereby releasing cells 
which are attached to the scaffold. 
 
Figure 9. Schematic representation of thermo-responsive electro-spun scaffolds. 
a) Below 37°C PEGMA chains exist in an extended conformation with repulsive forces acting 
between the fibres resulting in cell release. b) At 37°C, the extended chain structure collapses, 
resulting in attractive interactions between the fibres and facilitating cell attachment to the 
scaffold. 
Naturally-derived Polymers 
Biomaterials are also derived from a range of polymers found in nature. They 
have their own advantages in terms of being biodegradable and biologically 
active. However, they can have immunogenic effects due to their origin and 
their molecular constituents can be difficult to standardise due to variation 
between batches (Tibbitt and Anseth, 2009). 
In this work, two collagen-based hydrogels were investigated. Hydrogels are 
widely used in the field of tissue engineering and regenerative medicine (El-
Sherbiny and Yacoub, 2013). They are an attractive class of biomaterial since 
their highly hydrated, porous structure closely resembles the natural 
extracellular matrix (ECM) of soft tissues (Slaughter et al., 2009). 
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Collagen & Gelatin methacryloyl (GelMA) 
Collagen is a highly abundant natural protein, distributed in the extracellular 
matrix of all animal tissues. It can be isolated from tissue by neutral salt-
solubilisation, acid-solubilisation or pepsin-solubilisation (Mocan et al., 2011). 
Collagen is present in vivo in a variety of forms, including types I, II, III, V and 
XI which form fibres.  
As depicted in Figure 10, the collagen molecule is formed from three α chains. 
The repeating amino acid sequence, -Gly-X-Y- allows the tight assembly of the 
chains to form the collagen molecule. Triple helix collagen molecules go on to 
self-assemble into fibrils (van der Rest and Garrone, 1991, Knupp and Squire, 
2003). 
 
Figure 10. Schematic of collagen molecular structure. 
a) Repeating amino acid sequence, glycine-X-Y, with X and Y usually being proline and 
hydroxyproline. b) The collagen α chain subunit. c) Three α chains intertwine to form the 
characteristic triple helix of the collagen molecule. Diagram modified from Knupp and Squire 
2003. 
Collagen generally possesses properties associated with good biocompatibility. 
This includes features such as cell adhesion motifs. These are specific 
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sequences of amino acids that are recognised by various cell-surface ECM 
receptors, such as integrins (Knight et al., 2000, Parenteau-Bareil et al., 2010), 
and which mediate cell attachment, motility, survival, and differentiation 
(Rosso et al., 2004). In most instances, collagen is not significantly 
immunogenic. Its ubiquitous presence in the body normally results in the 
development of immune tolerance and therefore the frequency of 
immunological responses towards collagen products is low (Lynn et al., 2004). 
Collagen also demonstrates minimal cytotoxicity and is biodegradable (Khan 
and Khan, 2013). 
Collagen has been successfully used for a range of tissue engineering 
applications both in vivo and in vitro, with type I collagen being the most 
widely used (Glowacki and Mizuno, 2008). For example, collagen hydrogels 
have been used extensively to provide 3D scaffolds for the study of fibroblast 
wound healing behaviour (Kanta, 2015), tumour progression (Szot et al., 2011) 
and hepatocyte culture (Gomez-Lechon et al., 1998).  In addition, collagen has 
previously been shown to be an appropriate biomaterial for immune cell 
culture applications, for example in the development of a tissue-engineered 
platform for immuno-therapy (Stachowiak and Irvine, 2008). 
Gelatin methacryloyl (GelMA) is a collagen-derived hydrogel. The synthesis of 
GelMA involves chemical modification of the hydrolysed form of collagen, 
gelatin. The reaction of gelatin with methacryloyl derivatives results in the 
formation of polymerisable methacrylate side groups, as shown in Figure 11. 
These side-chains enable tuning of the physical properties of GelMA 
derivatives in a way not possible for its unmodified counterparts, collagen and 
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gelatin. Thus, the mechanical strength and degradability of GelMA hydrogels 
may be controlled depending on the desired application (Van Den Bulcke et al., 
2000). Methacrylate-functionalised gelatin retains properties similar to 
unmodified gelatin, however, polymerisation gives rise to a highly cross 
linked, rigid hydrogel (Van Den Bulcke et al., 2000). For example, with the 
addition of a photo initiator, GelMA is photo-polymerisable upon exposure to 
an ultra violet (UV) light source. 
 
Figure 11. Schematic to demonstrate synthesis and photo-polymerisation of GelMA. 
Unmodified gelatin (a) is reacted with methacrylic anhydride resulting in the synthesis of 
gelatin methacryloyl (b). In the presence of a photoinitiator (Irgacure 2959) GelMA can be 
photo-polymerised thereby forming a stable, porous hydrogel (c). Modified from (Jung and Oh, 
2014). 
GelMA retains biocompatible features, including the preservation of cell 
adhesion motifs (Hutson et al., 2011). It has been used successfully as a 
biomaterial for various applications in tissue engineering, including cardiac 
(Shin et al., 2013, Saini et al., 2015) , bone (Ovsianikov et al., 2011, 
Dolatshahi-Pirouz et al., 2014)  and vascularization (Chen et al., 2012, 
Bertassoni et al., 2014), as well as development of tumour microenvironment 
models (Peela et al., 2016).  
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Due to its mechanical stability, GelMA is an attractive material for 
incorporation into microfluidic systems. This has been successfully 
implemented by Chen et al. in the development of a microfluidic device which 
models the heart valve microenvironment (Chen et al., 2013). Although 
GelMA is evidently compatible with a range of cell types, based on the current 
available literature, the immunological properties of GelMA have not yet been 
characterised. 
Chapter aims 
This chapter describes the characterisation of synthetic and naturally derived 
biomaterials to develop an ECM platform for immune cell culture. The aim of 
the work in this chapter was to investigate how human immune cells interacted 
with the candidate biomaterials including a colloidal gel system, electrospun 
scaffolds, GelMA and collagen hydrogels. This was done by assessing immune 
cell viability, phenotype and response to immunological stimuli when cultured 
in the presence of the biomaterials. 
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2.2. Materials and Methods 
PBMC Isolation from Peripheral Blood 
Heparinised blood (buffy coats) from healthy donors obtained from the 
National Blood Service following ethics committee approval (National Blood 
Services, Sheffield, UK: 2009/D055). PBMCs were separated by density 
gradient centrifugation on Histopaque-1077 (Sigma Aldrich) as described 
before (Garcia-Nieto et al., 2010). 
Generation of Monocyte-Derived Dendritic Cells  
Monocytes were purified by CD14
+
 selection from PBMCs using a magnetic 
cell separation method (kit purchased from Miltenyi Biotech) as previously 
described (Royer et al., 2010, Ghaemmaghami, 2002). The CD14
+
 cells (>95% 
purity) were plated (1x10
6
 cells\well) in a 24-well tissue culture-treated plate in 
500µL complete RPMI-1640 medium  containing 10% foetal bovine serum 
(FBS) , 100U\mL penicillin, 100mg\mL streptomycin and 2mM L-glutamine 
(all purchased from Sigma Aldrich). The media was supplemented with GM-
CSF (50ng/mL) and IL-4 (250U/mL) (cytokines purchased from Miltenti 
Biotech). Cells were maintained under standard tissue culture conditions 
(37°C, 5% CO2) for 6 days. An additional 500µL complete RPMI-1640 media 
containing GM-CSF and IL-4 was added on day 3. 
Thermo-Responsive Particulate Gels  
The materials were kindly donated for experiments by Shwana Braim, Polymer 
Therapeutics Group, University of Nottingham. 
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Synthesis of polyPEGMA 
As previously described by Al Ghanami et al, the polymer was prepared by 
free radical polymerisation.  The monomer (in the case of polyPEGMA-EE246 
PEGMA (Mn =246, 10 g, 40 mmoles) was weighed into a round bottom flask 
to which 1-dodecanethiol (0.05 g, 0.25 mmoles) and butanone (15ml) were 
added. AIBN (0.05 g, 0.3 mmoles) was added last, and the mixture was 
degassed with argon for 15 minutes. The flask was then immersed in an oil 
bath, and the polymerization was conducted at 70°C for 1 hour. PolyPEGMA-
EE246 was precipitated into a large excess (10 fold) of hexane. The polymer 
was further purified by dialysis against deionised water for 7 days in a cold 
room (5°C; dialysis membrane of a molecular weight cut off: 6000), then 
freeze dried for 2 days and stored at 8°C. 
Preparation of Polycaprolactone microparticles  
As described by Al Ghanami, the single emulsion solvent evaporation method 
was used. Poly(caprolactone)(Mn=10000, 300mg) dissolved in 
dichloromethane (DCM, 10ml) was added to a 100ml of 0.3wt% 
polyvinylalcohol (PVA, Mw=13-23 kDa) solution in water. The mixture was 
homogenised at 24000rpm for 2 minutes and then left to stir at 400 rpm for 6 
hours, for DCM evaporation and microparticles hardening. The microparticles 
were collected by centrifugation at 3000 rpm for 4 minutes, and then freeze 
dried. 
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Preparation of the Particulate Gel (illustrated in Figure 5 of this 
chapter). 
The colloidal gels were made according to the protocol set out by Al Ghanami 
et al. with minor modifications (Al Ghanami et al., 2010). 
To sterilise the particles, the required weight was measured into a transparent 
glass container. Large clumps were crushed to a fine powder using a spatula. 
The container was then set on a roller under a UV bar (245nm) for 30 minutes 
in order to sterilise the particles. 
pPEGMA 188 was dissolved in complete RPMI-1640 media to achieve a 4% 
(w/v) solution. The solution was sterilised by filtering it through a 0.2µm filter. 
The pre-gel mixture was prepared by mixing 300mg particle with 1mL 4% 
(w/v) pPEGMA 188 (which had been dissolved in complete RMPI-1640 
media).The mixture was kept on ice, it was vortexed and sonicated to obtain a 
smooth, milky suspension. 
Encapsulation of Cells Within Particulate Gels 
Based on a cell density of 5x10
5
 cells/50µL particulate gel, the required 
number of monocyte-derived dendritic cells was pelleted in a 1.6mL sterile 
Eppendorf, then re-suspended in the appropriate volume of gel mixture. A 48 
well tissue culture plate containing 500µL complete RPMI-1640 media per 
well was prepared and transferred to the incubator. When required, the plate 
was removed from the incubator and placed on a heat block (set at 37°C). 
Under sterile conditions, 50µL of the cell-laden particulate gel suspension was 
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slowly and gently pipetted into each well forming a droplet-like gel matrix. 
The plate was carefully transferred back to the incubator and maintained under 
standard tissue culture conditions for 24 hours (37°C, 5% CO2). 
Retrieval of Cells from Particulate Gels  
The plate containing the gels was transferred to the refrigerator (4°C) for 10 
minutes. The dispersed gel\cell mixture was collected using ice cold PBS and 
passed through a 40µM filter to remove large particles. The suspension was 
divided between FACS tubes and washed with cold PBS before proceeding 
with staining methods for phenotypic analysis and the Annexin V cell viability 
assay. 
Electrospun Scaffolds 
Materials for this work were kindly provided by Afnan Aladdad, Polymer 
Therapeutics Group, University of Nottingham. 
Preparation of PLGA and PET polymer solutions  
The PLGA polymer (Sigma-Aldrich, lactide/glycolide ratio 75/25, Mn [gel 
permeation chromatography, GPC] = 68 kDa, Ð = 1.7) was prepared as a 
18.5% (w/v) solution in 5mL dichloromethane (DCM). This was done by 
stirring continuously at room temperature for 24 hours. 
The PET polymer (sigma, molecular weight of repeating unit: 192.2g/mole) 
was prepared as a 30% (w/v) solution in a mixture of DCM and trifluoroacetic  
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acid (TFA). Complete dissolution was achieved by continuous stirring at room 
temperature for 24 hours. 
Synthesis of the thermo-responsive polymer poly (poly (ethylene 
glycol) methacrylate), poly (PEGMA188)  
Poly (PEGMA188) was prepared by free radical polymerization following a 
published method (Al Ghanami et al., 2010). Di (ethylene glycol) methyl ether 
methacrylate (98%, Sigma, 188), (22 g, 0.12 moles) was weighed into a round-
bottom flask, to which 1-dodecanethiol (chain transfer agent; 98%, Sigma; 
0.225 g, 0.001 moles) and 15 mL of 2-butanone were added.  
Azobisisobutyronitrile (AIBN; 0.15 g, 0.001 moles) was added last and the 
mixture was degassed with nitrogen for 15 minutes.  The flask was then placed 
on a hot plate (Stuart®) and the polymerization reaction was conducted at 70°C 
for 1 h.  The prepared poly (PEGMA188) was precipitated three times in 500 
mL of hexane and re-dissolved in 50 mL of 2-butanone to remove any residual 
PEGMA188 monomer.  The precipitated poly (PEGMA188) was placed in a 
desiccator for 48 h to remove any remaining solvent. 
Preparation of the co-polymer solutions 
The PLGA co polymer solution was prepared as 20% (w/v) with 1% (w/v) poly 
(PEGMA188). The PET co polymer solution was prepared as 30% (w/v) with 
2% poly (PEGMA188). 
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Electrospinning 
10mL plastic syringes, fitted with an 18-gauge blunt needle, were loaded with 
5mL polymer/ co polymer solution which had been prepared as described 
above. The syringes were mounted onto a syringe pump (Harvard) and the flow 
rate set to 4mL/hour for the PLGA polymer solution and 0.5mL/hour for the 
PET polymer solution.  A voltage of 14 or 19kV was applied to the needle tip 
for PET or PLGA polymer solutions repectively using a high-voltage unit 
(Glassman High Voltage Inc). The solution was spun onto a 6cm2 stainless-
steel grounded collector plate. The working distance between the needle and 
collector plate was approximately 15cm. The electrospinning process was 
performed at room temperature, the entire 5mL polymer solution was spun and 
the collector plate was rotated every 20 minutes. Finally, the electrospun mats 
were air0dried for 48 hours at room temperature, manually peeled off the plate 
and stored at room temperature. 
Preparation of Scaffolds for Cell Culture  
1cm
2
 sections of electrospun scaffolds were cut and sterilised under a UV bar 
(245nm) for 20 minutes each side. Steel rings, which had been sterilised by 
autoclaving, were used to hold the scaffolds in place in a sterile, non-tissue 
culture treated 24-well plate. A 20% v/v antibiotic\antimycotic (Ab/Am) 
solution was prepared by diluting Antibiotic Antimycotic Solution 100X 
(purchased from Sigma) in PBS. Scaffolds were immersed in the 20% v/v 
Ab/Am solution overnight. The next day, the Ab\Am solution was removed 
and scaffolds were washed in complete RPMI-1640 media. The scaffolds were 
soaked in the media for at least 2 hours before cell seeding. 
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Dendritic Cell Culture on Electrospun Scaffolds  
Monocyte-derived dendritic cells were seeded onto scaffolds at a density of 
5x10
5
 cells in 300µL cytokine-free complete RPMI-1640 media. Cells were 
maintained under standard tissue culture conditions (37°C, 5% CO2) for 24 
hours. Cells were harvested from scaffolds by washing in ice cold PBS. The 
PEGMA-coated scaffolds were incubated at 4°C for 10 minutes to facilitate the 
release of cells from the scaffolds. Samples were divided between FACS tubes 
for staining for phenotypic analysis and the Annexin V cytotoxicity assay. 
Endotoxin neutralisation was done using Polymyxin B sulphate (PMB) 
(purchased from Sigma). A 50µg/mL solution was prepared in sterile PBS. 
Scaffolds were incubated with the PMB solution for 45 minutes and washed 
thoroughly with media before cell seeding. 
Preparation of Gelatin Methacryloyl (GelMA) Hydrogels  
The GelMA foam was synthesised as described previously (Van Den Bulcke et 
al., 2000) and kindly provided by the Khademhosseini Lab, Massachusetts 
Institute of Technology, USA. 
The photoinitiator, 2-Hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone 
(Irgacure 2959) (purchased from Sigma) was dissolved in PBS to make a 
0.25% (w/v) solution. 
A 5% (w/v) GelMA pre-polymer solution was prepared by dissolving GelMA 
into 0.25% photoinitiator solution at 60°C. 
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100µL of pre-polymer GelMA solution was added per well of a 48-well tissue 
culture plate and photo-cross linked by UV exposure (40 seconds, 800mW, 
8cm). Hydrogels were washed in PBS and sterilised by submersion in a 20% 
v/v Ab\Am solution overnight. A final wash was done with sterile PBS before 
cell seeding. 
PBMC Culture on GelMA Hydrogels  
5x10
5
 PBMCs were seeded per gel in 500µL complete RPMI-1640 media. For 
the LPS-simulated conditions, 0.1µg/mL E. coli LPS (0111:B4) (purchased 
from Sigma) was added to the appropriate wells. Plates were transferred to a 
humidified incubator (37°C, 5% CO2). Cultures were maintained for 5 days to 
assess cell viability. Supernatant was sampled after 4 and 24 hours for cytokine 
and gene expression analysis. 
TNF-α Depletion on GelMA Hydrogels  
Recombinant human TNF-α protein (purchased from Invitrogen) was added to 
complete RPMI-1640 media at 5 or 2.5ng/mL. GelMA hydrogels were made as 
described above in Preparation of GelMA hydrogels . 500µL of media with 
or without TNF-α was incubated with the GelMA hydrogels for 4 hours in a 
humidified incubator (37°C, 5% CO2). Supernatant was collected and stored at 
-80°C for analysis of TNF-α by ELISA. 
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Preparation of Thin-Layer GelMA Hydrogels (for immuno-
fluorescent staining) 
GelMA was photo-polymerised on surface-treated glass slides. The glass slides 
were coated with 3-(Trimethoxysilyl) propyl methacrylate (TMSPMA) in order 
to functionalise the surface to enhance hydrogel attachment. Briefly, glass 
microscope slides were submerged in a 10% (w/v) sodium hydroxide solution 
overnight. Slides were thoroughly rinsed and soaked overnight in dH2O. They 
were washed 3 times in 100% ethanol and air-dried. Slides were then stacked 
in a beaker and wetted with TMSPMA. The beaker was covered with 
aluminium foil and the slides were baked at 80°C overnight. Finally, slides 
were washed in 100% ethanol 3 times, wrapped in aluminium foil and baked 
for a further 2 hours at 80°C. The glass slides were then cut into chips of 1cm
2
. 
A 5% (w/v) pre-polymer GelMA solution was prepared, as described 
previously in Preparation of GelMA hydrogels . 5µL of GelMA pre-
polymer solution was dispensed onto a glass chip, a spacer with a depth of 
100µm was placed on top to form an even layer and then the gel was 
crosslinked for 8.5 seconds (Nikkhah et al., 2012). The glass chips were 
transferred to a 24 well plate and washed with PBS. Then gels were submerged 
in control RPMI-media or media containing recombinant human TNF-α and 
incubated for 4 hours in a humidified incubator (37°C, 5% CO2). 
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Immuno-Fluorescent Staining GelMA Hydrogels for TNF-α 
Following the incubation with or without TNF-α-containing media, the 
supernatant was removed and the GelMA hydrogels were washed in PBS. The 
samples were blocked for 30 minutes with 5% (w/v) FBS in PBS. A 1:200 
dilution in 5% (w/v) FBS in PBS was made for the mouse anti-human TNF-α 
monoclonal antibody, clone 2C8 (purchased from abcam) and samples were 
incubated overnight at 4°C. Samples were washed 3 times in PBS, then 
incubated for 1 hour at room temperature with a Rhodamine red-conjugated 
goat anti-mouse secondary antibody (purchased from Life Technologies) 
diluted 1:250 with 5% (w/v) FBS in PBS. Samples were washed in PBS and 
mounted on cover glass for imaging. A Zeiss LSM710 confocal microscope 
system, with a 20X objective, was used to image the GelMA hydrogels. 
Image analysis 
ImageJ was used for the analysis of fluorescent images (Schneider et al., 2012). 
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Preparation of Collagen Hydrogels  
Collagen, Type I, derived from rat tail (3mg/mL) (purchased from Life 
Technologies).  
0.5mg/mL collagen hydrogels were prepared using the following calculation: 
Vt = Total volume of collagen hydrogel needed 
Volume of collagen needed (V1) =  
(𝐹𝑖𝑛𝑎𝑙 𝑐𝑜𝑛𝑐. 𝑜𝑓 𝑐𝑜𝑙𝑙𝑎𝑔𝑒𝑛)𝑥 (𝑇𝑜𝑡𝑎𝑙 𝑉𝑜𝑙𝑢𝑚𝑒(𝑉𝑡))
𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑐𝑜𝑛𝑐. 𝑜𝑓 𝑐𝑜𝑙𝑙𝑎𝑔𝑒𝑛
 
Volume of 10X PBS needed (V2) = 
𝑇𝑜𝑡𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 (𝑉𝑡)
10
 
Volume of 1N NaOH needed (V3) = (V1) x 0.025 
Volume of dH2O needed (V4) = (Vt)-(V1 + V2 + V3) 
Cell Culture on Collagen Hydrogels 
100µL of collagen hydrogel solution was added per well of a 48-well tissue 
culture plate and incubated at 37°C for 40 minutes to polymerise. 5x10
5
 cells 
were seeded per gel in 500µL complete RPMI-1640 media. For the LPS-
simulated conditions, 0.1µg/mL E. coli LPS (0111:B4) (purchased from 
Sigma) was added to the appropriate wells. Plates were transferred to a 
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humidified incubator (37°C, 5% CO2). Cultures were maintained for 5 days to 
assess cell viability. Supernatant was sampled after 24 hours for cytokine 
analysis. 
Annexin-V-FITC\Propidium Iodide Cytotoxicity assay 
The Annexin V-FITC cell viability kit (purchased from Beckman Coulter) was 
used for the assessment of cell viability. This assay is based on the principle 
that in early apoptosis cells lose the asymmetry of the plasma membrane. Thus, 
phosphatidylserine (PS), normally located on the inside of the cell membrane, 
appears on the outer surface. Annexin V has a high affinity for PS, therefore 
when conjugated with a fluorochrome (e.g. FITC), can be used to label cells in 
early apoptosis. During late apoptosis, the integrity of the cell membrane is lost 
allowing penetration of propidium iodide (PI), which intercalates DNA. Upon 
DNA binding, PI fluoresces allowing detection of dead cells. 
To perform the assay, harvested cells were immediately placed on ice. After 
washing in PBS, cells were re-suspended in 1X Annexin V binding buffer and 
the staining method was carried out according to manufacturer’s instructions. 
Samples were analysed immediately on the Beckman Coulter FC500. 
Dendritic Cell Phenotypic Analysis  
Harvested cells were washed twice in ice cold PBS (supplemented with 0.5% 
bovine serum albumin (BSA) and 0.1% sodium azide). Cells were immuno-
fluorescently stained for CD11c (clone MJ4-27G12, PE, IgG2b, Miltenyi 
Biotech), CD40 (clone HB14, PE, IgG1, Miltenyi Biotech), CD83 (clone 
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HB15e, FITC, IgG1, eBioscience) CD86 (clone FM95, PE, IgG1, Miltenyi 
Biotech), CD54 (clone 84H10, FITC, IgG1, Beckman Coulter) for 20 min at 
4°C. Relevant isotype matched control antibodies were used (all purchased 
from Miltenyi Biotech). The cells were then washed twice in ice cold PBS 
(with 0.5% BSA and 0.1% sodium azide) and fixed in 0.5% formaldehyde in 
PBS. Cells were analysed within 2 days. 
Flow Cytometric Analysis 
Flow cytometry was performed using a Beckman Coulter FC500 and 30,000 
events were collected per sample. 
Data were analysed using the flow cytometry WEASEL software. For 
phenotypic analysis, dead cells were excluded by forward and side scatter 
characteristics. For cell viability, no exclusion gate was applied. 
Scanning Electron Microscopy 
Scaffolds were fixed in 4% (v/v) paraformaldehyde (Electron Microscopy 
Sciences, United Kingdom) overnight at 4°C and then dehydrated through an 
ascending series of ethanol concentrations. The scaffolds were then placed onto 
carbon-coated electron microscope stubs and sputter-coated with gold (3 min, 
Blazers SCD 030 Blazers Union Ltd., Liechtenstein) under an argon 
atmosphere (BOC, U.K.) prior to analysis. Samples were kindly imaged by 
Christine Grainger-Boultby using SEM (Scanning Electron Microscopy) 
analysis (JEOL JMS-6060 LV microscope, JEOL Ltd., U.K.) operating at an 
accelerating voltage of 10 kV (Harrington et al., 2014). 
66 
 
Cytokine Detection 
Interleukin 1β, interleukin 6, interleukin 8 and tumour necrosis factor-α were 
measured using a multiplex bead-based analyte detection system according to 
manufacturer’s instructions (Procartaplex) (purchased from eBioscience) as 
described by (Sharquie et al., 2013). 
Supernatants from cell-free TNF-α and IFN-γ depletion experiments were 
analysed by ELISA following manufacturer’s instructions (kits for TNF-α and 
IFN-γ purchased from R&D systems). 
PCR 
Preparation of cell lysate for mRNA isolation  
Cells were harvested from GelMA hydrogels by washing with cold PBS and 
immediately transferred to a Falcon tube on ice. Cells were washed twice in 
PBS, then 1mL of MACS lysis/ re-suspension buffer was added to 10
7
 cells 
and mixed until lysate was clear. 
mRNA isolation and cDNA synthesis  
mRNA purification and cDNA synthesis were carried out using the µMACS 
one-step cDNA kit (Miltenyi Biotech) following the manufacturer`s 
instructions. The purity and quantity of the cDNA was assessed with a 
NanoDrop 1000 Spectrophotometer (Thermo Scientific). 
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Primer Design 
The primers for TNF-α that were used in this work for both conventional and 
quantitative real-time PCR TNF-α were originally described by Breen et al. 
2000 (Breen et al., 2000). To check primer specificity, the sequences were 
mapped with NCBI Reference Sequence: NM:000594.3. For both the forward 
and reverse primer, the homology was shown to be 100% over the full length 
of the primers. Mapping to the reference sequence showed that the TNF-α 
forward primer spans exon 1 and exon 2. The TNF-α reverse primer is non 
exon spanning and internal to exon 4. The amplicon size for these primers is 
325bp. Primers were obtained from Eurofin, UK: TNF-α Forward (5’–
CAGAGGGAAGAGTTCCCCAG-3’), TNF-α Reverse (5’- 
CCTTGGTCTGGTAGGAGACG-3’). 
The primers for Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were 
kindly provided by Fabian Salazar, Immunology and Allergy Tissue Modelling 
Group, University of Nottingham. The specificity of the primers was checked 
by mapping the sequences with NCBI Reference Sequence: NM_001289746.1. 
The homology was shown to be 100% for both the forward and reverse 
primers. The GAPDH forward primer spans exon 1 and exon 2, the reverse 
primer is non exon spanning. The amplicon size for these primers is 185bp. 
Primers were obtained from Eurofin, UK, Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) Forward (5`-GAGTCAACGGATTTGGTCGT-3`), 
GAPDH Reverse (5`-GACAAGCTTCCCGTTCTCAG-3`). 
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Conventional PCR 
Conventional PCR was carried out in a TC-312 PCR Thermocycler (Bibby 
Scientific Ltd, UK) using the Phusion Flash High-Fidelity PCR Master Mix 
(Thermo Fisher Scientific) and 20ng of µMACS cDNA per reaction.. 
PCR was carried out with an initial denaturation at 98°C for 10 seconds, 
followed by 32 cycles of denaturation (98°C, 0-1 seconds), annealing (62°C, 
30 seconds), extension (72°C, 30 seconds), final extension was performed at 
72°C for 60 seconds. Then, the PCR products were analysed in an E-gel pre-
cast 2% agarose electrophoresis system (Thermo Fisher Scientific) and the 
molecular weight of the bands were calculated with a standard 100bp 
Directload DNA ladder (Sigma-Aldrich). 
Quantitative real-time PCR analysis 
Real time PCR was performed in a Stratagene MxPro 3005P qPCR System 
with the Brilliant III Ultra-Fast SYBR Green qPCR Master Mix (Agilent 
Technologies, USA). Primers were obtained from Eurofin, details for GAPDH 
and TNF-α as above. Cycling was initiated at 95°C for 3 minutes, followed by 
45 cycles of 95°C for 20 seconds and 62°C for 30 seconds. Melt curves were 
performed at the end in order to show the presence of a single, specific product, 
representative melt curves from these experiments are shown in Appendix I. 
Samples were run in triplicates and relative expression calculated using 
comparative threshold cycle method normalized to GAPDH (Livak and 
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Schmittgen, 2001).  This method is commonly referred to as the ΔΔCt method 
and uses the following equation: 
Relative quantity to the calibrator = 2-( ΔΔCt)  
Where Δ ΔCt =  
(CtTNF-α – CtGAPDH)calibrator – (CtTNF-α – CtGAPDH)unknown 
Statistical Analysis  
One-way ANOVA or t-tests were performed in the statistical analysis. The 
analysis was carried out using GraphPad Prism version 6.00 for Windows, 
GraphPad Software, La Jolla California USA (www.graphpad.com).  
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2.3. Results and Discussion 
Investigating Synthetic Biomaterials for Immune Cell 
Culture 
Thermo-Responsive Particulate Gel 
Formation of cell-laden thermo-responsive particulate gels 
The immune cells used for this work were human monocyte-derived dendritic 
cells (moDCs), generated from peripheral blood mononuclear cells (PBMCs). 
To establish cell densities which were compatible with gel formation, a range 
of densities were tested from 5 x 10
4
 – 5 x 105 cells\50µL matrix. Figure 12A 
illustrates the thermo-responsive generation of the particulate gels at 37°C and 
their dispersal after a 10 minute incubation at 4°C. Figure 12B shows the 
formation of the particulate gels laden with moDCs. Gels were produced 
successfullywith the highest cell density of 5 x 10
5
 cells\50µL gel in a 
reproducible manner at 37°C. 
 
Figure 12. Thermo-responsive formation of particulate gels with dendritic cells. 
A. Formation of a robust particulate gel matrix at 37°C and dispersal following incubation at 
4°C. B. Generation of reproducible droplet-like 3D gels with encapsulated moDCs.  
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This work established that 5 x 10
5
 cells could be incorporated into the matrix 
without affecting the integrity of the gel. Although the formation of gels with 
encapsulated cells has previously been described by Al Ghanami et al., it was 
important to optimise the protocol specifically for moDCs. The reason for this 
is that, 3T3 fibroblasts used in the study by Al Ghanami are larger cells (18µm) 
compared with moDCs (10µm)., It was found that the number of moDCs that 
could be encapsulated was higher compared to the number of 3T3 cells used in 
Al Ghanami’s work (Al Ghanami et al., 2010).  It was also important to 
determine that sufficient numbers of moDCs could be incorporated into the 
gels so that they could be collected for analysis.  
moDC analysis after 24 hours in culture with particulate gels  
The gels, containing 5 x 10
5
 moDCs\50µL matrix, were maintained under 
standard tissue culture conditions (37°C, 5% CO2) for 24 hours. The 
temperature-sensitive property of the material was used in order to disassemble 
the gels for cell retrieval and analysis by flow cytometry. 
The results from the flow cytometry analysis are displayed in Figure 13. The 
dot plots show forward scatter (FS) and side scatter (SS) cell properties, 
expression of the moDC marker CD11c and Annexin V-FITC\propidium 
iodide (PI) staining for cell viability of the moDCs harvested from tissue 
culture plastic (TCP) and particulate gel. 
The FS\SS profile gives an indication of the size and granularity of a 
population of cells. Based on the profile of the cells collected from TCP, a 
region was drawn to indicate the moDC population. When this region was 
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transposed onto the FS\SS dot plots for the particle gel samples, it was difficult 
to detect moDCs due to the large number of events representing particles from 
the gel. As labelled on the dot plot, this population is likely to be a mixture of 
particles, cells and debris. 
One explanation for the difference in the distribution of cells in the FS\SS dot 
plots could be due to cell attachment to, or cells taking up, the particles. In 
terms of the latter, this is highly likely due to the actively endocytic nature of 
unstimulated moDCs (Garcia-Nieto et al., 2010). This would alter the size and 
granularity properties of the cells, therefore they wouldn’t fall in the same 
region as cells from TCP. 
Samples collected from the particulate gels were also fluorescently stained for 
CD11c. A distinct population of cells, >90%, was CD11c
+
 in samples 
harvested from TCP. For gel samples, a population of cells, 6%, was detected 
which expressed CD11c. Labelling cells for CD11c was useful to differentiate 
the moDC population from the particulate material, which could not be done 
based on FS\SS. 
Finally, cell viability was measured using the Annexin V-FITC\PI cytotoxicity 
assay. This is a flow cytometric-based assay, which distinguishes between live 
cells (Annexin V
-
\ PI
-
), apoptotic cells (Annexin V
+
\ PI
-
) and dead cells 
(Annexin V
+
\PI
+
). Analysis of Annexin V-FITC\PI staining allows quantitative 
determination of the level of cytotoxicity.  
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The viability of moDCs harvested from TCP was >80%. In the samples from 
the gel, the proportion of viable cells could not be distinguished from the 
particles and debris, which also feature in the Annexin V
-
\PI
-
 quadrant. 
Therefore determination of cytotoxicity was difficult since the particulate 
material could not be differentiated from unstained (viable) cells in the lower 
left quadrant of the dot plots. Overall, the flow cytometric approach used for 
the analysis of cells collected from the particulate gel was limited by the 
inability to separate\distinguish cells from the particulate gel material. 
 
Figure 13. Flow cytometric analysis of moDCs following culture with particulate gel. 
FS/SS: A distinct population of moDCs was detected based on FS/SS properties of the cells 
collected from TCP. A discreet cell population could not be distinguished based on FS/SS 
profile of cells collected from the particulate gel. CD11c: The population of cells harvested 
from TCP was 93.6% positive for CD11c. In the particulate gel samples, a population of 6% 
CD11c expressing cells was identified. Annexin V\PI: Cell viability of moDCs harvested from 
TCP was >80%. The cytotoxicity couldn’t be determined for the particulate gel samples (n = 3 
independent experiments). 
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PET-based Electrospun Scaffolds 
In the work performed to characterise electrospun PET scaffolds for immune 
cell culture applications, human moDCs were used for all experiments. Cells 
were seeded on to sterilised uncoated PET and PEGMA-coated PET 
(PET\PEGMA) scaffolds, then, they were maintained under standard tissue 
culture conditions for 24 hours (37°C, 5% CO2). Cells were harvested from the 
scaffolds for analysis of viability and phenotype by flow cytometry. The 
temperature-sensitive properties of PET\PEGMA scaffolds were taken 
advantage of for cell retrieval by incubating at 4°C for 10 minutes before 
washing with ice cold PBS to collect the cells. 
Electrospun PET scaffold cytotoxicity 
Cell viability was measured using the Annexin V\PI cytotoxicity assay. Figure 
14 shows the results from this. It was found that the proportions of viable cells 
collected from PET (88.8%) and PET\PEGMA (83.0%) scaffolds were not 
significantly different (P≥0.05) from TCP (88.0%). There was no significant 
difference in the percentage of non-viable cells collected from uncoated PET 
(9.2%) or PET\PEGMA (15.7%) with respect to TCP (10.2%). This data 
suggested that moDC viability was not impaired by PET-based electrospun 
scaffolds. 
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Figure 14. PET-based electrospun scaffolds are not cytotoxic to moDCs. 
Viability of moDCs was not significantly affected after 24 hours in culture with PET or 
PET\PEGMA scaffolds. One-way ANOVAs performed to determine significant differences in 
the proportion of viable\non-viable cells collected from each of the conditions respectively. No 
significant differences found for either non-viable or viable (P>0.05) (n = 3 independent 
experiments). Error bars represent standard deviation. Representative dot plots of Annexin 
V/PI staining profile shown below. 
Induction of moDC maturation by PET electrospun scaffolds 
The phenotype of moDCs seeded on the scaffolds was assessed by the 
expression of the dendritic cell maturation marker, CD83. Immuno-fluorescent 
staining of cells was performed for analysis of CD83 expression by flow 
cytometry. 
Figure 15 shows the expression of CD83, presented as the percentage of CD83 
positive cells, of moDCs harvested from uncoated PET (56.4%), PET\PEGMA 
(62.7%) and TCP (3.25%). Statistical analysis revealed that CD83 expression 
was significantly increased by cells when cultured on uncoated PET and 
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PET\PEGMA scaffolds (P≤0.05, *). The increase in CD83 was indicative that 
the PET-based scaffolds caused the maturation of moDCs. 
Due to the methods involved in the synthesis of electrospun materials, the 
potential of endotoxin contamination causing cell maturation could not be 
overlooked. A further experiment was performed to control for this using the 
antibiotic polymyxin B (PMB). Scaffolds were incubated with PMB to 
neutralise endotoxin prior to cell seeding. Since moDC activation was also 
induced on PMB-treated scaffolds, the results indicated that endotoxin 
contamination was not responsible for the induction of moDC maturation on 
PET scaffolds (data not shown).  
 
Figure 15. PET scaffolds induce moDC maturation. 
moDC maturation was elicited in culture on PET electrospun scaffolds. Expression of CD83 
was significantly increased with both PET and PET\PEGMA scaffolds after 24 hours of 
culture. One-way ANOVA used to test for significance (P≤ 0.05, *) (n = 3 independent 
experiments). Error bars represent standard deviation. 
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Weak attachment of moDCs on PET scaffolds 
To visualise the interaction and attachment of moDCs with the scaffolds, 
samples were prepared for scanning electron microscopy (SEM). Figure 16 
shows representative micrographs of the samples. 
Attachment of moDCs on uncoated PET scaffolds was sparse, cells present on 
the scaffolds had a rounded morphology and occurred in clumps. moDCs that 
had attached to PET\PEGMA scaffolds could be seen stretched across the 
fibres, and cells were distributed unevenly. These observations indicated 
moDCs did not interact strongly with the materials; low adhesion likely led to 
cells being lost during the fixation and dehydration steps of SEM sample 
preparation. 
 
Figure 16. moDCs interact weakly with PET electrospun scaffolds. 
Scanning electron microscopy of PET scaffolds seeded with dendritic cells. On PET scaffolds, 
moDC attachment was sparse and cells occured in clumps. Slightly more cells were attached 
on PET\PEGMA scaffolds, cells appeared stretched across the fibres but cell distribution was 
uneven. 1,000X magnification was used to acquire the images. Scale bars represent 10µm. 
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PLGA-based Electrospun Scaffolds 
To characterise uncoated PLGA and PEGMA-coated PLGA (PLGA\PEGMA) 
electrospun scaffolds for immune cell culture, all experiments were performed 
with human moDCs. The thermo-sensitive properties of PLGA\PEGMA 
scaffolds were utilised by incubating for 10 minutes at 4°C before cell 
collection. 
Cytotoxicity of PLGA electrospun scaffolds 
Figure 17 shows the results from the Annexin V\PI viability assay carried out 
to assess the cytotoxicity of the PLGA-based scaffolds on moDCs. The 
percentages of non-viable moDCs collected from uncoated PLGA (27.6%) and 
PLGA\PEGMA (18.2%) scaffolds were slightly increased compared to cells 
harvested from TCP (10.2%), however, no significant differences were found 
(P>0.05). Also, there was no significant difference between the proportions of 
viable cells collected from uncoated PLGA (70.4%), or PLGA\PEGMA 
(78.9%) with TCP (88.0%). These results suggested that PLGA-based scaffolds 
may have had a long term detrimental effect on cell health but in a 24 hour 
period, levels of cytotoxicity were not significant. 
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Figure 17. Electrospun PLGA scaffolds do not significantly impair the viability of 
moDCs. 
Cell viability was slightly reduced after 24 hours of culture in the presence of PLGA and 
PLGA\PEGMA scaffolds. However, one-way ANOVAs of viable\non-viable cells did not 
reveal any significant differences compared to TCP (P>0.05) (n = 3 independent experiments). 
Error bars represent standard deviation. 
Induction of moDC maturation by PLGA electrospun scaffolds 
The effect of PLGA scaffolds on moDC phenotype is shown in Figure 18, 
presented as the percentage of CD83 positive cells. Expression of CD83 was 
increased by cells cultured with uncoated PLGA scaffolds (53.9%), however, 
this was not found to be significant (P>0.05). Seventy percent of cells collected 
from PLGA\PEGMA scaffolds were CD83 positive, which was significantly 
higher (P≤0.05, *) compared with TCP (3.3%). The increased expression of 
CD83 by moDCs cultured on PLGA scaffolds suggested that the material 
induced cell maturation. 
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Figure 18. PLGA electrospun scaffolds induce moDC maturation. 
Maturation of moDCs was seen after 24 hours of culture with thermo-responsive 
PLGA\PEGMA scaffolds. One-way ANOVA determined a statistically significant increase of 
CD83 expression in moDCs harvested from PLGA\PEGMA scaffolds (P≤0.05, *) (n = 3 
independent experiments). Error bars represent standard deviation. 
As previously described for PET scaffolds, an experiment to test for the effects 
of endotoxin contamination was carried out by treating the scaffolds with 
polymyxin B (PMB) prior to cell seeding. PMB was not found to affect the 
expression of CD83, thereby ruling out endotoxin contamination as a cause for 
cell maturation (data not shown). 
moDCs attach weakly to PLGA scaffolds 
SEM was performed to visualise moDC interaction with the scaffolds, as 
shown in Figure 19. Few cells were found attached to the PLGA scaffolds, this 
suggested weak attachment and cells were most likely lost during the washing, 
fixing and dehydration steps involved in SEM sample preparation. Clumps of 
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cells were found to be attached on PLGA\PEGMA scaffolds, although these 
were relatively few and far between. 
 
Figure 19. moDCs interact weakly with PLGA electrospun scaffolds. 
Scanning electron microscopy of PLGA electrospun scaffolds seeded with moDCs. Very few 
cells were attached to PLGA scaffolds. Cells attached to PLGA\PEGMA scaffolds were in 
clumps and few and far between. The magnification used was 1,000X. The scale bars represent 
10µm. 
Naturally-derived Biomaterials 
Gelatin Methacryloyl Hydrogel 
Viability of immune cells harvested from GelMA 
Peripheral blood mononuclear cells (PBMCs), isolated from the blood of 
healthy donors, were used as a source of primary human immune cells in these 
experiments. The cellular composition of PBMCs is 70-90% lymphocytes (T 
cells, B cells and natural killer (NK) cells), 10-30% monocytes, 1-2% dendritic 
cells and small numbers of basophils. The total PBMC population was used in 
these experiments since it comprises the cell types of interest for this work and 
requires minimal processing following the initial purification step performed 
by density centrifugation. 
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To set up these experiments, PBMCs were seeded onto a pre-photo-
polymerised GelMA hydrogel layer. After 5 days in culture, cell viability was 
assessed by Annexin V\PI staining. 
Figure 20 shows the results from the cytotoxicity assay, A and B illustrate 
representative dot plots of Annexin V\PI stained cells harvested from TC 
(tissue culture plastic) and GelMA respectively. As shown by the graph in C, 
after 5 days in culture, the proportions of live cells collected from GelMA 
hydrogels (mean = 67%) were not found to be significantly different compared 
to TC (mean = 76%). Apoptotic and dead cells were combined to determine the 
amount of non-viable cells for GelMA (mean = 33%) and TC (mean = 24%). 
No significant difference was found between the percentages of non-viable 
cells harvested from GelMA, compared to TC. 
 
Figure 20. PBMC viability is not impaired by culture with GelMA hydrogels. 
A & B. Annexin V\PI staining profiles of cells harvested from TC and GelMA cultures 
respectively. C. Percentage of viable (solid bar) and non-viable (striped bar) cells collected 
from GelMA and TC. Two-tailed t tests determined that there were no significant differences 
(P > 0.05) in the proportion of viable cells, or non-viable cells harvested from GelMA cultures 
compared to TC (n=3). Error bars represent standard deviation. 
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Cell health is a critical parameter when assessing the suitability of a 
biomaterial for in vivo and in vitro applications (Williams, 2008). This 
encompasses several cell functions, including cell death. With regards to the 
method of polymerisation, the photoinitiator can potentially have detrimental 
impacts on cell survival. Although in this experiment GelMA hydrogels were 
photo-polymerised prior to cell seeding, persisting free radical species, 
produced as a result of the photoinitiator being exposed to UV, have the 
potential to cause oxidative damage to the cells, leading to cell death (Mironi-
Harpaz et al., 2012, Williams et al., 2005). Based on the findings from these 
experiments, however, the photoinitiator did not appear to induce cell death. 
Immune-modulatory effect of GelMA on the production of 
inflammatory cytokines 
To characterise the immune-modulatory properties of GelMA, the 
responsiveness of PBMCs to immunological manipulation in the presence of 
GelMA was investigated. This was done by assessing the response of PBMCs 
to lipopolysaccharide (LPS). 
PBMCs were cultured on GelMA hydrogels, with or without LPS stimulation 
for 4 hours. Secretion of a panel of inflammatory cytokines (IL-1β, IL-6, IL-8 
and TNF-α) was used to determine the immune response. In Figure 21, graphs 
A-D show the production of TNF-α, IL-1β, IL-6 and IL-8 respectively 
following immunogenic stimulation with LPS. 
In the TC condition, levels of all cytokines increased significantly in response 
to LPS. Within the PBMC population, monocytes are the main responders to 
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LPS (Tazi et al., 2006) and are largely accountable for the production of pro-
inflammatory cytokines, including IL-1β, IL-6, IL-8 and TNF-α. In the 
presence of GelMA hydrogels, background levels of all inflammatory 
cytokines were raised and there was large variation in the response to LPS 
between donors. This may account for there being no significant up-regulation 
for any of the cytokines upon stimulation with LPS. Interestingly, there was a 
significant difference in the concentration of TNF-α detected in GelMA+LPS 
cultures compared with TC+LPS cultures, with higher levels of TNF-α in 
TC+LPS samples. 
 
Figure 21. Modulatory effect of GelMA on inflammatory cytokine production, with and 
without LPS stimulation. 
Cytokine production after 4 hours by PBMCs cultured on GelMA hydrogels or TC, with (+) or 
without (-) LPS stimulation. A. TNF-α was not significantly increased following LPS 
stimulation in GelMA cultures. Secretion of TNF-α was found to increase significantly in the 
LPS-stimulated TC control (P ≤ 0.0001, ****). A significant difference in the level of LPS-
induced TNF-α production was found between GelMA and TC conditions (P ≤ 0.001, ***). B. 
Production of IL-1β was not significantly increased with LPS stimulation in the presence of 
GelMA, whereas in TC it was (P ≤ 0.05, *). C. IL-6 secretion was not significantly increased in 
GelMA cultures following LPS stimulation, this was found to be significant in TC (P ≤ 0.05, 
*). D. No significant rise in IL-8 production with LPS stimulation in GelMA or TC cultures (P 
≥ 0.05). One-way ANOVA performed to determine statistically significant differences in 
cytokine production (n = 3 independent donors). Error bars represent standard deviation. 
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The possibility of endotoxin contamination causing the induction of 
inflammatory cytokine production was ruled out by incubating the GelMA 
hydrogel with PBM prior to cell culture (data not shown). Immunogenicity is a 
common problem with natural biomaterials. Since the origin of the gelatin used 
for the synthesis of GelMA was porcine, the elicitation of a pro-inflammatory 
cytokine response may be explained by the antigenicity caused through the use 
of a xenogenic source of gelatin (Chan and Leong, 2008). 
Given that TNF-α is a key inflammatory cytokine, it was surprising to find that 
the levels detected were not increased upon LPS stimulation in the presence of 
GelMA. In terms of its induction in response to LPS, under standard culture 
conditions, secretion of TNF-α by monocytes is rapidly increased, generally 
peaking around 4 hours after immunogenic stimulation (Tazi et al., 2006). The 
observations for TNF-α were particularly striking since the three other pro-
inflammatory cytokines did increase to some extent with LPS stimulation in 
the presence of GelMA, although not significantly. 
TNF-α has diverse roles in the function and regulation of the immune system, 
dependent on tissue type, immunological context and timing (Wajant et al., 
2003). It predominantly has pro-inflammatory effects in affected tissues and 
can exacerbate disease states such as, rheumatoid arthritis and chronic wounds 
(Albillos et al., 2004). 
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GelMA suppresses LPS-induced TNF-α gene expression in 
PBMCs. 
Given the observation that GelMA potentially diminished the levels of TNF-α, 
further investigation at the level of gene expression was carried out. In these 
experiments, PBMCs were cultured on photopolymerised GelMA hydrogel 
layers, with and without LPS stimulation. Then, they were harvested for 
analysis of TNF-α gene expression after 30 minutes and 4 hours of culture. 
TNF-α gene expression by PBMCs in culture with GelMA hydrogels was 
measured by reverse transcription PCR. Both conventional gel-based PCR and 
quantitative real-time PCR were used to analyse TNF-α mRNA. 
Figure 22A and B show the results obtained by conventional gel-based PCR 
and quantitative PCR respectively. Levels of TNF-α mRNA increased after 30 
minutes with LPS stimulation, this indicated that TNF-α gene expression was 
up-regulated both in TC and GelMA cultures in response to LPS. After four 
hours, the quantity of TNF-α mRNA in PBMCs cultured on GelMA hydrogels 
was reduced, suggesting TNF-α gene expression had been suppressed. In 
contrast, LPS-stimulated PBMCs cultured in the TC condition maintained 
expression of TNF-α. 
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Figure 22. LPS-induced TNF-α gene expression is down-regulated in PBMCs cultured on 
GelMA.  
A. Measurement of TNF-α gene expression by conventional ethidium bromide gel-based RT 
PCR: after 30 minutes in culture, the band intensity indicates TNF-α gene expression had 
increased as a result of LPS stimulation in both GelMA and TC cultures. At 4 hours, 
expression of TNF-α was maintained in the TC control, however, it was down-regulated in the 
GelMA condition. B. Analysis of TNF-α gene expression by real time quantitative PCR: 30 
minutes after LPS stimulation the relative quantity of TNF-α expression increased in GelMA 
and TC cultures. After 4 hours, up-regulation of TNF-α gene expression was maintained in TC 
cultures, however, LPS-induced TNF-α gene expression was attenuated in the presence of 
GelMA. ∆∆ Ct Analysis normalised against GapDH. Error bars represent standard error. Data 
shown is from one donor but is representative of results from 3 independent donors. Refer to 
Appendix I for supplementary data. 
GelMA hydrogels ‘mop up’ TNF-α 
A cell-free system was used to determine whether levels of soluble TNF-α 
protein were depleted by GelMA. In these experiments, recombinant human 
TNF-α was added to the tissue culture media and incubated with GelMA 
hydrogels. After 4 hours, the supernatants were collected for cytokine analysis 
by ELISA. 
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As shown in Figure 23A, there was a large reduction in soluble TNF-α detected 
in supernatants collected from GelMA, compared to TC. This was shown over 
a titration of concentrations of TNF-α in Graph 1 of Figure 23A. By calculating 
the residual TNF-α in the media collected from GelMA (30%), relative to TC 
(100%), a significant reduction of TNF-α recovered from GelMA was 
determined (P = 0.0006, **), as shown in Graph 2 of Figure 23A. 
To confirm the fate of the TNF-α protein, GelMA was incubated with TNF-α-
containing media for 4 hours. Immuno-fluorescent staining of the gel was 
performed for TNF-α in order to determine whether it was bound within the 
gel. As shown in Figure 23B, GelMA hydrogels which had been incubated 
with TNF-α were positively and specifically stained for human TNF-α, 
indicating the presence of TNF-α bound within the hydrogel. 
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Figure 23. Depletion of soluble TNF-α by GelMA hydrogels. 
A. Residual TNF-α detected after incubation of GelMA hydrogels in media containing 0.5, 2.5 
and 5ng/mL recombinant TNF-α. Error bars represent standard error of the mean. B. TNF-α 
recovered from TC (100%) and GelMA (30%), a significant reduction in residual TNF-α 
recovered from GelMA was found relative to TC (P = 0.0006, **). A two-tailed t test was 
performed to determine statistical significance (n = 3 independent experiments). Error bars 
represent standard deviation. C. TNF-α-treated GelMA, labelled with mouse anti-human TNF-
α (primary) and rhodamine red goat anti-mouse (secondary) antibodies. Untreated GelMA, 
stained with primary and secondary antibodies. GelMA, secondary antibody control. GelMA, 
unlabelled. Images acquired on an LSM710 META Zeiss confocal system, using a 20X 
objective. Scale bars represent 100µm. 
It is plausible that GelMA exhibits the ability to adsorb certain polypeptides 
and proteins, including some cytokines. Gelatin has a repeating amino acid 
sequence of Gly-Pro-X but does include other amino acids with a range of side 
chains (Van Den Bulcke et al., 2000). It may be possible that GelMA based on 
the specific gelatin source displayed sufficient functional groups able to 
interact non-covalently with TNF-α, as has been noted for a variety of small 
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molecules, providing a potential cytokine sequestration mechanism (Nezu and 
Winnik, 2000, Taravel and Domard, 1993, Vaidyanathan et al., 2003). In 
addition, the 3D, porous nature of the GelMA hydrogel could also assist in the 
wicking away of cytokines (Benton et al., 2009). 
Characterisation of Collagen Hydrogel 
Both human PBMCs and moDCs were used in the experiments to characterise 
collagen for immune cell culture. Collagen hydrogel layers were formed under 
sterile conditions before seeding cells and maintained under standard tissue 
culture conditions (37°C, 5% CO2). 
Cell health is not impaired by collagen hydrogels 
For cell viability studies, PBMCs were cultured on collagen hydrogel layers for 
5 days. The Annexin V\PI cytotoxicity assay was performed to analyse cell 
viability by flow cytometry. 
Representative dot plots for Annexin V\PI-stained cells harvested from TCP 
and collagen hydrogels are illustrated in Figure 24A and B respectively. As 
shown in Figure 24C, the percentages of viable (79.4%) and non-viable 
(20.6%) cells collected from collagen hydrogels were not found to be 
significantly different from those collected from TCP, 76.0% viable and 24.0% 
non-viable cells (P>0.05). These results suggest that collagen hydrogels do not 
impair immune cell health. 
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Figure 24. Collagen hydrogels are not detrimental to PBMC viability. 
Annexin-V\PI profiles of cells harvested from TCP (A) and collagen hydrogels (B). C. 
Percentage of viable (solid bars) and non-viable (striped bars) cells collected from TCP and 
collagen hydrogel. No significant differences were found using two-tailed t-tests to compare 
the proportions of viable or non-viable cells collected from each condition (P>0.05) (n = 3 
independent experiments). Error bars represent standard deviation. 
Collagen hydrogels support PBMC immune responses 
PBMCs were used to investigate immunological responsiveness in the presence 
of collagen hydrogels. LPS was used to stimulate a pro-inflammatory response, 
which was assessed by the production of a panel of cytokines including IL-1β, 
IL-6, IL-8 and TNF-α. Supernatants were collected for cytokine analysis by a 
multiplex bead array method. 
The results from this experiment are shown in Figure 25. Graphs A-D show the 
production of IL-1β, IL-6, IL-8 and TNF-α respectively. IL-1β was 
significantly upregulated by PBMCs cultured on collagen hydrogels following 
LPS stimulation (P = 0.0128, *). There was also a significant increase in IL-6 
upon LPS stimulation in collagen hydrogel cultures (P = 0.0048, **). 
Production of IL-8 was raised, with respect to TCP, in unstimulated collagen 
hydrogel cultures and there was no augmentation with LPS. Production of 
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TNF-α was increased following stimulation by LPS in collagen hydrogel 
cultures, however, this was not found to be statistically significant (P≥0.05).  
Overall, the increase in the production of inflammatory cytokines in collagen 
cultures with LPS stimulation indicated the induction of a typical immune 
response to such an immunogenic agent by PBMCs cultured in the presence of 
collagen hydrogels. 
 
Figure 25. PBMC inflammatory cytokine response is supported by collagen hydrogels. 
A. IL-1β production by PBMCs increased significantly in TCP (P = 0.0134, t=5.263, df=3) and 
collagen hydrogel cultures (P=0.0128, t=5.343, df=3) with LPS stimulation. B. Levels of IL-6 
significantly increased with LPS stimulation for TCP (P=0.0026, t=9.331, df=3) and collagen 
hydrogels (P=0.0048, t=7.569, df=3). C. Increased IL-8 production in LPS-stimulated TCP 
cultures but this was not found to be significant. Levels of IL-8 increased in unstimulated 
collagen cultures, no effect seen +LPS. D. TNF-α production increased with LPS stimulation, 
this was significant for TCP (P=<0.001, t=63.00, df=3) but not collagen hydrogel cultures. T 
tests were used to determine significant differences (n = 3 independent experiments). Error 
bars represent standard deviation. 
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Phenotypic maturity of dendritic cells is not affected in culture 
with collagen hydrogels 
To confirm the suitability of collagen for immune cell culture, the interaction 
with a purified cell type, moDC, was investigated. In these experiments moDC 
were seeded on collagen hydrogels and cultured for 24 hours before harvesting 
for phenotypic analysis. The phenotype of moDCs was assessed by staining for 
CD40, CD54, CD83 and CD86. These markers of moDC maturation include 
co-stimulatory and adhesion molecules. The level of expression of each marker 
was used to judge the maturation state of the cells. 
Figure 26 shows the expression of these markers under resting conditions on 
the collagen hydrogels. Graphs A-D represent the expression of CD40, CD54, 
CD83 and CD83 respectively presented as median fluorescence intensity 
(MFI). Reassuringly, collagen hydrogels did not cause any significant changes 
in the expression of the four markers (P≥0.05). This indicated that collagen 
hydrogels did not affect the maturation state of moDCs. 
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Figure 26. Dendritic cell maturity is unchanged in culture with collagen hydrogels. 
A, B, C & D show expression of CD40, CD50, CD83 and CD86 by dendritic cells is not 
affected by culture with collagen hydrogels. One-way ANOVA used to determine statistical 
significance (P≤0.001, ***), (P≤0.0001, ****), (P≤0.01, **) (n = 3 independent experiments). 
Error bars represent standard deviation. MFI = median fluorescence intensity. 
Dendritic cells are responsive to immunological stimulation in 
collagen hydrogel cultures 
LPS-stimulations were performed to check whether moDCs were still 
responsive to an immunogenic stimulus when cultured on collagen hydrogels. 
Cells were stimulated for 24 hours and then collected for phenotypic analysis. 
In Figure 27, graphs A-D show the expression of CD40, CD54, CD83 and 
CD86 as MFI. Expression of CD40 is increased with LPS stimulation in the 
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context of collagen, although this was not found to be statistically significant. 
There was a significant increase in the expression of CD54 (P = 0.0071, **), 
CD83 (P = 0.0199, *) and CD86 (0.0466, *) by moDCs following LPS 
stimulation in the presence of collagen. These results suggested that moDCs 
were immunologically competent when cultured in the presence of a collagen 
hydrogel. 
 
Figure 27. Dendritic cells are responsive to LPS stimulation in culture with collagen 
hydrogels. 
The response of collagen-cultured moDCs upon LPS stimulation was assessed by expression of 
cell surface maturation markers. A. CD40 expression increaseed with LPS stimulation, this was 
found to be significant for TCP-cultured dendritic cells (P=0.0493, t=2.791 df=4) but not for 
collagen hydrogels. B. Expression of CD54 increased significantly by both TCP (P=0.0074, 
t=5.020 df=4) and collagen-cultured (P=0.0071, t=5.071 df=4) dendritic cells. C. CD83 
expression was significantly up-regulated in response to LPS by dendritic cells cultured on 
TCP (P=0.0444, t=2.894 df=4) and collagen hydrogel (P=0.0199, t=3.750 df=4). Expression of 
CD86 is increased following stimulation by LPS stimulated, this was significant for collagen-
cultured cells (P=0.0466, t=4.469 df=2) but not TCP. T tests used to determine significance (n 
= 3 independent experiments). Error bars represent standard deviation. 
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Depletion of the soluble cytokine, IFN-γ, by collagen 
hydrogels 
As noted in this work and by others, certain ECM-derived biomaterials, 
including collagen, can bind cytokines with potentially immune-modulatory 
effects (Wiegand et al., 2010, Lortat-Jacob et al., 1991).  
For the purposes of this thesis, interferon (IFN)-γ was an important readout for 
the down-stream assessment of antigen-specific T cell activation, as described 
in Chapter 4 of this thesis (Xu et al., 1996). 
To determine whether the collagen hydrogel dramatically affects levels of 
soluble IFN-γ, a cell-free system was used. Collagen hydrogels were prepared 
at two different concentrations, 1.7mg/mL and 0.5mg/mL. At time zero (T0) 
the concentration of IFN-γ in the media was 500pg/mL. This was incubated 
with the collagen hydrogels under standard conditions (37°C, 5% CO2) and 
sampled after 30 minutes, 1 hour, 2 hours and 4 hours. 
The results from this experiment are shown in Figure 28. Graphs A-B represent 
the IFN-γ concentration detected after 30 minutes, 1 hour, 2 hours and 4 hours 
respectively. The concentration of IFN-γ decreased rapidly over the 4 hour 
time course in all conditions. There was an indication that the rate of depletion 
was only slightly faster in the presence of the collagen hydrogels, with no 
effect of collagen concentration, compared to TCP. 
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Figure 28. IFN-γ depletion with collagen hydrogels. 
IFN-γ depletion over 4 hours on TCP and two collagen hydrogels at different concentrations,  
0.5mg/mL and 1.7mg/mL. 
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2.4. Conclusions and Further Work 
Characterisation of biomaterials is an important step in the development of 
tissue-engineered immune-competent constructs. The thermo-responsive 
particulate gel showed promise in terms of creating a porous matrix to mimic 
the ECM of the natural LN tissue. This was the first time primary human 
immune cells have been cultured within a thermo-responsive particulate gel. 
The temperature-sensitive properties allowed in situ gelation under mild, 
physiological conditions creating a robust, cell-laden matrix. 
Based on the FS\SS properties, the moDC population could not be easily 
discriminated from the particulate material of the gel. One reason for this could 
have been that moDCs either stuck to, or engulfed the particles, thereby 
altering their size and granularity. To investigate this further, fluorescently 
labelled particles could be used, then, fluorescent imaging could be performed 
to determine the localisation of the particles with respect to the cells. 
Fluorescent labelling for specific markers, such as CD11c, allowed moDCs to 
be distinguished from the gel material. This showed the potential for a wider 
array of markers to be used, for example, to assess the effect of the colloidal 
gel on moDC maturation. It is important to bear in mind that due to the large 
number of events that account for the particulate material, the sensitivity in 
terms of detecting markers which are expressed at relatively low levels may be 
limited. 
Flow cytometry was also used to assess cell viability by Annexin V\PI staining. 
In the analysis, it was impossible to determine the number of viable cells since 
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they could not be distinguished from the particulate material. Alternative 
methods to measure cell death, which would not require cell separation from 
the particles, could include the lactate dehydrogenase (LDH)  or MTT assays. 
Overall, analysis of the cells by flow cytometry was limited since the material 
derived from the gel could not be separated. To assess the effect of the 
colloidal gel on moDC biology, without the need to separate the cells from the 
particles, alternative methods such as, cytokine production and gene 
expression, would be appropriate. 
The inability to separate moDCs from the particulate material would also be 
preventative of downstream applications, such as co-culture with T cells. The 
use of magnetic particles could be explored in order to purify the cells from the 
gel material to increase the potential for downstream applications. Due to a 
shortage of time and resources it was decided not to pursue studies of this 
biomaterial in this work. 
Electrospinning offers a convenient method to produce scaffolds for cell 
culture. The fibrous structure of these materials reflects the ECM network, 
which guides cell motility and interactions in vivo. The PEGMA-coated PET 
and PLGA scaffolds provided further benefit since their temperature-sensitive 
properties were used to facilitate the collection of cells. The results from the 
cell viability assay were encouraging since none of the electrospun scaffolds 
tested caused a significant level of cell death. 
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Dendritic cell maturation marker, CD83, was used to assess the effect of the 
scaffold on the maturation state of moDCs. The significant increase in 
expression of CD83 on cells harvested from the electrospun materials was 
indicative that the scaffolds induced cell maturation. SEM revealed that cell 
coverage on the scaffolds was sparse, suggesting that the cells had not attached 
strongly and had easily been displaced during sample preparation. 
Although the scaffolds demonstrated compatible architectural features and low 
cytotoxicity, the induction of DC maturation was not a desirable effect for the 
purposes of this work since it may have potentially affected the immunological 
specificity of the system. 
Investigation of the effect of the fibre diameter and different coatings on DC 
maturation and attachment would be interesting to determine whether the 
immunogenicity and immune cell-responsiveness of electrospun scaffolds can 
be modified. 
Hydrogels have a highly hydrated, porous structure which closely resembles 
the ECM of soft tissues and are therefore popular candidates for tissue 
engineering purposes. GelMA has been used successfully in a variety of 
bioengineering applications, it has advantages over unmodified counterparts 
due to its mechanical stability and flexibility in fabrication methods. 
This was the first time GelMA had been characterised for its compatibility with 
immune cells. The initial results from the cell viability assay were encouraging, 
since GelMA did not significantly impair cell viability. However, background 
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levels of inflammatory cytokines were raised in GelMA cultures, indicating it 
had immunogenic properties. Also, when immune cells were tested for their 
ability to mount an inflammatory response to LPS, there was little 
enhancement of inflammatory cytokines. 
The species from which natural biomaterials are sourced can have implications 
on immunogenicity. It would be worth testing the immunogenicity of GelMA 
synthesised from gelatin derived from other species. 
Also, this work was done with the total PBMC population. It would be 
informative to study the cell-material interaction in more detail using purified 
populations of immune cells, i.e. monocytes, DCs, T cells and B cells. 
TNF-α was the subject of particular attention in this work due to its key role in 
modulating inflammatory responses in vivo. GelMA was found to deplete 
levels of soluble TNF-α, presumably though adsorption. GelMA is likely to 
have greater potential for protein interactions, compared with collagen. As it 
has undergone chemical modification, there are likely to be more chemically 
reactive groups exposed which may be involved in protein binding. Properties 
of the cytokines measured in this experiment, including protein size and 
isoelectric point, were compared and no striking differences were identified. 
Therefore, it is not clear what property sets TNF-α apart from the other 
cytokines, IL-1β, IL-6 and IL-8, which caused it to preferentially bind GelMA. 
Gene expression studies showed that GelMA suppressed of LPS-induced TNF-
α gene expression. TNF-α is under strict regulatory mechanisms which control 
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its expression. LPS induces TNF-α expression in monocytes through Toll-like 
receptor 4 (TLR4). The signalling pathways involved in TNF-α production 
include MAP kinases (ERK1/2, p38 and JNK) and NF-kappaB (Tazi et al., 
2006). Soluble TNF-α signals through the receptor TNF-R1, which in turn 
activates a variety of signal transduction pathways, including MAP kinases and 
NF-kappaB. These regulate transcription factors involved in the production of 
inflammatory cytokines (MacEwan, 2002, Ronkina et al., 2010). It is feasible 
that TNF-α provides positive feedback to cells via paracrine or autocrine 
signalling in order to maintain its own expression. 
In the context of the observations made in this work, a mechanism for the 
suppression of the expression of TNF-α can be postulated, whereby, the 
GelMA hydrogel  sequesters TNF-α. This would deplete the soluble signal 
(TNF-α) required for maintaining TNF-α gene expression, which would 
presumably result in switching off the positive feedback mechanism, as 
depicted in Figure 29. 
The mechanism by which GelMA influences the expression of LPS-induced 
TNF-α requires deeper investigation in order to confirm the suppressive effect 
seen at the level of gene expression. This could be done by assessing the effect 
of GelMA on components of the pathways involved in the regulation of TNF-α 
gene expression. 
Although GelMA was shown to deplete soluble TNF-α and suppress gene 
expression, it was not clear whether this actually translated into a reduction in 
cytokine secretion. This could be confirmed by measuring the amount of TNF-
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α present in the supernatant and bound in the hydrogel following PBMC 
stimulation by LPS. It would also be worth testing whether there would be 
normal activation in response to LPS if GelMA was already saturated with 
TNF-α. 
Finally, further work into the long-term effects of TNF-α sequestration would 
be interesting to determine what the implications of TNF-α leaching back out 
of the GelMA hydrogel would be for the inflammatory status of immune cells 
in the proximity 
Since GelMA was observed to have potentially both immunogenic and 
immune-modulatory effects, it was not considered appropriate as a platform for 
immune cell culture applications in this work. 
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Figure 29. A role for GelMA in the modulation of TNF-α. 
TNF-α gene expression increased within 30 minutes of LPS stimulation in both TCP and 
GelMA conditions. After 4 hours, LPS-induced TNF-α expression is maintained through a 
positive feedback mechanism and levels of secreted TNF-α peak in TCP. Whereas the GelMA 
hydrogel sequesters secreted TNF-α protein, thereby effectively removing it from solution. 
This disrupts the relay of positive feedback signals to the cell for the maintenance of TNF-α 
expression. Thus, by 4 hours, there is no detectable increase in soluble TNF-α and gene 
expression is suppressed in the context of GelMA. 
Collagen has already been used successfully to engineer immune-competent 
constructs. To characterise it in terms of this study, assays to determine cell 
viability and immune responses with mixed (PBMCs) and purified (moDCs) 
primary human immune cell populations were carried out. 
The collagen hydrogel did not induce significant cytotoxicity. Upon 
stimulation with LPS, PBMCs cultured on collagen hydrogels mounted typical 
inflammatory responses based on cytokine secretion. 
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The resting moDC phenotype was not affected in the presence of collagen 
hydrogels, since there was no significant change in the expression of moDC 
activation markers, CD40, CD54, CD83 or CD86. In culture with collagen 
hydrogels, moDCs responded appropriately to immunogenic stimulation by 
LPS, demonstrated by a significant increase in expression of activation 
markers. 
Future work could focus on the effect of encapsulating immune cells within the 
hydrogel. This would expose the cells to a truly 3D environment. 
In a cell-free system, levels of soluble IFN-γ were depleted marginally faster in 
the presence of collagen hydrogel, compared to TCP. This is likely to be partly 
due to adsorption of IFN-γ by collagen, as previously described. This 
experiment was a snapshot of the fate of one dose of IFN-γ in vitro. 
Fluorescent labelling of the hydrogel for IFN-γ, or digesting the gel and 
measuring the levels of IFN-γ recovered would also help to give a deeper 
insight. 
In vivo, IFN-γ has important physiological roles in terms of modulating 
immune responses, therefore its production is under tight regulatory 
mechanisms (Philip and Epstein, 1986, Arai et al., 1990, Younes and Amsden, 
2002). It has a very short half-life, presumably to allow the rapid cessation of 
its potent immunological effects (Miyakawa et al., 2011).  
Activation of a robust T cell response in a biological assay would result in the 
continuous and increased production of IFN-γ. It was therefore anticipated that 
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the slight depletion in IFN-γ concentration would not be of significant 
consequence in terms of using IFN-γ secretion as a readout for T cell activation 
in collagen hydrogel cultures. 
In conclusion, the work in this chapter has described the characterisation of 
synthetic and natural biomaterials for immune cell culture. This is the first time 
a particulate gel and GelMA hydrogel, have been cultured with immune cells. 
Finally, this study highlighted the importance of investigating biomaterial 
biocompatibility based on cell function, in this case immune cell function, for 
specific applications. It has also generated some new, useful information 
regarding the interaction of biomaterials with immune cells. This contributes to 
the current trend in the field in establishing the immune-compatibility of 
biomaterials to ensure scaffolds are appropriate for particular purposes. 
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Chapter 3 
Design, Fabrication & 
Characterisation of a Fluidic 
Platform for Immune Cell Culture 
3.1. Introduction 
Chapter Overview 
The development of fluidic platforms for the culture of cells has revolutionised 
the field of tissue engineering. Such systems are intended to expose cells, either 
directly or indirectly, to the physical forces of shear fluid stress, also referred to 
as flow (Inamdar and Borenstein, 2011). In addition to removing waste and 
providing nutrients, flow is also a physiological mechanical stimulus which has 
crucial roles in modulating the function of a variety of cells and tissues in vivo. 
The application of fluidics to in vitro cell culture is anticipated to have a 
number of advantages through increasing the physiological relevance of tissue 
engineered constructs. Exposure to flow may help to promote in vivo-like cell 
phenotypes and prevent de- differentiation, which is a common problem 
associated with in vitro culture of certain cell types (Goral et al., 2010). 
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Flow also allows the formation of gradients, this is useful for studying the 
effects of concentration gradients of factors such as oxygen, growth factors, 
chemokine and cytokines on cell behaviour (Cimetta et al., 2010). 
Three-dimensional (3D) in vitro cell culture is often limited by the delivery of 
nutrients to the centre of the construct and removal of waste products. Flow 
facilitates mass transport of these factors; increasing the availability of 
nutrients and preventing the accumulation of toxic waste products improves the 
viability and longevity of 3D tissue-engineered constructs (van Duinen et al., 
2015). 
Fluidic systems are now being designed for a wide variety of applications in 
tissue engineering, including disease models, drug discovery and safety testing 
(Inamdar and Borenstein, 2011). This chapter describes the work involved in 
the design, development and characterisation of a novel fluidic platform 
suitable for the culture of immune cells. 
Immune Modulation by Fluid Shear Stress 
Evidence for the effect of mechanical forces on modulating the immune system 
is growing, although research into elucidating the mechanisms is still in the 
early stages. Based on recent findings, inflammatory responses are suppressed 
by ‘normal’ mechanical physiological stimuli, whereas physical stimuli outside 
of this range can elicit inflammation (Previtera, 2014). 
Flow is a particularly relevant mechanical stimulus in the study of immune 
function since immune cells are exposed to the effects of fluid shear stress in 
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various anatomical sites. For example, immune cells within the vessels of 
circulatory and lymphatic systems will be exposed to the flow of blood and 
lymph respectively. The magnitude of the force depends on vessel type, 
location and the position of the cell within the lumen (Previtera, 2014, Makino 
et al., 2007). 
Cells residing within tissues, including lymph nodes, are subject to interstitial 
flow which is caused by the movement of fluid in the extracellular space 
around cells (Previtera, 2014). Interstitial flow is driven by systemic 
hydrostatic and osmotic pressure differences. It is generally slow and 
heterogeneous making flow rate quantification almost impossible. Although 
exact velocities are unknown, interstitial flow increases in the context of 
inflammation (Swartz and Fleury, 2007). Recent research has highlighted an 
important role for fluid shear stress in the maintenance and regulation of the 
immune system. 
Non-immune cells of lymphatic tissues have been shown to be responsive to 
flow with immunologically relevant effects. Stromal cells within the lymph 
node paracortex, known as T zone fibroblastic reticular cells (TRCs), express 
the chemokines CCL21 and CCL19. These chemokines are ligands for the 
receptor CCR7, which is expressed on DCs and T cells. CCL21 and CCL19 are 
required to guide cell migration to and within lymph nodes (Comerford et al., 
2013). Disruption of CCR7 binding leads to impaired immune responses 
(Förster et al., 1999). 
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Tomei et el. showed that slow interstitial flow was required to maintain TRC 
expression of CCL21 in a tissue-engineered lymph node microenvironment. 
The study also suggested that CCL21 expression is up-regulated in response to 
increased flow. Change in flow may therefore provide an early inflammatory 
signal which prepares secondary lymphoid organs, such as lymph nodes, for 
cell trafficking and the induction of efficient immune responses (Tomei et al., 
2009). 
The functions of the lymphatic endothelium include the transport of lymph 
fluid, containing antigen and cytokines, and antigen presenting cells from 
peripheral sites to lymph nodes. Fluid shear stress has been found to increase 
the expression of CCL21, as well as molecules involved in cell adhesion and 
transmigration, ICAM-1 and E-selectin, on lymphatic epithelial tissue. The 
modulation of the expression profile of these molecules by flow contributes to 
effective DC migration and homing to the lymph node (Miteva et al., 2010). 
It is likely that the physical action of flow is also involved in directing DC 
migration. This is because the distances from peripheral tissues to lymph nodes 
are too large for chemokine concentration gradients alone to be efficient, 
particularly as the direction of flow goes against the gradient (Swartz et al., 
2008). 
The motility of T lymphocytes has been shown to be modulated by flow. The 
interaction of CCL21\CCL19 with CCR7 supports T cell entry into lymph 
nodes and promotes their ‘random walk’ within the T cell zone. T cell arrest is 
mediated by these chemokines in synergy with ligands for integrin LFA-1, 
111 
 
expressed on DCs and TRCs. Woolf et al. demonstrated that shear flow was 
required to activate lymphocyte integrins to allow them to efficiently adhere to 
their ligands, in conjunction with chemokine priming. In the absence of shear 
forces, integrin adhesiveness was ‘silenced’ (Woolf et al., 2007). 
Finally, mild shear stress has been shown to initiate T cell signalling. In an 
elegant study, Li et al. generated artificial antigen presenting cells by coupling 
CD3 ligands to the surface of 3T3 fibroblasts. Elongated CD3 ligands bound 
but did not activate T cells via the T cell receptor complex. When shear stress 
was applied to the cells, there was an increase in calcium mobilisation in T 
cells bound to the extended CD3 ligands. Calcium signalling is an early 
indicator of T cell activation and this suggested that T cells were mechanically 
sensitive to physical forces, with the TCR acting as a mechanosensor (Li et al., 
2010). 
The implication of these observations is that flow has various roles in 
regulating immune function. Some of these include providing an early 
indication of inflammation to prime the lymphatic tissues, modulating 
migration of immune cells to and within lymph nodes and contributing to the 
induction of T cell activation (Miteva et al., 2010). These effects ultimately 
contribute to ensuring appropriate and effective immune responses. 
Considerations for the Design & Development of Fluidic 
Platforms 
The design and development of fluidic platforms for cell culture applications 
requires the specialist knowledge of engineers and biologists in order to 
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produce a robust system that suits the intended application. There are numerous 
factors to consider in this process, the key elements are outlined here. 
Materials and Machining 
Materials commonly used for the fabrication of fluidic systems for tissue 
engineering include polydimethylsiloxane (PDMS) and poly(methyl 
methacrylate) (PMMA). PDMS is a silicone-based polymer, it is an attractive 
material due to its oxygen permeability, and amenability to fabrication methods 
and patterning techniques. One limitation of PDMS, however, is its capacity to 
bind proteins, an effect which has largely been ignored in the development of 
fluidic systems. PMMA is a rigid, thermoplastic polymer, which is often 
chosen for its mechanical and chemical stability (Inamdar and Borenstein, 
2011). 
Materials such as PDMS and PMMA are amenable to routine engineering 
methods, such as laser cutting. The majority of methods involved in the 
manufacture of the components for fluidic systems can be done in standard labs 
and are scalable to allow high volume output of the devices. PDMS and 
PMMA are relatively inexpensive and are generally re-usable. Accessibility of 
materials and transferability of fabrication methods are important in enabling 
the widespread use of fluidic technologies by researchers around the world 
(Rizvi et al., 2013). 
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Cell Culture Substrate 
A variety of synthetic and natural biomaterials have been shown to provide 
suitable cell culture substrates for fluidic systems, some of these are described 
in more detail in Chapter 2, Biomaterials for Tissue Engineering, of this thesis. 
In addition to the range of biomaterials already described, paper-based 
scaffolds are starting to show promise in tissue engineering. Several 
applications, published and unpublished, have demonstrated good 
compatibility with cell culture and fluidic systems. Rahimi et al. successfully 
combined a microfluidic system with a hydrogel-coated paper-based scaffold 
to generate an air-liquid-interface for epithelial cell culture (Rahim et al., 
2015). A novel method, named cells-in-gels-in-paper (CiGiP), has recently 
been described by Camci-Unal et al. This involved stacking paper scaffolds, 
embedded with cell-laden hydrogel, to assemble 3D co-cultures of human lung 
cancer cells and fibroblasts (Camci-Unal et al., 2016). 
Pumping System 
Pumping systems used in fluidics are usually commercially available syringe or 
peristaltic pumps. Syringe pumps provide a steady (non-pulsatile) flow and are 
usually used in one-pass systems. This means media does not recirculate and 
requires large volumes of reagents. It also prevents the accumulation of soluble 
signalling molecules, such as cytokines, which provide important feedback to 
cells. 
Peristaltic pumps generate a pulsatile flow. They allow continuous perfusion of 
media, therefore secreted factors recirculate, which may be more representative 
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of the in vivo microenvironment. These systems require much lower volumes 
of media. 
The importance of pulsatile versus non-pulsatile flow for in vitro cell culture 
applications has not yet been fully determined. Research in the field indicates 
the nature of the flow has more significant effects on certain cell types than 
others. This could be partially dependent on the flow conditions in the native 
tissue from which the cells are originally derived (Balcells et al., 2005, Abe et 
al., 2013). 
Data Collection 
The device must be accessible for sampling, the application and type of 
samples will determine the design for this. For example, optical transparency 
would be a requirement for a platform where imaging methods are central in 
the experimental approach. Likewise, the addition of ports for the collection of 
supernatant and cells would facilitate sample collection over a time course 
study without interrupting the experiment. 
Interpretation of data obtained from fluidic platforms may be limited in terms 
of its comparability to conventional methods. Due to the novelty of such 
techniques, incorporating relevant controls into experiments is essential since 
the field is in its infancy and such information does not yet exist. 
Operator 
Following initial optimisation, fluidic platforms must be suitable for use in a 
tissue culture lab. A general method can be outlined and applied to the setup of 
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a range of fluidic platforms as follows. First, the components are sterilised, 
then, the platform is assembled and seeded with cells under sterile conditions. 
Finally, it is transferred to an incubator and connected to the pumping system. 
These steps have the potential to be fraught with operational barriers, such as 
keeping the components sterile, tubing attachment, accessibility for cell 
seeding and leakage or evaporation of media. Careful planning during the 
design process can avoid this. 
Chapter Aims 
This chapter describes the construction of fluidic systems and characterisation 
of a fluidic platform for immune cell culture. In this chapter, the aim of the 
work was to develop a cell culture platform to investigate the effects of shear 
flow on immune cells in vitro. This was achieved by first developing a robust 
fluidic system. Then, the platform was utilised to characterise the effect of 
shear flow on human immune cells based on dendritic cell viability, maturation 
and response to immunological stimulation. 
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3.2. Materials and Methods 
Fluidic Platform Assembly 
Three-channel microfluidic device 
The device was constructed from 3.175mm-thick PMMA, which was cut to 24 
x 40mm, with inlet and outlet ports 2.2mm in diameter, using a laser cutter 
(VersaLASER, Universal Laser Systems Inc.). Double-sided adhesive (DSA) 
films were cut to the same dimensions, then, three channels were cut out of the 
centre measuring 4mm wide. Six DSA films were stacked to give the channels 
a depth of 3mm. The DSA stack was stuck down on to a #1.5 thickness cover 
glass slide. 
The surface of the glass slide was plasma etched under the following 
conditions to increase the hydrophilicity of the surface for subsequent collagen 
hydrogel coating, time = 60, seconds, power = 40 watts, pressure = 300 mTorr. 
The devices were sterilised by UV irradiation (245nm) for 15 minutes. 10µL 
collagen hydrogel (0.5mg/mL), prepared according to the method described in 
Chapter 2 of this thesis, 2.4. Materials and Methods: Preparation of Collagen 
Hydrogels, was then spread evenly over each channel, then transferred to the 
incubator for 40 minutes to allow the hydrogel to set. 
The PMMA sheet was attached to the top layer of DSA and the inlet and outlet 
tubing (TYGON 3350 silicone; Cole Parmer) was glued in place using 5 
minute epoxy (Devcon). Tubing was attached to syringes loaded on the syringe 
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pump (Harvard Appartus PHD 2000 Syringe Pump) with 18G blunt fill 
needles. A flow rate of 2µL/minute was used to test the device. 
Fluidic device with paper-based scaffold 
The platform was fabricated using 2mm-thick polymethyl methacrylate 
(PMMA) and 1mm-thick PDMS. A CO2 laser system (Universal Laser 
Systems Inc., Scottsdale, AZ) was used to cut all components to required 
dimensions. The PMMA was cut to 5cm(L) by 3.5cm(W), with 8 holes 
(5mmø) around the perimeter, 2mm from the edge, for the insertion of bolts. 
Inlet and outlet ports were bored into the sheets of PMMA which formed the 
top of the flow platform. 
For static platform, central channels were cut out of PMMA sheets. Two of 
these sheets were glued together to form the cell culture chamber. 
The PDMS was cut to 5cm(L) by 3.5cm(W), with 8 5mmø holes. PDMS sheets 
had channels cut out, 2cm (L) by 5mm(W), to form cell culture chambers 
which were used for static and flow devices. 
The silicone-coated cellulose based paper scaffold (purchased from Reynolds 
Kitchens, Reynolds® parchment paper roll) was cut to 5cm(L) by 3.5cm(W). 
The surface of the paper treated using a CO2 laser, where the power was 10W 
and scanning speed was 35mm/second, to achieve a hydrophilic surface. 
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Components were sterilised by UV irradiation (245nm), followed by 
submersion in a 20% antibiotic\ antimycotic solution overnight, then they were 
washed PBS and air-dried under sterile conditions. 
Assembly of the platform was conducted in a laminar flow hood. Static device: 
Paper scaffold interleaved between PDMS films, upper film with channel cut 
out. Two layers of PMMA glued together, centre channel cut out to create cell 
culture chamber. Sheets of PMMA enclosed the device. Flow platform: Paper 
scaffold inserted between PDMS films, channel cut out of upper film. Sheets of 
PMMA encased device, upper sheet with inlet and outlet ports for fluidic 
tubing to be attached. PVC double manifold tubing (purchased from Watson 
Marlow) was attached to the inlet port and a gas-permeable silicone tubing 
(TYGON) was connected to the outlet port using epoxy glue (5-minute epoxy, 
Devcon) to fix the tubing in place. 5mm nuts and bolts used to hold 
components together. 
A peristaltic pump, 323S Drive 400rpm, fitted with a 314MC five channel, four 
roller microcassette pumphead (Watson-Marlow) was used as the pumping 
system for this device. 
Flow rate calibration (µL\min) was performed by measuring the volume of 
buffered saline solution that passed through the platform in 5 minutes. This 
was done for the following settings for the peristaltic pump: 3rpm, 5rpm and 10 
rpm. Each measurement was repeated 3 times and the average volume 
collected was calculated. 
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The volume capacity of the flow platform, including tubing but not the 
reservoir, was 200µL. 
Collagen Hydrogel-Coated Paper Scaffold 
The collagen hydrogel was prepared according to the method described in 
Chapter 2 of this thesis, 2.4. Materials and Methods: Preparation of Collagen 
Hydrogels. The collagen solution was retained on ice until required. 
10µL of the collagen hydrogel was evenly spread over the hydrophilic surface 
of the paper scaffold. It was then transferred to the incubator for 40 minutes to 
set. 
Generation of Monocyte-Derived Dendritic Cells  
This was done according to the method described in Chapter 2 of this thesis, 
2.4. Materials and Methods: Generation of Monocyte-Derived Dendritic Cells. 
Dendritic Cell Culture on Collagen Hydrogel -Coated Paper 
Scaffolds 
5 x 10
5
 monocyte-derived dendritic cells were seeded per scaffold and 
transferred to the incubator for 2 hours to allow cells to adhere. For flow 
platforms, 500µL complete RPMI media was contained in the reservoir. The 
manifold tubing was connected to the peristaltic pump and a flow rate of 
5µL\min (3rpm) was used for all experiments. For static platforms, 500µL 
media was added directly to the cell culture chamber. Flow and static platforms 
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were maintained under standard tissue culture conditions (5% CO2, 37°C) for 
the duration of the experiment. 
Dendritic cell stimulation was performed using E. coli lipopolysaccharide 
(LPS) (0111:B4) (purchased from Sigma) at a concentration of 0.1µg/mL for 
24 hours. 
Endotoxin neutralisation was done using Polymyxin B sulphate (PMB) 
(purchased from Sigma). A 50µg/mL solution was prepared in sterile PBS. 
Scaffolds were incubated with the PMB solution for 45 minutes and washed 
thoroughly with media before cell seeding. 
Annexin-V\Propidium Iodide Cytotoxicity assay 
This was done according to the method described in Chapter 2 of this thesis, 
2.4. Materials and Methods: Annexin-V\Propidium Iodide Cytotoxicity assay. 
Dendritic Cell Phenotypic Analysis  
This was done according to the method described in Chapter 2 of this thesis, 
2.4. Materials and Methods: Dendritic Cell Phenotypic Analysis. 
Flow cytometric analysis  
This was done according to the method described in Chapter 2 of this thesis, 
2.4. Materials and Methods: Flow Cytometric Analysis. 
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Immuno-Fluorescent Staining moDCs with Phalloidin Alexa Fluor-
488 and DAPI 
Samples were gently washed in PBS then fixed in 4% paraformaldehyde for 20 
minutes at room temperature. They were then washed twice with PBS before 
permeablising cells with 0.15% Triton X for 20 minutes. Samples were washed 
twice in PBS, then blocked using a 5% solution of goat serum for 30 minutes. 
Samples were washed three times in PBS. A 1:20 dilution of Phalloidin Alexa 
Fluor-488 (Life technologies) was made and incubated with samples for 20 
minutes, in the dark, at room temperature. They were washed three times in 
PBS. 4’,6-Diamidino-2-Phenylindole (DAPI) was diluted 1 : 20,000 and added 
to samples for 5 minutes. Samples were washed three times in PBS and then 
mounted using #1.5 thickness cover slips. 
Confocal microscopy 
Samples were imaged using a Zeiss LSM710 confocal microscope. 10X and 
20X objectives were used. Lasers 405 and 488 were selected for DAPI 
(Excitation\Emission: 358\461) and Phalloidin Alexa Fluor 488 (Ex\Em: 
490\525) respectively. 
Image analysis 
ImageJ was used for the analysis of fluorescent images (Schneider et al., 2012). 
Statistical analysis  
Analysis was carried out using GraphPad Prism version 6.00 for Windows, 
GraphPad Software, La Jolla California USA (www.graphpad.com)
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3.3. Results and Discussion 
Construction of Fluidic Platforms for Cell Culture 
A three-channel microfluidic device 
Two different fluidic platform designs were tested to determine their suitability 
for this work. The first was based on a microfluidic device originally described 
by Rizvi et al. with minor modifications (Rizvi et al., 2013). As illustrated in 
Figure 30, the device had 3 channels which were created by stacking layers of 
medical-grade double sided adhesive (DSA) onto a cover glass slide. Three 
channels were laser cut out of the DSA films and 6 films were stacked together 
to give the channels depth. A sheet of PMMA with inlet and outlet ports bored 
into it was attached to the top layer of DSA film. The fluidic tubing was then 
glued into the inlet and outlet ports. 
 
Figure 30. Diagram to show assembly of the three-channel microfluidic device. 
Stack of 6 DSA films, with 3 channels cut out, assembled on cover glass slide. Channels coated 
with collagen hydrogel, then device enclosed by PMMA sheet with inlet and outlet ports. 
Tubing glued into ports and system attached to syringe pump. 
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Before assembly, the channels were coated with a collagen hydrogel to provide 
a substrate for cell culture. First, the channels were plasma etched to increase 
the hydrophilicity of the glass surface. Then, the device was sterilised by UV 
exposure at 245nm and collagen hydrogel was spread evenly over the channels. 
The pumping system used for the optimisation of this device was a syringe 
pump. This meant that it was a one-pass flow system. 
There were numerous advantages of the design of this device for cell culture 
applications. It was fabricated from inexpensive and widely available 
components. The channel coating was not limited to collagen, other ECM 
substrates, such as Matrigel™, could be used. The cover glass base meant it 
was optically transparent, which gave it the potential for in situ real-time 
imaging of cells within the channels at high resolution. The continuous flow of 
media through the system enabled sequential cell seeding. 
However, several limitations were identified during assembly and optimisation: 
 The cover glass base meant that devices were very fragile and easily 
fractured. 
 
 One-time use device. 
 
 Manually stacking 6 films of DSA led to difficulties in lining up the 
films evenly. 
 
o Leakage and air bubbles occurred due to gaps between layers of 
DSA films. 
 
 The design lacked flexibility in terms of the construction, therefore no 
opportunity to make modifications. 
 
 One-pass system used large volume of media. 
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Despite the efforts to optimise this device, it was not reliable or robust enough 
to withstand the duration, 3 – 6 days, of the cell culture studies. In light of the 
drawbacks of the device, it was not pursued for this work. 
Fluidic device with a paper-based scaffold 
The design of the second device was based on a removable paper insert, which 
provided the scaffold for cell culture. The paper scaffold was a cellulose-based 
paper with a silicon coating. The paper was surface treated using a CO2 laser to 
increase its hydrophilicity. Paper scaffolds were coated with a collagen 
hydrogel to provide an appropriate substrate for immune cell culture. 
The fluidic platform and the static counterpart are illustrated in the diagram in 
Figure 31. For both configurations, the paper scaffold was sandwiched between 
two films of PDMS. The upper film had a channel cut out of the centre to 
create the cell culture chamber.  
Sheets of PMMA were used to give the devices structural support. Uniquely to 
the flow device, the top sheet of PMMA had two ports to allow for the 
insertion of inlet and outlet tubing. For the static device, double layered 
PMMA, with a central channel cut out, was used to form the cell culture 
chamber. Uncut sheets of PMMA were used as the base for the devices and to 
seal the static chamber.  
For both devices, nuts and bolts were used to hold the components in place. 
This allowed easy assembly and disassembly of the devices without destroying 
the components so that they were re-usable. 
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To ensure the static and flow platforms were comparable, the total volume of 
media supplied to each system was the same - 500µL. For the static device, this 
was added directly to the cell culture chamber. The flow system had a reservoir 
to allow the collection and re-circulation of the media. 
A peristaltic pump was used to achieve continuous perfusion of the flow 
system. The flow rate (µL/min) was calibrated using the Watson-Marlow 
peristaltic pump, summarised in Table 2. A flow rate of 5µL/min was selected 
for all cell culture studies to mimic interstitial flow. 
The advantage of the modular nature of the device described here was the 
flexibility it allowed in the assembly. Various configurations of the 
components were tested to establish a robust setup. The ability to make 
adjustments was useful in troubleshooting, as specific changes to address 
leakage and evaporation could be made. The compact design of the devices 
meant that several platforms, along with the pump, could be set up on a single 
shelf of a standard tissue culture incubator. Overall, this design was found to 
provide a sturdy, flexible and user-friendly fluidic platform with potential for 
cell culture applications. 
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Figure 31. Schematic representation of flow and static paper-based platforms. 
Flow device: Paper scaffold inserted between PDMS films, channel cut into centre of top film 
creates cell culture chamber. Sheets of PMMA encase device, upper sheet with inlet and outlet 
ports for attachment of fluidic tubing. 
Static device: Paper scaffold interleaved between PDMS films, upper film with central channel 
cut out. Double layer of PMMA with centre channel cut out. Sheets of PMMA enclose the 
device. 
Table 2. Calibration of flow rate for fluidic platform using Watson-Marlow peristaltic 
pump. 
W-M peristaltic pump 
(rpm) 
Fluidic Platform 
(µL/min) 
3 5 
5 8 
10 15 
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Characterisation of a Paper-Based Scaffold for Immune 
Cell Culture 
All of the work for the characterisation of the paper-based scaffold for immune 
cell culture was performed using human moDCs. Cells were seeded onto 
sterilised, collagen hydrogel-coated paper scaffolds at a density of 5 x 10
5
 and 
maintained under standard tissue culture conditions (5% CO2, 37°C). 
Dendritic cell viability is not impaired by paper scaffolds 
The viability of moDCs cultured on the scaffold was established using the 
setup described for the static platform. Cell viability was determined by flow 
cytometric analysis of cells stained with Annexin V\ PI. 
Figure 32 shows the results from this experiment, the dot plots in Figure 32A 
and B show the Annexin-V\ PI staining profile of cells collected from TCP and 
the paper scaffold respectively. Figure 32C compares the proportions of viable 
and non-viable cells quantified by the assay. The percentage of viable cells 
harvested from the paper scaffold (71%) was not found to be significantly 
different to that collected from TCP (79%). Also, numbers of non-viable cells 
were not significantly different, with 28% and 20% for the paper scaffold and 
TCP respectively. The results from this experiment confirmed that the collagen 
hydrogel-coated paper scaffold did not impair moDC viability. 
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Figure 32. Dendritic cell viability is not impaired by paper scaffolds. 
Cell viability after 24 hours in culture with paper scaffolds assessed by the Annexin-V\ PI 
cytotoxicity assay. A & B: Dot plots of Annexin V\ PI-stained cells harvested from TCP and 
paper scaffold respectively. C. Graph presenting the percentages of viable (solid colour) and 
non-viable (striped) cells harvested from each condition. There was no significant difference in 
the proportion of viable cells collected from the scaffold (71%), compared to TCP (79%). The 
percentages of non-viable cells for scaffold (28%) and TCP (20%) cultures were not found to 
be significantly different. T tests were used to determine significance. Difference not 
significant if P ≥ 0.05 (n = 3). Error bars represent standard deviation. 
The paper scaffold induces a mature dendritic cell phenotype 
The effect of the scaffold on the phenotype of moDCs was assessed based on 
the expression of the cell-surface maturation markers, CD40, CD54, CD83 and 
CD86. After 24 hours in culture, cells were harvested and immunofluorescent 
staining was performed. Phenotypic analysis of the cells was then done by flow 
cytometry. 
The results from this experiment are shown in Figure 33. Graphs A, B, C and D 
represent the expression of CD40, CD54, CD83 and CD86 respectively, 
presented as median fluorescence intensity (MFI). There was a tendency 
towards an increase in the expression of all markers by moDCs collected from 
paper scaffolds. This was not found to be significant for CD40, CD83 or CD86 
compared to TCP. However, the level of expression of CD54 was found to be 
significantly higher on cells harvested from the paper platform (P≤0.05, *) as 
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opposed to those from TCP. Overall, the data indicate the paper scaffold 
induced the maturation of moDCs. 
 
Figure 33. Dendritic cells collected from paper scaffolds have a mature phenotype. 
Phenotypic analysis of moDCs after 24 hours in culture with paper scaffold. A. Expression of 
CD40 was raised by cells collected from scaffolds. B. CD54 expression was significantly 
increased on cells harvested from scaffolds (P = 0.0341, *, t = 5.276, df = 2). C & D. Levels of 
CD83 and CD86 respectively were higher for cells cultured on paper scaffolds but not found to 
be significant. T tests were performed to determine statistical significance. Not significant if P 
≥ 0.05 (n = 3). Error bars represent standard deviation. 
Due to the methods of manufacturing and handling of the paper scaffold, the 
possibility of endotoxin contamination was examined as an explanation for the 
maturation of moDCs. An experiment whereby scaffolds were pre-incubated 
with Polymyxin B sulphate (PMB) to neutralise endotoxin was carried out 
(data not shown). 
The results from this experiment demonstrated that incubation of the scaffold 
with PMB had no effect on the expression of maturation markers. This ruled 
out endotoxin as a cause for the maturation of moDCs. 
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Since the collagen hydrogel had already been well-characterised for immune 
cell culture (see Chapter 2 of this thesis), the effect of coating the paper 
scaffold was anticipated to be minimal and not to significantly affect the 
phenotype of the moDCs. It is possible that the collagen coating was not 
efficient and uneven coverage led to direct cell exposure to the paper scaffold. 
In this case, it is likely that some property of the paper scaffold itself was 
responsible for the raised maturation state of moDCs. Others have 
demonstrated that antigen presenting cells (APCs) are sensitive to a multitude 
of substrate properties, including topography, surface chemistry and substrate 
stiffness (Rostam et al., 2015). These variables can determine the functional 
activity of APCs and the outcome of immune responses. 
Phenotypic response of dendritic cells to LPS is limited in 
cultures with paper scaffolds 
To determine whether moDCs were responsive to an immunogenic challenge 
when cultured on paper scaffolds, they were stimulated with LPS for 24 hours. 
Phenotypic analysis was performed to determine the response based on the 
expression of maturation markers.  
The results of the analysis are displayed in Figure 34. Graphs A, B, C and D 
represent CD40, CD54, CD83 and CD86 expression, plotted as MFI. There 
was a slight increase in the expression of the markers following stimulation by 
LPS by cells harvested from paper scaffolds. However, none were found to 
change significantly (P ≥ 0.05). 
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When cultured on paper scaffolds, the phenotype of unstimulated moDCs was 
barely discernible from those stimulated with LPS. This is likely due to an 
intrinsic property of the scaffold which caused the increased expression of 
maturation markers under resting conditions. Therefore, the extent to which 
expression could be further up-regulated upon immunogenic stimulation was 
limited. 
 
Figure 34. Limited moDC phenotypic response to LPS on paper scaffolds. 
Expression of maturation markers after 24 hours of LPS stimulation by cells cultured on paper 
scaffolds. A. Significant increase in CD40 expression with LPS in TCP (P = 0.0121, *, t = 
9.012, df = 2). CD40 expression also raised following stimulation by LPS in cells harvested 
from paper scaffolds but not significantly. B. Significant difference between CD54 background 
expression in TCP and paper scaffold (P = 0.0341, *, t = 5.276, df = 2). CD54 expression 
significantly increased in TCP with LPS (P = 0.0414, *, t = 3.433, df = 3, slight increase in 
CD54 expression by cells stimulated with LPS on paper scaffolds, not found to be significant. 
C. CD83 expression increased in response to LPS on paper scaffolds, however not found to be 
significant. Expression of CD83 increased significantly in TCP with LPS stimulation (P = 
0.0026, **, t = 9.314, df = 3). D. No distinct change in CD86 expression by cells cultured on 
paper scaffolds when stimulated by LPS. Significance determined using t tests, not significant 
if P ≥ 0.05 (n=3). Error bars represent standard deviation. 
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Change in dendritic cell morphology with LPS stimulation on 
paper scaffolds 
Immunofluorescent staining of moDCs cultured on the paper platforms was 
performed to visually examine how the cells responded to LPS stimulation. 
DAPI and Alexa Fluor 488 Phalloidin were used to visualise the nuclear and 
cytoskeletal aspects of the cells. The images acquired in these experiments are 
shown in Figure 35. Unstimulated moDCs were found to be evenly spread over 
the scaffold and exhibited a rounded morphology, characteristic of resting 
dendritic cells. With LPS stimulation, cell clustering and elongated cell 
morphologies, indicative of activation, were seen. 
Observations from fluorescent microscopy suggest that moDCs cultured paper 
scaffolds were responsive to immunological stimulation. The changes observed 
for cell organisation and morphology were consistent with the induction of 
inflammatory responses to LPS. This indicated that despite the poorly defined 
LPS response in the phenotypic analysis, moDCs cultured on the paper scaffold 
were immune competent. This highlights the need to investigate more than one 
feature of the cell response. 
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Figure 35. Visualisation of moDC response to LPS paper scaffolds. 
moDCs cultured on collagen hydrogel-coated paper scaffolds for 24 hours under resting or 
LPS-stimulated conditions. Cells fluorescently labelled using Phalloidin Alexa-Fluor488 and 
DAPI to visualise the actin cytoskeleton and nuclei of the cells. Cells were unevenly 
distributed over the scaffolds. Unstimulated cells had a rounded morphology. LPS-stimulated 
cells formed concentrated clusters and some cells were elongated. Images acquired using 10X 
and 20X objectives on a LSM710 confocal system. 
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Characterisation of Fluidic Platform with a Paper 
Scaffold for Immune Cell Culture 
Flow does not significantly impair dendritic cell viability 
The viability of moDCs was assessed after 24 hours of culture on paper 
scaffolds under flow conditions. Annexin-V\ PI staining was used to 
quantitatively measure cell death.  The results from the viability assay are 
shown in Figure 36. Figures A and B are dot plots showing the Annexin-V\ PI 
staining of moDCs harvested from flow and static devices respectively. The 
proportions of viable and non-viable cells are presented in the graph in Figure 
36C. Numbers of viable cells harvested from the flow device (64%) were 
slightly lower than those from the static device (71%) but this reduction was 
not found to be significant. Accordingly, the proportion of non-viable cells was 
slightly increased under flow conditions (36%), compared to static samples 
(28%), however this was not found to be statistically significant. It is perhaps 
not surprising that cell viability is slightly reduced under flow due to the 
fragility of mammalian cells (Tirella et al., 2008). 
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Figure 36. Flow does not significantly impair dendritic cell viability. 
Analysis of the viability of moDCs harvested from flow and static platforms after 24 hours. A 
& B. Dot plots of Annexin-V\ PI-stained cells from flow and static devices respectively. C. 
Percentage of viable (solid colour) and non-viable (striped) cells collected from flow and static 
cultures. Numbers of viable cells were slightly reduced in samples collected from flow devices 
(64%), compared to static (71%), however, this difference was not found to be significant. In 
concurrence, the proportion of non-viable cells increased under flow conditions (36%) but not 
significantly to static (28%). Statistical analysis was performed using t tests, differences were 
not significant if P ≥ 0.05 (n = 3). Error bars represent standard deviation. 
Dendritic cells attach to the paper scaffold under flow 
Fluorescent staining was used to assess moDC attachment to the collagen-
coated paper scaffold under flow conditions after 24 hours. The fluorescent 
images taken are displayed in Figure 37. The cell distribution and density 
across the scaffolds was found to be comparable between static and flow 
platforms. The results suggest that moDCs interact with the scaffold 
sufficiently to remain attached under the flow rate, 5µL/min, used in this study. 
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Figure 37. Dendritic cell attachment to paper scaffolds on static and flow platforms. 
Confocal microscopy was performed to visualise cells stained with Phalloidin Alexa-Fluor488 
and DAPI. moDCs were seeded on paper scaffolds coated with collagen hydrogels and 
maintained under flow or static conditions for 24 hours. The distribution and density of cells 
attached on the paper scaffolds under flow was similar to that observed for static cultures. 
Images acquired using a LSM710 confocal system with a 20X objective (n = 2). 
Dendritic cells exhibit a less mature phenotype under flow  
The effect of flow on the phenotype of moDCs cultured on paper scaffolds was 
compared to that of their counterparts cultured under static conditions. Cell 
phenotype was assessed based on the expression of the panel of markers 
associated with moDC maturation. 
The analysis from this experiment is shown in Figure 38; graphs A, B, C and D 
represent the expression of CD40, CD54, CD83 and CD86 respectively. Data is 
presented as MFI. Expression of CD40 and CD54 were found to be 
significantly decreased on cells cultured under flow compared to static. CD83 
and CD86 were slightly decreased in cells harvested from flow platforms, 
however, no significant differences were found compared to static cultures. 
Overall, the trend in the reduction of the expression of all markers under flow 
was indicative that cells had a less mature phenotype. 
137 
 
Local cell density is a key regulator of a variety of cell behaviours, such as 
proliferation, differentiation, motility and survival (Snijder and Pelkmans, 
2011). Therefore, the phenotype of dendritic cells will be dependent on cell 
concentration to some extent. Although the same number of cells was seeded 
on flow and static platforms at the start, there is the possibility for a greater 
reduction in the number of cells on the flow platform as a result of cell death, 
or washing away. 
An alternative reason for the lower levels of expression of activation markers 
under flow conditions could be due to the dilution of inflammatory mediators 
throughout the system. As shown previously, the paper scaffold induced moDC 
maturation which likely resulted in the production of inflammatory cytokines, 
such as TNF-α, IL-1β and IL-6 (Schildberger et al., 2013). These cytokines 
promote pro-inflammatory responses, including the up-regulation of maturation 
markers by dendritic cells (Zou and Tam, 2002, Motta and Rumjanek, 2016). 
Under static conditions, a concentrated extracellular milieu of soluble 
inflammatory factors may build up, which in turn would enhance pro-
inflammatory responses, including DC maturation. Continuous perfusion 
would reduce the concentration of cytokines to which the cells are directly 
exposed. The dilution effect would dampen pro-inflammatory cytokine 
feedback and cells would not be activated as strongly, hence the less matured 
phenotype observed on the flow platform. 
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Figure 38. Dendritic cells maintain a less mature phenotype under flow. 
moDCs were cultured on flow or static platforms for 24 hours before collection for phenotypic 
analysis. A. CD40 expression was significantly reduced under flow (P = 0.0135, *, t = 5.247, 
df = 3). B. Expression of CD54 was found to be significantly lower in flow conditions (P = 
0.0270, *, t = 5.960, df = 2). C. No change in expression of CD83 under flow. D. Reduction in 
expression of CD86 under flow. Statistical analysis was performed using t tests. Differences 
not significant if P ≥ 0.05 (n = 3). Error bars represent standard deviation. 
Dendritic cells mount appropriate responses to LPS under 
flow 
Maturation of moDCs harvested from the paper scaffold following LPS 
stimulation was compared between static and flow platforms. The moDC 
markers, CD40, CD54, CD83 and CD86 were included in the phenotypic 
analysis. The cells were cultured for 24 hours on paper scaffolds under static or 
flow conditions, with or with LPS stimulation. 
The results from this study are displayed in Figure 39, graphs A, B, C and D 
show the expression of CD40, CD54, CD83 and CD86 respectively, plotted as 
MFI. The results from the stimulation of moDCs on the static platform have 
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already been described in this chapter, and so will not be repeated here. For the 
cells collected from the flow platform, expression of all of the maturation 
markers was slightly increased upon LPS stimulation. However, no significant 
differences in expression between unstimulated and stimulated conditions were 
found. Although the response to LPS was not well defined under flow, the 
pattern of marker expression observed was indicative of LPS-induced cell 
maturation. The level of expression of all the markers was slightly lower under 
flow conditions, however, the trend with and without LPS stimulation was 
similar to static platforms. The effect of the paper scaffold in spontaneously 
eliciting moDC maturation is most likely the cause for the poor definition of 
the LPS response, not the effect of flow. 
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Figure 39. The phenotype of moDCs cultured on flow platforms shifts towards a more 
mature state with LPS stimulation. 
Dendritic cells collected for phenotypic analysis after 24 hours of culture on paper scaffolds 
from static and flow devices, with or without LPS stimulation. The cells harvested from the 
flow platforms showed a slight increase in CD40 (A), CD54 (B) and CD83 expression (C) but 
no effect was seen on CD86 expression (D). T tests were performed to determine statistical 
significance, if P ≥ 0.05 result was not significant (n = 3). Error bars represent standard 
deviation. 
Fluorescent microscopy was performed to visualise the moDCs cultured on 
static and flow platforms, with or without LPS stimulation. Cells were 
fluorescently stained with phalloidin and DAPI. Representative images from 
these experiments are displayed in Figure 40. Unstimulated cells cultured 
under static conditions were distributed evenly over the paper scaffold. They 
had a rounded shape, a morphology typically associated with immature 
moDCs. Unstimulated moDCs cultured under flow had comparable features to 
their static counterparts. In the static device, LPS-stimulated moDCs were 
observed to form cell clusters and some cells took on an elongated 
morphology, which is characteristic of activated moDCs. Similar observations 
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were made for the distribution and morphology of LPS-stimulated cells 
cultured under flow. 
Overall, the visual appearance of moDCs cultured on paper scaffolds was 
comparable between flow and static platforms. Resting moDCs displayed 
characteristic features of cells which have not experienced immunological 
stimulation. Cells under both static and flow conditions appeared responsive to 
LPS stimulation due to changes in their spatial organisation and morphology. 
Based on the observations made here, the mechanical impact of flow did not 
seem to have an effect on cell distribution or morphology on the paper scaffold 
in the context of immune stimulation. 
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Figure 40. Visualisation of moDC response to LPS on static and flow platforms. 
moDCs were cultured on collagen hydrogel-coated paper scaffolds for 24 hours under static 
and flow conditions, with or without LPS stimulation. Cells were fluorescently stained with 
Phalloidin Alexa Fluor 488 and DAPI. For unstimulated static and flow samples, cell 
distribution over the scaffolds was comparable and cells had rounded morphologies. With LPS-
stimulation, formation of cell clusters was seen and cell elongation was apparent in static and 
flow platforms. Images were acquired using the LSM710 confocal system with 10X and 20X 
objectives (n = 2). 
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3.4. Conclusions and Further Work 
The development of in vitro fluidic cell culture platforms is useful to simulate 
the mechanical forces cells experience in natural tissues. This chapter has 
described the construction of two different devices and the characterisation of 
one of these platforms for the culture of immune cells under flow. 
The first microfluidic device described, fabricated from DSA film, cover glass 
and PMMA had a number of advantages. In particular, its optical properties, 
which suited the platform to applications requiring high resolution in situ 
imaging. However, a number of significant limitations, which could not be 
overcome with minor troubleshooting, prevented further study. 
The fluidic device with a paper-based scaffold showed promise as an 
accessible and appropriate platform for cell culture. The modular design 
allowed convenient adjustment of the configuration to suit the requirements for 
this work. The numerous advantages of this platform, including not having a 
fixed design, have been demonstrated in this study and also by others in our 
group in the generation of air-liquid interface cultures (personal 
communication). 
A removable paper insert provided the basis of the cell culture scaffold. The 
advantage of this was that it increased the options in terms of cell seeding 
methods, which could be done on or off the platform. The paper scaffold was 
also amenable to a variety of surface treatments and coatings. This allowed the 
incorporation of a collagen hydrogel, previously characterised for immune cell 
culture in Chapter 2 of this thesis. 
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The paper scaffold was characterised for its compatibility with moDCs, this 
was the first time it had been used for the culture of immune cells. moDCs 
cultured on the paper scaffolds exhibited good viability, however, the 
phenotype of moDCs harvested from the scaffolds was indicative of their 
maturation. Endotoxin contamination was ruled out as an explanation for this 
by pre-treating scaffolds with PMB. 
It was anticipated that the paper scaffold would have minimal impact on the 
moDCs as it was coated with collagen hydrogel. It is possible that there were 
limitations with the efficiency of the coating, which would have caused some 
of the cells to be directly exposed to the paper scaffold. Therefore, an inherent 
property of the paper, such as topography, surface chemistry or substrate 
stiffness, may be responsible for inducing the up-regulation of the markers 
(Rostam et al., 2015). 
To determine whether this was the case, collagen-coated scaffolds could be 
fluorescently stained for collagen in order to visualise the coverage of the 
hydrogel on the scaffold by confocal microscopy. Further to this, moDC 
responses on uncoated and collagen-coated scaffolds would provide useful 
information on the direct effect of the paper on cell maturation. 
moDCs cultured on paper scaffolds were tested to determine whether they were 
immunologically responsive to LPS. The trend in the expression of maturation 
markers and changes in the distribution and morphology of cells following 
stimulation by LPS were suggestive of their immunological responsiveness. 
146 
 
In hindsight, the range of readouts selected for this experiment was probably 
insufficient to conclusively determine the immune-competence of moDCs 
cultured on paper scaffolds. Including other measures of biological function, 
such as, cytokine production and endocytic activity, would be informative for 
future studies. 
The fluidic device with the paper scaffold was characterised for dendritic cell 
culture. Encouragingly, cell viability was only slightly reduced under flow 
conditions. Also, the density of cells that remained attached on the scaffold 
under flow was comparable with that under static conditions. 
Phenotypic analysis of moDCs indicated that they maintained a less mature 
phenotype in the context of flow. It has been suggested that, physical stimuli, 
such as flow, can modulate immune responses. Due to the heterogeneous 
nature of interstitial flow it is difficult to compare the flow rate used in these 
experiments with in vivo conditions. However, owing to the maintenance of an 
immature phenotype by moDCs under flow, it could indicate that the flow rate 
used in these experiments was representative of physiological conditions which 
contribute to the suppression of the inflammation. By testing the effect of a 
range of different flow rates on moDC maturation, it may be possible tell 
whether the flow rate used here specifically contributed to the maintenance of 
the immature moDC phenotype. 
Alternatively, the increased maturation state of moDCs cultured under static 
conditions may have been due to the build-up of inflammatory cytokines in the 
147 
 
cell culture chamber. On the flow platform the effect of the cytokines may have 
been diluted by their circulation throughout the system. 
Another factor which should be noted is the potential for the silicone tubing, 
which was only used for the flow platform, to absorb proteins. This could 
immobilise inflammatory cytokines circulating in the media, thereby removing 
the positive feedback for cell activation and suppressing the induction of 
moDC maturation. 
The immunological competence of moDCs was assessed on the fluidic 
platform. The pattern of increased expression of activation markers following 
LPS stimulation indicated cells cultured under flow were responsive. This was 
supported by fluorescent microscopy, whereby the effect of LPS was apparent 
on the spatial organisation and morphology of the cells. 
No significant effect of the introduction of flow was seen on moDC responses 
to LPS, compared to static. As mentioned previously, the readouts used in this 
work may not have been sufficient to pull apart differences between static and 
flow cultures. It would also be interesting to investigate the effect of the rate of 
flow on moDC responses in the context of immunological stimulation. 
In conclusion, the work in this chapter has described the development and 
characterisation of a fluidic platform with a paper-based scaffold for immune 
cell culture. This fluidic platform showed promise for the study of the effect of 
flow on immune responses. However, it was important to take in to account the 
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limitations identified with regards to the influence of the scaffold and flow on 
the phenotype of the cells in further studies. 
 
149 
 
Chapter 4 
Application of Physiologically 
Relevant Platforms for the Study 
of Antigen-Specific Dendritic Cell 
– T Cell Interactions 
4.1. Introduction 
Chapter Overview 
T cell activation underpins efficient adaptive immunity. To date, much research 
has been undertaken to elucidate the mechanisms involved in both protective 
and pathological T cell-mediated immune responses. 
Mixed lymphocyte reactions (MLRs) are useful in vitro tools for studying T 
cell activation in disease, drug development and safety testing (Kashipaz et al., 
2002). Traditionally these assays are performed in static 2D cultures and in the 
absence of ECM. They often involve the co-culture of purified T cell 
populations with antigen presenting cells, such as DCs or irradiated PBMCs. In 
addition to the biological or chemical entity being tested, co-stimulatory 
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factors, including cocktails of cytokines or antibodies, are also frequently 
added. 
These assays provide important insights into immunological mechanisms, 
however, the immunological reactions take place under artificial conditions and 
the outcome may be biased by the cellular or biochemical composition. This 
limits their translation for predicting immune responses (Pörtner and Giese, 
2006, Giese and Marx, 2014). 
In vivo, induction of adaptive immunity occurs in the complex 
microenvironment of secondary lymphoid tissues, such as the lymph node. 
Here, a variety of cues such as, cellular and extracellular matrix components, 
mechanical forces and biochemical signals, provide a balance of stimulatory 
and regulatory cues to ensure the induction of appropriate T cell responses 
(Gasteiger et al., 2016). 
This chapter describes the work carried out to investigate the effect of 
incorporating physiologically relevant features into MLRs for antigen-specific 
T cell activation. 
Physiological relevance was incorporated into this work by the application of: 
1. A collagen hydrogel ECM platform. 
a. Also combined with the chemokine, CCL21. 
 
2. A paper scaffold-based fluidic platform. 
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Cell-Mediated Adaptive Immunity 
All cells of the immune system originate from pluripotent hematopoietic stem 
cells in the bone marrow. From these cells, lymphoid-primed multipotent 
progenitors give rise to the cells that comprise the adaptive immune system, 
namely T and B cells (Bhandoola and Sambandam, 2006). 
The fundamental features of the adaptive immune system are antigen 
specificity and immunological memory. This enables the generation of targeted 
immune responses to rapidly eliminate pathogens, to which an individual has 
been previously exposed (Murphy et al., 2008). 
Cell-mediated adaptive immunity is imparted by the functions of T 
lymphocytes (Murphy et al., 2008). There are two key subsets within the T 
lymphocyte population, distinguished by the expression of CD8 or CD4 
(Germain, 2002). These markers reflect the effector function of the cell, as 
illustrated in Figure 41. CD8 is found on cytotoxic T cells, which directly kill 
cells harbouring a cytosolic viral or bacterial infection (Harty et al., 2000). 
CD4
+
 T cells have the potential to differentiate to carry out different types of 
effector activity, termed Th1, Th2 and Th17 (Annunziato et al., 2015b). 
Th1 cells help control intracellular bacterial, parasitic and viral infection 
through the activation of the programme of cell death of the antigen presenting 
cell. Th1 cells also have a role in stimulating antibody production. Th2 effector 
cells activate B cells into producing antibodies to help eliminate toxins or 
extracellular pathogens. Finally, Th17 responses provide defence against 
extracellular bacteria and fungi. Th1\Th2\Th17 polarisation depends on the 
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combination of antigen, co-stimulatory molecules and cytokines during antigen 
presentation (Annunziato et al., 2015a). 
 
Figure 41. Effector functions of T cells in cell-mediated adaptive immune responses. 
T cell effector function targets pathogens based on location. CD8
+
 T cells have cytotoxic 
effects on cells presenting antigen derived from the cytosol. CD4
+
 T cells differentiate to carry 
out a variety of effector functions depending on the nature of the pathogen; Th1 contributes to 
killing cells harbouring intracellular pathogen, Th2 stimulates antibody production by B cells 
to combat extracellular pathogens and Th17 produces cytokines which promote an 
inflammatory tissue response to eliminate extracellular infections. 
T Cell Activation 
The molecules involved in the recognition of specific antigen which are 
expressed by T cells are known as T cell receptors (TCRs). As depicted in 
Figure 42, the TCR is membrane-bound and composed of two chains, α and β, 
each with a variable and a constant region. The variable regions of the α and β 
chains combine to give rise to the antigen binding site. During development 
within the thymus, a programme of genetic re-arrangement of the α and β 
chains results in each cell having a unique TCR. This generates a T cell 
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repertoire capable of recognising a phenomenal number of antigenic peptides 
(Zuniga-Pflucker and Lenardo, 1996). 
 
Figure 42. The T Cell Receptor. 
The TCR is membrane-bound and composed of α and β chains linked by a disulphide bond. 
Each chain has a constant (C) and a variable (V) region. The variable region forms the antigen-
specific binding site. 
Typically, the TCR only recognises antigen bound to major histocompatibility 
complex (MHC) molecules (Rudolph et al., 2006). The principle classes of 
MHC molecules are MHC-I and MHC-II which are preferentially bound by the 
T cell co-receptors, CD8 and CD4 respectively. As a rule, MHC-I displays 
antigen derived from the cytosol, indicative of an intracellular infection, which 
elicits CD8 T cell-mediated immunity. Dendritic cells are also able to present 
exogenous peptides through MHC-I, a mechanism known as cross presentation 
(Ackerman and Cresswell, 2004, Williams et al., 2002). Peptides originating 
from extracellular sources are presented by dendritic cells through MHC-II, 
this cues CD4
+
 T cell effector functions (Villadangos, 2001). 
The TCR alone does not have signalling capability. As shown in Figure 43, 
association with the accessory molecules CD4 or CD8, CD3 complexes and the 
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ζ chain, is required for optimal signalling. The CD3 complex is comprised of 
dimers of CD3γ, CD3δ and CD3ε, which interact with the α and β chains of the 
TCR (Kane et al., 2000). Signalling comes about through immunoreceptor 
tyrosine-based activation motifs (ITAMs) present in the cytoplasmic tails of the 
CD3 complexes and the ζ chain. Phosphorylation of ITAM sequences initiates 
a cascade of intracellular signalling pathways which directs the specific cellular 
response. 
 
Figure 43. The TCR signalling complex. 
The α:β TCR heterodimer provides the antigen-specific binding site. The CD3 complex, 
comprised of ε, δ and γ chains, stabilises the TCR and allows signalling via ITAMs upon 
antigen recognition. The ζ chain homodimer contains ITAMs and is also involved in signalling 
following antigen binding. Diagram adapted from Murphy et al. 2008. 
Recognition of peptide-loaded MHC (pMHC) by the TCR in conjunction with 
its accessory molecules is required for efficient T cell activation, as shown in 
Figure 44. The antigen-specific interaction is known as Signal 1. In 
conjunction with the antigen-specific interaction, efficient T cell activation 
requires additional signals. This includes co-stimulation through CD28, or 
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CD28-related molecules, termed Signal 2. Finally, the third signal is provided 
by cytokines (Tseng and Dustin, 2002, Gonzalo et al., 2001, Curtsinger and 
Mescher, 2010). 
 
Figure 44. Efficient T cell activation via the TCR requires 3 signals. 
Signal 1. The antigen-specific induction of the TCR complex through the recognition of 
peptide-loaded MHC (pMHC). Signal 2. Co-stimulation through molecules expressed on 
surface of antigen-presenting cell. Signal 3. Extracellular milieu of soluble factors, e.g. 
cytokines, which provide co-simulation and contribute to T cell polarisation. Schematic 
modified from Murphy et al. 2008. 
This is a brief overview intending to illuminate the key aspects involved in T 
cell activation. In reality, it is a highly complex immunological event with 
multiple levels of regulation. In normal circumstances, T cell-mediated 
immune responses effectively protect the body from pathogens. Dysregulation 
of T cell activation and resultant inappropriate responses can lead to pathology, 
such as uncontrolled infection, allergy, autoimmunity and cancer. 
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T Cell Activation In Vitro 
Modelling antigen-specific T cell activation in vitro has many useful 
applications in areas of immunology research, therapeutic development, 
diagnostic and immunotoxicology screening. Activation of T cells via the TCR 
complex can be achieved through the application of a variety of antigenic 
entities, including pathogen or allergen-derived extracts and antibodies. 
Purified protein derivative (PPD) from Mycobacterium tuberculosis (Mtb) is an 
example of a pathogen-derived agent used to stimulate T cells. PPD is derived 
from Mtb cultures through purification by ammonium sulphate precipitation. 
The resulting preparation has high protein content and is low in 
polysaccharides, nucleic acids and lipids (Yang et al., 2012). Currently, 
preparations contain a mixture of peptides, however, work is underway to 
identify individual peptides with the most potent antigenic activity (Cho et al., 
2012, Brusasca et al., 2001). 
PPD is considered as the tuberculin standard by the World Health Organisation 
(Guld et al., 1958). It is used for the tuberculin skin test (TST) for the 
identification of individuals with asymptomatic tuberculosis (TB), known as 
latent TB infection (LTBI). 
Mtb is an intracellular pathogen and it is able to persist in macrophages at the 
site of infection, usually the lungs, without causing clinical symptoms of TB. 
The protective response against Mtb infection is principally mediated by 
cellular immunity, involving Th1-polarised CD4
+
 T cells and CD8
+
 T cells 
(Flynn and Chan, 2001). 
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The TST is performed by intradermal injection of PPD into the forearm, 
followed by monitoring for the onset of a delayed-type hypersensitivity (DTH) 
response within 48-72 hours (Mackin, 1998). The DTH response indicates an 
individual’s immune system has been sensitised to the antigen and is 
suggestive of LTBI, or previous vaccination against Mtb with the Bacillus 
Calmette-Guérin (BCG) vaccine. 
PPD has also been used to stimulate immune cells in vitro for diagnosis of Mtb 
infection with some success (Katial et al., 2001, Lein and Von Reyn, 1997). 
Individuals who have been vaccinated against Mtb with the BCG vaccine will 
also respond to PPD in these assays. T cell proliferation and IFN-γ production 
demonstrate the induction of T cell-mediated responses as a result of PPD 
stimulation. 
The wealth of information available regarding the immunology and antigenic 
properties underlying the activity of PPD make it a useful tool for the study of 
antigen-specific T cell responses in cell-mediated immunity. 
Physiological Considerations for T Cell Activation 
Extracellular Matrix 
The ECM can have profound effects on the function of immune cells. As 
discussed in more detail in Chapter 2 of this thesis, a number of studies have 
highlighted the role of ECM components in potentially determining the 
outcome of immune responses. 
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Three-dimensional (3D) collagen hydrogels have previously been used to study 
T cell motility and interaction with APCs in order to provide an environment 
more representative of the lymph node (Gunzer et al., 2000, Gunzer et al., 
2004). T cell behaviour in 3D collagen hydrogels was found to reflect in vivo 
observations in terms of the dynamics of interactions with APCs and formation 
of small cell aggregates. This is in contrast to the cell behaviour seen in 
conventional liquid culture, where large cell aggregates occur. 
Therefore, through introducing components of the natural tissue, the T cell 
response to antigen in vitro may be more representative of that in secondary 
lymphoid organs. This may be achieved by employing biomaterials, such as 
collagen hydrogels, in artificial ECM platforms for modelling T cell activation. 
Biochemical Cues 
The biochemical milieu is critical for T cell activation and polarises the 
effector activity of immune cells in vivo. Cytokines are often added to in vitro 
assays to provide co-stimulatory signals to T cells. 
Chemokines also have important functions in directing immune cell responses. 
The chemokine, CCL21, is important in terms of its role in facilitating efficient 
immune responses in vivo. It is expressed within the lymph node on T cell zone 
fibroblastic reticular cells. CCL21 is a ligand for the receptor CCR7, which is 
found on DCs and T cells. CCL21 is required for T cell and DC homing to 
lymph nodes and cell motility within the paracortex. 
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Studies are emerging which demonstrate CCL21 may have further functional 
roles in the induction of immune responses (Forster et al., 2008). It has been 
suggested that CCL21 may act as a natural adjuvant. Marsland et al. 
demonstrated it induced DC maturation, resulting in the enhanced ability to 
prime T cells (Marsland et al.). Interestingly, CCL21 induced endocytosis in 
mature DCs but not immature DCs (Yanagawa and Onoe, 2003). These studies 
indicate CCL21 may modulate DC antigen presenting efficiency with 
important implications for T cell activation. 
With regards to the functional effects of CCL21 on T cells, there is evidence to 
suggest it is an early co-stimulatory molecule during T cell priming. CCL21 
induced proliferation of CD8
+
 and CD4
+
 T cells and promoted Th1 
differentiation (Flanagan et al., 2004). This work implicated CCL21 as a 
significant molecule for T cell activation. 
Since CCL21 has been observed to have profound effects on immune cell 
behaviour in vivo and in vitro, it has the potential to contribute to the 
enhancement of the physiological relevance of DC-T cell interaction studies in 
vitro. 
Shear Flow 
The effect of extra-cellular mechanical forces on immune cell behaviour is 
gaining increasing attention (Previtera, 2014). As highlighted in Chapter 3 of 
this thesis, the influence of shear flow has been shown to have a role in the 
modulation of immune responses. 
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Physical extra-cellular forces can exert their effects on cells through the 
activation of cell-surface receptors. This has implications on the regulation of 
phosphorylation and kinase signalling (Giannone and Sheetz, 2006). CD3 
complexes, associated with the TCR, carry out signalling functions upon 
pMHC recognition through the phosphorylation of tyrosine residues within the 
ITAM. An elegant study carried out by Li et al. demonstrated that mechanical 
forces acting via the TCR complex caused T cell signalling (Li et al., 2010). 
T cells are exposed to the physical effects of interstitial flow within the lymph 
node. Based on the accumulating evidence that mechanical forces modulate 
immune cell responses, flow is likely to be a physiologically relevant influence 
on the elicitation of T cell activation. Thus, it is reasonable for flow to be 
incorporated into in vitro T cell assays in order to simulate the mechanical 
stress T cells experience during antigen presentation. 
Chapter Aims 
This chapter seeks to examine how the extra-cellular environment affects the 
outcome of antigen-specific DC-T cell interactions in vitro through the 
application of the ECM and fluidic platforms developed in Chapters 2 and 3 of 
this thesis. This was done by comparing the antigen-specific T cell response 
induced on the biomimetic platforms with that generated under conventional 
cell culture conditions.  
  
161 
 
4.2. Materials and Methods 
Generation of Monocyte-Derived Dendritic Cells  
This was done according to the method described in Chapter 2 of this thesis, 
2.4. Materials and Methods: Generation of Monocyte-Derived Dendritic Cells. 
Isolation of T Cells  
T cells were isolated from PBMCs by negative selection. Pan T cell isolation 
(kit purchased from Miltenyi Biotech) by magnetic cell separation was 
performed, as previously described (Horlock et al., 2007). The purity of 
isolated T cells was typically >95%. 
Autologous Mixed Lymphocyte Reaction  
Immature moDCs and T cells, obtained from the same donor, were co-cultured 
at a ratio of 10 T cells to 1 moDC. Cells were stimulated with 5µg/mL 
tuberculin PPD (Statens Serum Institut) and maintained in a humidified 
incubator (37°C, 5% CO2) for 6 days. For the tissue culture control, cells were 
seeded in a U-bottom 96-well TCP plate. Collagen cultures were set up in flat 
96-well plates which had been prepared with 100µL of a 0.5mg/mL collagen 
hydrogel, onto which the cells were seeded. 
Preparation of Collagen Hydrogels  
The collagen hydrogel was prepared according to the method described in 
Chapter 2 of this thesis, 2.4. Materials and Methods: Preparation of Collagen 
Hydrogels. The collagen solution was retained on ice until required. 
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Paper-Based Fluidic Platforms (static & flow) 
Platforms were assembled according to the method described in Chapter 3 of 
this thesis, 3.4 Materials and Methods: Fluidic platform assembly, Paper-based 
fluidic device. 
IFN-γ Detection  
Enzyme-linked immunosorbant assays (ELISAs) were used to detect IFN-γ in 
the supernatants collected from AMLRs. The IFN-γ Duo-set ELISA kit 
(purchased from R&D systems) was used according to manufacturer’s 
instructions. 
Light Microscopy 
Brightfield images were acquired on an Olympus CRX 41 microscope using a 
4X objective with Infinity Analyse Lumenera software. 
Image analysis 
ImageJ was used for the analysis of fluorescent images (Schneider et al., 2012). 
Statistical analysis  
Analysis was carried out using GraphPad Prism version 6.00 for Windows, 
GraphPad Software, La Jolla California USA (www.graphpad.com).
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4.3. Results and Discussion 
Optimising Antigen-Specific T cell Activation In Vitro 
A mixed lymphocyte assay was established for the study of DC-T cell 
interactions. For this, moDCs and T cells were purified from the same donor 
and co-cultured in a multi-well tissue culture plate. In this thesis, these assays 
are referred to as Autologous Mixed Lymphocyte Reactions (AMLRs). 
T cell activation was induced using two model antigens, purified protein 
derivative (PPD) from Mycobacterium tuberculosis (Mtb) and lysate from 
Aspergillus fumigatus (AF). AF lystate produced the same pattern of T cell 
response as PPD, however, the intensity of the response was found to be lower 
compared to PPD. Only the data for PPD is presented. 
Initially, both T cell proliferation and cytokine production were considered as 
measures for T cell activation. Two methods were tested for assessing 
proliferation of T cells. These were the BrdU (5-bromo-2’-deoxyuridine) 
proliferation assay and CFSE (Carboxyfluorescein succinimidyl ester) staining. 
These assays are well-established for measuring cell proliferation and provide a 
safe (i.e. non-radioactive) and quantitative measure. Cytokine production was 
measured by enzyme-linked immunosorbant assays (ELISA) using the 
supernatants collected from the AMLRs. 
It was found that T cell proliferation did not give a consistent result for 
antigen-specific immune activation for all donors. This could have been due to 
differences in their exposure to Mtb (e.g. vaccination history and exposure to 
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environmental mycobacteria that cross react with Mtb). For weak-responders, 
this was probably due to the low frequency of PPD-specific T cells in the 
samples. It is likely that the proliferation assays were not sensitive enough to 
measure very low numbers of actively dividing cells. 
Cytokines IL-2 and IFN-γ were both found to be good indicators of antigen-
specific T cell activation. However, since there was greater variability in IL-2 
production, IFN-γ was selected as the readout for T cell activation in this work. 
The AMLRs were set up in U-bottom well tissue culture-treated plastic (TCP) 
plates. The experimental parameters considered during optimisation included 
the ratio of T cells to moDCs, moDC maturation state and duration of the 
reaction. 
During the preliminary experiments (data not shown) two different ratios of 
moDCs to T cells were tested, 1:10 and 5:10. This was done with both 
immature and LPS-matured moDCs. T cells (CD3
+
) isolated from PBMCs 
were used directly, without further enrichment, to reflect the natural 
composition of the T cell population. To determine the appropriate length for 
the experiments, supernatants were initially sampled between days 3 and 6. 
The AMLRs in all of the experiments described in this chapter were set up 
using a ratio of 1:10 moDCs to T cells, with immature moDCs. Cultures were 
stimulated with PPD and maintained for 6 days. 
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Induction of PPD-specific T cell response in conventional 
cultures 
Figure 45 shows the results obtained in static liquid culture, using a 
conventional U-bottom well TCP format. There was an antigen-specific 
increase in IFN-γ production (1641.21pg/mL) with PPD stimulation compared 
to No Antigen (10.53pg/mL) and this was found to be statistically significant 
(P = 0.0044, **). No increase in IFN-γ was detected with the addition of PPD 
in the T cell control. Overall, this reaction generated reproducible, PPD-
specific activation of T cells. Also, it demonstrated that T cell activation was 
dependent on the antigen presenting role of moDCs. 
 
Figure 45. Antigen-specific T cell activation in vitro. 
IFN-γ production by T cells stimulated with PPD for 6 days. There was a significant increase 
in IFN-γ secretion with the addition of PPD to AMLRs (P = 0.0044, **, t=4.434, df=6). No 
antigen-specific IFN-γ production was detected when T cells alone were exposed to PPD (nd = 
not detected). T tests were performed to determine statistically significant differences. Not 
significant if P ≥ 0.05 (n=4). Error bars represent standard deviation. 
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Investigating Antigen-Specific T cell Activation on an 
ECM Platform 
Collagen hydrogels were found to be biocompatible with immune cells and 
have the potential to increase the physiological relevance of in vitro cell 
culture, as discussed in more detail in Chapter 2 of this thesis. 
In this study, a collagen hydrogel was tested for its effects on the induction of 
antigen-specific immune responses. Six donors were tested and the U-bottom 
well TCP format was run in parallel with the hydrogel cultures. Three of the 
donors were found to have high levels of background IFN-γ in unstimulated 
TCP cultures, they were analysed separately from the three individuals with 
low levels of background IFN-γ. 
PPD-specific T cell activation in the presence of collagen 
hydrogel 
The results from the donors who produced low levels of background IFN-γ are 
shown in Figure 46. In collagen hydrogel AMLRs, levels of IFN-γ were 
increased with PPD stimulation (307.47mg/ml), compared to No Antigen 
(10.93pg/mL); this was found to be statistically significant (P = 0.0352, *). For 
the TCP control, as expected, the level of IFN-γ produced in PPD-stimulated 
cultures (326.72pg/mL) was found to be significantly higher compared to No 
Antigen (12.74pg/mL) (P = 0.0233, *). 
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Figure 46. Antigen specific T cell activation on an ECM platform by donors with low 
background IFN-γ. 
TCP: The increase in IFN-γ production in response to PPD stimulation was found to be 
significant (P = 0.0233, *, t = 6.435, df = 2). Collagen: Production of IFN-γ increased 
significantly with PPD stimulation (P = 0.0352, *, t = 5.187, df = 2). T tests were used for 
statistical analysis (n=3). Error bars represent standard deviation. 
Figure 47 shows the results from the donors who produced high levels of IFN-γ 
in the unstimulated TCP condition. In TCP cultures, levels of IFN-γ were 
raised in response to PPD (2,281.31pg/mL), however this was not found to be 
significantly different to No Antigen (318.4pg/mL) (P ≥ 0.05). In the collagen 
hydrogel cultures from corresponding donors, a PPD-specific increase in IFN-γ 
was detected (237.185pg/mL) compared to No Antigen (3.57pg/mL) and this 
was found to be significant (P = 0.0027, **). 
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Figure 47. Antigen specific T cell activation on an ECM platform by donors with high 
background IFN-γ. 
TCP: The increase in IFN-γ production in response to PPD stimulation was not found to be 
significant. Collagen: Production of IFN-γ increased significantly with PPD stimulation (P = 
0.0027, **, t = 19.32, df = 2). T tests were used in the statistical analysis (n=3). Error bars 
represent standard deviation. 
All of the donors tested mounted a specific T cell response towards PPD in the 
context of the collagen hydrogel. Notably, the magnitude of PPD-induced IFN-
γ production was lower in collagen cultures than TCP. This may be explained 
by the tendency of collagen to adsorb proteins, including cytokines, which 
results in their depletion from the media, as demonstrated in Chapter 2 of this 
thesis. 
This ties-in with the potential anti-inflammatory effects collagen may have 
through mopping up cytokines. Wiegand et al. demonstrated Type I Collagen 
bound significant amounts of inflammatory cytokines, including IFN-γ, with 
anti-inflammatory effects in chronic wounds (Wiegand et al., 2010). In these 
experiments, such an effect on soluble cytokine concentration could affect the 
intensity of the T cell response, leading to a reduction in IFN-γ secretion. 
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An alternative explanation for the lower magnitude of T cell responses in 
collagen cultures may be due to differences in the spatial organisation of cells. 
This is because the potential for DC-T cell interactions will determine the 
overall level of T cell activation. 
As demonstrated in Figure 48, cells were densely packed in the centre of the U-
bottom wells. This gave rise to a high probability of cell-cell interactions and 
thus T cell activation. The collagen hydrogels formed a slightly concave 
surface, due to surface tension around the sides of the wells, but were not as 
deep as a TCP well. Therefore, the cells were more spread out across the 
surface the hydrogel. As a result, there were likely to be fewer direct cell-cell 
interactions. The reduced potential for cell interactions in the hydrogel cultures, 
compared with TCP, may account for the lower magnitude in T cell activation 
seen in collagen AMLRs. 
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Figure 48. Cell distribution in TCP and collagen hydrogel cultures stimulated with PPD. 
The U-bottom well of TCP cultures caused cells to settle at a high density in the centre of the 
cell. This encouraged close cell contacts. With PPD stimulation, significant cell clustering was 
observed which is indicative of T cell activation. Cells did not pack together at such high 
densities on the surface of the collagen hydrogel. Therefore, cell-cell contacts were reduced. 
Less cell clustering was seen with PPD stimulation, compared to TCP. Images were acquired 
on an Olympus CRX 41 brightfield microscope using a 4X objective, with Infinity Analyse 
Lumenera software. Scale bars represent 200µm. Images are representative of 3 experiments. 
It is worth addressing the variation in the magnitude of IFN-γ production 
between individual donors. Natural biological variation in the PPD response is 
common in this type of cell-based assay (Katial et al., 2001). This can be 
influenced by a range of factors such as donor age and prior antigen exposure, 
via the environment or vaccination. 
For three of the donors, levels of IFN-γ were very high in unstimulated TCP 
cultures, which was indicative of non-specific immune activation. This can be 
a result of the basal activation state of the cells, or culture contamination. 
Interestingly, in collagen cultures for these donors, levels of background IFN-γ 
were much lower. This reduces the likelihood of contamination being the cause 
of non-specific activation. 
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To highlight the differences in the antigen-specific immune response between 
TCP and collagen, the fold increase in IFN-γ production in response to PPD 
was calculated. This was done separately for the groups of donors with low and 
high background IFN-γ. This analysis is shown in Figure 49. Donors with low 
levels of background IFN-γ were found to have a similar fold increase in PPD-
induced IFN-γ production in TCP (44.43) and collagen (38.86) cultures. The 
fold increase in IFN-γ in response to PPD by donors with high background 
IFN-γ was relatively low in TCP cultures (8.34). However, the fold increase in 
the corresponding collagen hydrogel cultures was higher (68.08) and found to 
be significantly different from TCP (P = 0.0155, *). 
This data suggests that culture with collagen hydrogels may be beneficial in 
terms of reducing non-specific T cell activation, while generating appropriate 
immune response in the presence of a relevant antigen. 
 
Figure 49. Fold increase in IFN-γ production in response to PPD in TCP and collagen 
cultures. 
When donors produced low levels of background IFN-γ, there was no significant difference in 
the fold increase in IFN-γ production with antigen stimulation between TCP and collagen 
cultures. Donors with high background IFN-γ produced a relatively low fold increase in IFN-γ 
response to PPD. However, on collagen hydrogels, a large fold increase in IFN-γ production 
with PPD stimulation is seen for the same donors. This was found to be significantly greater 
than TCP (P = 0.0155, *). Difference not significant if P ≥ 0.05. Statistical analysis was 
performed using T tests (n=3). Error bars represent standard deviation. 
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CCL21 Slightly Enhances T Cell Activation in Collagen 
Cultures. 
CCL21 is important for T cell activation as it is known to have a role in cell 
homing and motility within the lymph node. It has also been shown to 
modulate key behaviours of dendritic cells and T cells with important 
implications for the outcome of the immune response. Soluble CCL21 was 
added to collagen hydrogel AMLRs to investigate whether it had an effect on 
the magnitude of antigen-specific T cell activation. Three independent donors 
volunteered for this study. 
The results from this experiment are shown in Figure 50. In the presence of 
CCL21 (+CCL21), IFN-γ production in response to PPD increased for all 
donors (88.13pg/mL), compared to the unstimulated cultures (9.72pg/mL). For 
the control reaction (-CCL21), antigen-specific T cell activation was apparent 
by the increased levels of IFN-γ in PPD stimulated cultures (52.85pg/mL), 
compared to unstimulated (1.75pg/mL). The increase in IFN-γ production by T 
cells in response to PPD was significant in both +CCL21 (P = 0.0107, *, 
t=4.518 df=4) and -CCL21 (P = 0.0155, *, t=4.045 df=4) reactions. The level 
of PPD-induced IFN-γ secretion appears slightly raised in the presence of 
CCL21, however, this was not found to be significantly different from -CCL21. 
Overall, CCL21 appeared to slightly enhance T cell activation although it was 
not found to have a significant effect in these assays. In vivo, ligand 
concentration and interactions with other cells and molecules likely contribute 
to its activity in modulating immune responses. In these experiments, the 
microenvironment is highly simplified compared to the natural tissue which 
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could explain the lack of significant difference in T cell responses in the 
presence of CCL21. 
 
Figure 50. CCL21 slightly enhances T cell activation in collagen hydrogel cultures. 
IFN-γ production in AMLRs cultured on collagen hydrogels with the addition of CCL21. 
AMLRs +CCL21 showed a significant increase in IFN-γ with PPD stimulation (P = 0.0107, *, 
t=4.518 df=4). Antigen-specific increase in IFN-γ for -CCL21 was also found to be significant 
(P = 0.0155, *, t=4.045 df=4). No significant difference was found in PPD-induced IFN-γ 
production between -CCL21 and +CCL21 AMLRs. T tests were used to determine statistical 
significance (n = 3) Not significant if P ≥ 0.05. Error bars represent standard deviation. 
Studying Antigen-Specific Immune Responses on a 
Fluidic Platform 
A novel fluidic platform, based on a collagen hydrogel-coated paper scaffold 
was characterised for immune cell culture applications in Chapter 3 of this 
thesis. It was utilised in this work to study antigen-specific T cell activation. A 
comparable static platform, with the same number of cells and volume of 
media, was set up in parallel with flow experiments. Three new donors were 
selected for these experiments. 
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Antigen-specific activation of T cells under static and flow 
conditions on a paper scaffold-based fluidic platform 
The results from the AMLR conducted on the scaffold under static conditions 
are shown in Figure 51A. A PPD-specific increase in the level of IFN-γ 
(578.86pg/mL) was found, compared with No Antigen (47.28pg/mL). 
Although this difference was not found to be significant, the results 
demonstrated the potential of the paper scaffold for the study of DC-T cell 
interactions but highlighted that its sensitivity may be limited. 
The propensity of the paper scaffold to induce a mature moDC phenotype, as 
described in Chapter 3 of this thesis, was taken into account in these 
experiments. Based on the results, the effect of the scaffold on moDC 
maturation did not result in high levels of non-specific T cell activation 
Figure 51B shows the results generated from the platform under flow 
conditions. IFN-γ production was increased in a PPD-specific fashion, the 
concentration of IFNγ detected with PPD was 151.64pg/mL, without PPD it 
was 0.81pg/mL. The increase in IFN-γ in response to PPD was found to be 
significant under flow conditions (P = 0.0224, *). 
It should be noted that significantly less IFN-γ was detected in PPD-stimulated 
AMLRs under flow conditions than the static cultures (P = 0.0224, *). There 
could be a number of reasons for the significant difference in the concentration 
of PPD-induced IFN-γ detected under static compared to flow conditions. To 
begin with, the effect of cell death cannot be ruled out as during the 
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characterisation of the fluidic platform in Chapter 3, cell viability was shown to 
decrease under flow. 
On the flow platform, T cells are able to recirculate the system, therefore, not 
all of them will be in contact with the DCs in the chamber all of the time. This 
may lead to reduced cell-cell interactions which would decrease the intensity of 
the response. 
Flow may also have prevented the accumulation of cytokines within the cell 
culture chamber. Cytokines provide important feedback to elicit and maintain 
cell activation therefore if they were diluted throughout the system by flow, 
this could account for a lower magnitude of the cytokine response. 
Finally, the silicone-based fluidic tubing, which is only used for the flow 
system, may also contribute to the reduction in the amount of IFN-γ detected. 
A limitation of silicone is that due to its hydrophobic nature it has a tendency 
to absorb proteins. 
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Figure 51. Antigen-specific T cell activation on a paper-based fluidic platform. 
Production of IFN-γ from PPD-stimulated AMLR established on paper-based platform under 
static and flow conditions. A. For the static control, the PPD-specific increase in IFN-γ 
production was not found to be significant. B. Under flow, IFN-γ production increased 
significantly in response to PPD (P = 0.0224, *, t=4.566 df=2) (n=3). Error bars represent 
standard deviation. 
The fold difference in PPD-induced IFN-γ production was compared between 
static and flow, as shown in Figure 52. A much greater fold difference was 
found between No Antigen and PPD-stimulated cultures under flow (113.06 
fold increase), compared with static (20.47 fold increase). A significant 
difference was found for the fold increase in response to PPD between the 
static and flow conditions (P = 0.0204, *). These results suggest that, on the 
paper scaffold platform, flow enhances the sensitivity of the DC-T cell assay to 
antigen stimulation. 
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Figure 52. Fold difference in IFN-γ production in response to PPD for static and flow 
conditions. 
The fold difference in PPD-induced IFN-γ production under static conditions (20.47) is 
significantly less than that found for flow cultures under flow (113.06) (P = 0.204, *, t = 4.796, 
df = 2). Statistical analysis performed using T tests (n=3) Error bars represent standard 
deviation. 
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4.4. Conclusions and Further Work 
Establishing biologically relevant assays to study T cell responses in vitro is 
important since it will reduce the requirement for animal testing. Also, with the 
utilisation of human cells, data will be translatable to human immunology. The 
limitation of conventional cell culture methods is that they are artificial and not 
representative of the tissue microenvironment, such as the lymph node, where 
T cell activation by antigen presenting DCs naturally occurs. Therefore, the 
development of platforms which mimic the in vivo setting is required. 
The T cell assay used for this work was robust as antigen stimulation elicited 
an increase in IFN-γ production by all donors tested. The variation in the 
magnitude of response between donors was normal for this type of study. 
Cytokine data can be normalised to account for this variation, however, for this 
work it was more informative to present the actual concentration of IFN-γ 
detected in the supernatant for each donor. 
The ECM Platform 
A collagen hydrogel platform was used to mimic the ECM that T cells are 
exposed to during antigen presentation in the lymph node. An increase in IFN-
γ secretion in response to antigenic stimulation was detected in all collagen 
hydrogel cultures.  
In the collagen hydrogel experiments, the magnitude of PPD-specific IFN-γ 
production was lower than that in TCP. This could have been due to the 
propensity of collagen to adsorb proteins, which would directly contribute to 
the reduction in the concentration of soluble cytokine. 
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A consequence of IFN-γ sequestration by collagen would be the disruption of 
the positive feedback loop which is required to elicit and maintain T cell 
activation. This would dampen the magnitude of the immune response and thus 
the concentration of IFN-γ would be reduced further. 
The fate of IFN-γ could be determined either by digesting the collagen 
hydrogel and measuring the IFN-γ recovered, or by fluorescent labelling of the 
collagen hydrogel for IFN-γ. 
Additionally, T cells could be treated with Brefeldin A to block cytokine 
secretion before the end of the experiment, then, fluorescently stained for 
intracellular IFN-γ. This would allow quantitative analysis of the frequency of 
antigen-specific T cells and magnitude of the immune response by flow 
cytometry. 
The differences observed between the spatial organisation of cells in TCP and 
collagen hydrogel cultures are also likely to influence the intensity of the 
immune response. Investigating the impact of well shape and size on the 
outcome of immune responses would be interesting. This could be done using 
microfabrication techniques, by which a range of micro-wells with varying 
depths and diameters can be made, described in Appendix II of this thesis. 
The results from this work suggested that collagen hydrogels may provide a 
simple method to increase the physiological relevance of T cell activation. It 
would also be worth investigating the effect of other ECM components, e.g. 
fibronectin and laminin, and ECM mixtures, on T cell responses to antigen. 
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The addition of the chemokine, CCL21, to collagen hydrogel cultures appeared 
to slightly enhance the level of antigen-specific T cell activation but not 
significantly. Profound effects of CCL21 on immune cells have been described 
in the literature with specific implications for enhancing T cell activation. The 
effects of CCL21 in vitro could be investigated further through titrating the 
concentration, creating concentration gradients and immobilisation within the 
collagen hydrogel. 
The Fluidic Platform 
T cell activation was induced under flow in an antigen-specific manner. Levels 
of PPD-induced IFN-γ detected under flow conditions were lower compared to 
the static counterpart, this could be due to a variety of reasons. Firstly, this may 
be accounted for by differences in the number of T cell-DC contacts on the 
flow and static platforms. To address this, the design of the flow device could 
be modified to ensure all of the T cells are retained within the chamber, while 
allowing media to circulate. 
There is the potential for IFN-γ depletion, either by the collagen hydrogel used 
to coat the paper scaffold, or the silicone tubing used for the fluidic system. To 
determine the significance of this, exogenous IFN-γ could be added to the 
media, in a cell-free system and changes in cytokine concentration monitored 
over time. 
In these experiments, flow was found to increase the sensitivity of the T cell 
response to antigen, compared to static conditions. Further study into the 
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impact of the rate of flow on T cell activation using this platform would be 
insightful. 
In conclusion, the data from this work suggest that traditional TCP methods 
may have a tendency to enhance non-specific T cell activation and exaggerate 
antigen-specific responses. This may be due to the artificial nature of TCP 
culture, which could, for example, promote the elicitation of cell activation due 
to the high cell density and concentration of inflammatory cytokines. 
Simple modifications, such as incorporating collagen hydrogel or flow, may 
generate responses which are more representative of the native tissue setting. 
Ultimately, however, it is impossible to tell whether the immune response in 
TCP, collagen hydrogel or fluidic platforms cultures is most representative of 
in vivo T cell activation. 
The work presented in this chapter contributes to the establishment of in vitro 
cell culture platforms which aim to reflect the natural microenvironment. By 
imitating features of the native tissue, it is anticipated that immune cells will 
respond in a way that is more representative of their in vivo counterparts. This 
has implications for advancing understanding in immunology and improving 
the accuracy of predicting immune responses to pathogen-derived materials, 
allergen extracts and therapeutics. 
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Chapter 5 
Investigating Immune Responses 
to Sensitisers on an ECM Platform 
5.1. Introduction 
Chapter Overview 
Promising progress has been made in establishing immune cell-based methods 
for the prediction of chemical sensitisation as an alternative to animal testing. 
However, the current panel of tests available is limited by the lack of emphasis 
on the value of DC-T cell interactions. In addition, most are performed under 
conventional cell culture conditions in the absence of biologically relevant cues 
derived from the extra-cellular microenvironment. 
Tissue engineering technologies have the potential to make a great contribution 
to the development of cell culture by creating more realistic conditions. This 
could be put into practice in the development of cell culture-based methods for 
chemical safety testing in order to enhance their biological relevance. This 
chapter investigates immune cell responses to sensitising chemicals in the 
context of a collagen hydrogel-based ECM platform. 
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Properties & Interactions of Sensitisers 
Understanding the chemistry and mechanisms through which sensitisers elicit 
contact hypersensitivity (CHS) responses is important for the development of 
non-animal tests which predict sensitisation. To induce a CHS response, a 
sensitiser must successfully negotiate a series of hurdles as depicted in Chapter 
1, Figure 2: Development of Contact Hypersensitivity, of this thesis. Failure at 
any single one will put the break on the development of the allergic condition 
known as allergic contact dermatitis (ACD) (Kimber and Dearman, 2003). The 
physicochemical properties of chemicals are key to determining their 
sensitising activity, these include molecular weight, solubility and electrophilic 
reactivity (Friedmann and Pickard, 2014). 
Sensitisers are characterised by having a low molecular weight of less than 500 
Daltons, which facilitates their access to the skin (Bos and Meinardi, 2000). 
The first barrier is the stratum corneum, through which sensitisers penetrate 
and then partition to the epidermis. The lipid solubility of contact sensitisers 
also contributes to skin penetration, as lipid-soluble molecules will pass across 
the stratum corneum more easily than water-soluble ones (Friedmann and 
Pickard, 2014). 
To acquire immunogenicity, most sensitisers form complexes with host 
peptides, a process termed haptenisation. In terms of the induction of T cell 
activation in vitro, the source of peptide with which sensitisers form 
immunogenic species is likely to be the serum component, namely albumin, of 
the cell culture medium. 
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The stability of the hapten-peptide interaction is important in determining their 
sensitising activity (Divkovic et al., 2005). However, as shown in Figure 53, 
there are a variety of possible combinations of high-affinity sensitiser-specific 
interactions which have the potential to elicit T cell activation. 
 
Figure 53. Activation of the TCR by sensitiser-peptide-MHC interactions. 
A. The TCR has low affinity for native self-peptide due to negative selection during 
development in the thymus. B. Covalent modification of self-peptide by sensitiser generates 
high affinity ligand for TCR. C. Non-covalent interaction of sensitiser with self-peptide 
generates high affinity TCR ligand. D. Sensitiser binds MHC complex in synergy with self-
peptide to form a high affinity TCR ligand. E. Sensitiser bridges MHC and TCR with high 
affinity, independently of MHC-bound peptide. High affinity MHC-TCR binding induces T 
cell activation. Modified from Louis-Dit-Sully and Schamel (2014). 
Since most sensitisers are electrophiles, covalent bonding is the principle mode 
by which they interact with host peptides (Figure 53B). The nucleophilic nature 
of amino acid residues provides reaction sites, with which electrophiles may 
react through a variety of mechanisms. For example, the reaction of the strong 
sensitiser, 2,4-Dinitrochlorobenzene (DNCB), with peptide takes place by a 
classic aromatic nucleophilic substitution (SNAr) mechanism (Aptula et al., 
2007). This is illustrated in Figure 54. 
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Figure 54. A common predicted reaction mechanism for DNCB with a host peptide. 
An aromatic nucleophilic substitution reaction resulting in the covalent modification of host 
peptide and the generation of a DNCB-specific immunogenic peptide. Nu = nucleophile, P = 
protein. Modified from Divkovic et al. (2005). 
Sensitisers do not necessarily interact with peptides covalently. For metal ions 
that cause ACD, such as Ni2+, immunogenic determinants arise through the 
formation of co-ordination bonds with the host peptide (Figure 53 C & D) 
(Divkovic et al., 2005). It has also been demonstrated that Ni
2+
 might directly 
bind the TCR and MHC, thereby bridging them with high affinity 
independently of peptide (Gamerdinger et al., 2003). 
Certain chemical sensitisers, including p-phenylendiamine, have been shown to 
take part in direct, non-covalent interactions with immune receptors (Figure 
53E). Although the exact mechanism is controversial, the pharmacological 
interaction of sensitisers with immune receptors is capable of eliciting T cell 
responses (Pichler et al., 2006). 
Not all chemicals that cause immune sensitisation are inherently reactive 
before contact with the skin (Gelardi et al., 2001). The weak contact sensitiser, 
eugenol, is an example of a pro-hapten. Upon application to the skin, it is 
converted by metabolic enzymes into a reactive species with immune-
sensitising activity (Karlberg et al., 2008). 
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Sensitisers Activate Innate and Cell-Mediated Immunity 
Sensitisers induce inflammation through the activation of cellular stress and 
innate immune responses by cells within the skin. This determines the 
maturation of dendritic cells, which is a crucial event for the efficient, 
sensitiser-specific activation of T cells (Kaplan et al., 2012). The severity of 
the CHS response is conditioned by the level of inflammation caused by the 
sensitiser (Bonneville et al., 2007). 
The specificity of the immune response is determined by the recognition of a 
sensitiser-(peptide)-MHC complex by the TCR (Louis-Dit-Sully and Schamel, 
2014). This takes place within lymph nodes, where T cells are activated in a 
sensitiser-specific fashion by dendritic cells. 
Following activation, clonal expansion of sensitiser-specific T cells takes 
place, generating effector (TEFF) and effector memory (TEM) T cells. These 
cells no longer re-circulate LNs and, due to the co-stimulatory signals they 
receive during priming, acquire a skin-homing phenotype (Dudda et al., 2004). 
Another subset of T cells, called central memory T cells, also differentiates, 
these cells re-circulate LNs and ensure a high frequency of sensitiser-specific T 
cells is maintained (Sallusto et al., 1999). 
CHS reactions are essentially effected by CD8
+
 T cells (Xu et al., 1996, Akiba 
et al., 2002). CD4
+
 T helper 1 (Th1), Th17 and regulatory T (Treg) cells have 
also been implicated in important mediatory roles in the pathology of CHS 
(Vocanson et al., 2009). Sensitiser-primed effector T cells are rapidly activated 
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upon repeated contact with the chemical and inflict keratinocyte cytotoxicity at 
the site of exposure, which results in severe dermatological inflammation. 
T Cells as Tools for the Prediction of Sensitisation 
The outcome of sensitiser-specific DC-T cell interactions, T cell activation, is 
arguably one of the most important factors in determining sensitisation, as it 
indicates the acquisition of specific immunity against a sensitiser and underpins 
the immune-pathology of ACD. 
As demonstrated by the LLNA, T cells are a valuable tool for the prediction of 
sensitisation. The magnitude of the T cell response correlates with the degree 
of sensitisation and potency of the sensitiser. The capability to calculate 
sensitising potency based on the T cell response is a major advantage of the 
LLNA for chemical safety assessment. 
Kimber identified three important characteristics of the T cell response in 
determining CHS, these are illustrated in Figure 55 (Kimber et al., 2012); 
1) Magnitude 
The magnitude of the T cell response is dependent on the kinetics, extent and 
duration of proliferation. Whether the threshold level of activation required for 
clinically relevant skin sensitisation is reached depends on the extent of the T 
cell response. 
2) Quality 
The quality of the T cell response can be described in terms of the balance 
between effector and regulatory sub-populations. It has been reported that 
188 
 
depletion of the regulatory T cell (Treg) population, characterised by the 
phenotype CD4
+
, CD25
+
, Foxp3
+
, increased the sensitivity of T cell sensitiser 
priming assays (Vocanson et al., 2008). However, such manipulations may 
result in responses which are less reflective of what is expected in vivo. 
3) Breadth 
The breadth of the T cell proliferative response is defined by the level of 
polyclonal activation. This depends on the number of different T cell epitopes 
present. Highly reactive chemicals will inflict many peptide modifications, thus 
generating large numbers of potential T cell epitopes and increasing the chance 
of T cell activation (Esser et al., 2014). 
This also depends on the antigen-specific TCR frequency, which is based on 
the size and diversity of the TCR pool. The cost of a broad TCR repertoire is 
having low numbers of cells specific for a given antigen. 
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Figure 55. CHS severity is mediated by the extent of the T cell response.  
1. Magnitude, determined by duration and kinetics of T cell activation. 2. Quality, depends on 
the balance of regulatory and effector T cells. 3. Breadth, defined by TCR frequency and level 
of polyclonal activation. Modified from Esser et al. (2014). 
Due to the complexity of the factors that determine T cell responses to 
sensitisers, the development of in vitro assays which measure this aspect of 
CHS is a challenging task. Various protocols have been developed and tested 
to assess the T cell response to sensitisers. The most recent assays are 
composed of co-cultures of purified naïve T cells (i.e. depleted of Tregs) and 
autologous moDCs. Readouts commonly include T cell proliferation and 
cytokine detection, either secreted or intracellular, such as IFN-γ (Martin et al., 
2010). 
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Enhancing the Biological Relevance of Immune 
Sensitisation In Vitro  
The ECM plays an important role in the modulation of immunological events 
in vivo, from innate inflammatory responses in peripheral tissues (e.g. the 
skin), to the acquisition of specific immunity in lymphoid tissues (e.g. LNs). 
In the context of CHS, sensitiser-induced danger signals derived from the ECM 
in the epidermis contribute to the activation of DCs (Esser et al., 2012). Since 
this is crucial for efficient T cell activation, sensitiser-induced DC activation in 
the context of a relevant ECM may be advantageous for the success of priming 
naïve T cells in vitro. 
With regards to T cell-DC interactions, the ECM is known to have important 
modulatory effects on the outcome of the T cell response in terms of DC 
antigen presenting capability and cell motility (Garcia-Nieto et al., 2010, 
Gunzer et al., 2000). This has been described in more detail in Chapters 2 and 4 
of this thesis. 
Biomaterials are used in tissue engineering to mimic the architectural and 
biological features of the ECM. There is a wide range of biomaterials available 
for cell culture applications. The suitability of biomaterials for immune cell 
culture was characterised and described in detail in Chapter 2 of this thesis. 
ECM components are not a common feature of current in vitro assays. 
However, the incorporation of biomaterials could be considered an effective 
solution to address concerns surrounding the lack of biological relevance of 
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current immune cell assays for the identification of sensitisers, as highlighted 
in Chapter 4 of this thesis. 
Chapter aims 
This chapter brings together the work described so far in this thesis regarding 
the application of a collagen hydrogel ECM platform for immune cell studies, 
with the investigation of immune responses to sensitisers. The aim of the work 
descrived in this chapter was to study the effect of the ECM on immune 
responses to chemical sensitiser. Using the ECM platform, dendritic cell 
maturation and T cell activation in response to sensitising chemicals was 
compared with a conventional cell culture method. 
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5.2. Materials and Methods 
Generation of monocyte-derived dendritic cells  
This was done according to the method described in Chapter 2 of this thesis, 
2.4. Materials and Methods: Generation of Monocyte-Derived Dendritic Cells. 
Isolation of T Cells  
This was done according to the method described in Chapter 4 of this thesis, 
4.4 Materials and Methods: Isolation of T Cells. 
Preparation of Collagen Hydrogels 
The collagen hydrogel was prepared according to the method described in 
Chapter 2 of this thesis, 2.4. Materials and Methods: Preparation of Collagen 
Hydrogels. The collagen solution was retained on ice until required. 
Preparation of Chemical Reagents 
All chemicals were purchased from Sigma. Fresh chemical solutions were 
prepared for each experiment. 50mM stock solutions of DNCB and eugenol 
were prepared in DMSO. 50mM stocks of SLS were prepared in tissue culture 
grade water. Further dilutions to achieve concentrations 4X the final test 
concentration required were carried out in complete RPMI-1640 media. 
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Pulsing Dendritic Cells with Chemicals  
Chemicals were directly applied to monocyte-derived dendritic cells and 
incubated under standard tissue culture conditions for 24 hours. Cells were then 
harvested for cell viability and phenotypic analysis, and co-culture 
experiments. 
Co-Culture of Chemical-Pulsed Dendritic Cells with T Cells  
This was done according to the method described in Chapter 4 of this thesis, 
4.4 Materials and Methods: Autologous Mixed Lymphocyte Reaction. 
Dendritic Cell Phenotypic Analysis  
This was done according to the method described in Chapter 2 of this thesis, 
2.4. Materials and Methods: Dendritic Cell Phenotypic Analysis. 
IFN-γ Detection  
Enzyme-linked immunosorbant assays (ELISAs) were used to detect IFN-γ in 
the supernatants collected from AMLRs. The IFN-γ Duo-set ELISA kit 
(purchased from R&D systems) was used according to manufacturer’s 
instructions. 
LDH cytotoxicity assay 
The LDH-Cytotoxicity Assay Kit II (Abnova #KA0786) was carried out 
according to manufacturer’s instructions. Absorbance was measured using the 
Fluorostar Optima Plate reader, 440nm to 490 nm filter. 
194 
 
This assay is based on the principle that lactate is oxidised by LDH generating 
NADH. This reacts with a water-soluble tetrazolium salt, causing a 
colorimetric change. The intensity of the colour can be quantified by a 
spectrophotometer, or plate reader at OD450nm. The absorbance measurement 
correlates with the amount of LDH released. 
Statistical Analysis  
Analysis was carried out using GraphPad Prism version 6.00 for Windows, 
GraphPad Software, La Jolla California USA (www.graphpad.com). 
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5.3. Results and Discussion 
Dendritic Cell Exposure to Sensitising Chemicals 
Sensitiser cytotoxicity 
Sensitiser cytotoxicity was determined in order to establish which 
concentrations to use for moDC exposure. The sensitisers DNCB and eugenol, 
and the non-sensitising irritant, sodium lauryl sulphate (SLS), were each tested 
at 4 different concentrations. Cell death was measured after 24 hours of 
exposure to these reagents using the lactate dehydrogenase (LDH) cytotoxicity 
assay. 
LDH is a cytosolic enzyme, dying cells release LDH into the supernatant as a 
result of the disruption to their plasma membrane. The LDH cytotoxicity assay 
is based on the principle that the LDH activity measured in the supernatant 
correlates with the level of cell death. 
It was important to consider that SLS inhibits LDH activity over concentrations 
of 1mM (Zheng et al., 2002). In this work, the concentration range of SLS did 
not exceed 0.5mM so that the activity of the LDH cytotoxicity assay was not 
affected. 
In Figure 56, graphs A, B and C show the percentage of cell death measured in 
moDC cultures following exposure to DNCB, eugenol and SLS respectively. 
5µM of DNCB was not found to have significant cytotoxic effects on moDCs 
(8.9%) compared to untreated cells (1.65%). When cells were exposed to 
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12.5µM, 25µM and 50µM, the mean cytotoxicity increased to 34.6%, 55.6% 
and 82.7% respectively. At concentrations of 12.5µM and above, cell death 
was found to be significantly higher (P ≤ 0.0001, ****). 
The lower concentrations of eugenol, 180µM and 500µM, did not cause 
significant cytotoxicity, with an average of 6.2% and 15.8% cell death 
measured for each concentration. Higher concentrations, 1000µM and 
1800µM, resulted in increased cell death, with 49.6% and 48.8% measured for 
each. The increase in cell death at the top concentrations was found to be 
significant (P ≤ 0.0001, ****). 
The vehicle control in graphs A and B represents 1% DMSO. This was the 
solvent used in the preparation of DNCB and eugenol and was not found to 
have a cytotoxic effect on moDCs (2.1%). 
SLS applied to moDCs at 7µM and 70µM did not cause significant levels of 
cytotoxicity, with an average of 0.4% and 4.7% cell death in the respective 
cultures. At higher concentrations of SLS, 250µM and 500µM, 51.2% and 
70.6% cell death was measured for each. These levels of cytotoxicity were 
found to be highly significant (P ≤ 0.0001, ****). 
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Figure 56. Sensitiser cytotoxicity. 
Cell death after 24 hours of exposure to DNCB, eugenol or SLS determined by the LDH 
cytotoxicity assay. A. DNCB caused significant cytotoxicity at concentrations over 12.5µM (P 
≤ 0.0001, ****). B. There was significant cytotoxicity when eugenol was applied at a 
concentration of 1mM or higher (P ≤ 0.0001, ****). C. SLS had significant cytotoxic effects at 
concentrations of 250µM and above (P ≤ 0.0001, ****). 1 way ANOVA used to determine 
statistical significance. Not significant if P ≥ 0.05 (n ≥ 3). Error bars represent standard 
deviation. 
The chemical concentrations tested and cytotoxicity data generated from these 
experiments are summarised in Table 3. This work was used as a basis for the 
further investigation into immune responses to chemical sensitising agents. A 
certain level of cytotoxicity can act as an adjuvant, which is a requirement of 
efficient immune activation. The level of acceptable cytotoxicity in DC 
sensitiser assays varies between reports but it is usually around 10-20% 
(Hulette et al., 2005). 
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Table 3. Summary of sensitiser cytotoxicity. 
Summary of the concentration range of chemicals tested and the respective level of 
cytotoxicity induced, with equivalent wt/vol. *Significant level of cytotoxicity. 
DNCB 
µM µg/mL Mean Cytotoxicity (%) 
5.00 1 8.9 
12.50 2.5 *34.6 
25.00 5 *55.6 
50.00 10 *82.6 
Eugenol 
µM µg/mL Mean Cytotoxicity (%) 
180 30 6.2 
500 82 15.8 
1000 160 *49.6 
1800 300 *48.8 
SLS 
µM µg/mL Mean Cytotoxicity (%) 
7 2 0.4 
70 20 4.7 
250 72 *51.2 
500 144 *70.6 
Sensitiser induced moDC phenotypic maturation 
The phenotypic response of moDCs to sensitisers was established in 
conventional TCP culture. This was done based on the expression of the DC 
maturation markers CD86 and CD54. The increase in the expression of these 
markers is routinely used for the prediction of sensitisers in the well-
established human cell line activation test (hCLAT), which uses the DC-like 
cell line, THP-1, and also in primary moDC assays. 
In these experiments, moDCs were exposed to the strong sensitiser, DNCB, the 
weak sensitiser, eugenol, and the non-sensitiser, SLS, for 24 hours. Cells were 
harvested and immunofluorescently labelled for CD54 and CD86, then 
analysed by flow cytometry. 
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The results from the analysis of moDC phenotypes following DNCB exposure 
are shown in Figure 57A, the data is presented as median fluorescent intensity 
(MFI) for each of the 5 donors tested. Figure 57B shows dot plots generated 
from flow cytometric analysis of the expression profiles of CD86 and CD54 
following DNCB treatment for Donor 1. 
Donors 1, 2 and 5, demonstrated an increase in CD86 expression in response to 
25µM DNCB. No increase in CD54 was seen for any of the donors in response 
to DNCB. However, CD54 was found to decrease at concentrations of 25µM, 
and above, for Donors 1, 2 and 3. 
Up-regulation of both CD86 and CD54 to the strong sensitiser DNCB has been 
reported to be reproducible in DC cell lines and primary DC assays (Nukada et 
al., 2012, Tuschl et al., 2000). Therefore it was surprising that the expression of 
CD54 did not positively correlate with CD86 in these experiments. 
The absence of response to DNCB observed for Donors 3 and 4 may be due to 
natural variation. This reflects the lack of sensitivity associated with primary 
DC assays, a limitation which has also been highlighted by others (Furio et al., 
2008). 
Notably, sensitiser cytotoxicity has been shown to determine the up-regulation 
of CD86. Levels of cell death of 10% and above have been shown to induce 
CD86 (Hulette et al., 2005). In these experiments, the level of cell death in 
moDC cultures exposed to 10µM DNCB may not have been sufficient to 
induce the up-regulation of CD86. 
200 
 
 
Figure 57. Phenotypic analysis of moDCs treated with DNCB. 
A. Median fluorescence intensity of CD86 and CD54 for Donors 1 – 5. Expression of CD86 
was seen to be increased in response to 25µM DNCB for Donors 1, 2 and 5. No increase in 
CD54 was seen in response to DNCB and it decreased for Donors 1, 2 and 3 at concentrations 
of 25µM and above. B. Dot plots to show the expression profile of CD86 and CD54 for 
moDCs treated with DNCB from Donor 1. 
The analysis of moDCs from 4 individuals exposed to the weakly sensitising 
agent, eugenol, is shown in Figure 58A. With 250µM eugenol, there was a 
slight increase in the expression of CD86 for Donors 1 and 4. Donors 2 and 3 
did not appear responsive to eugenol. For all of the donors, there was no 
change in CD54 expression as a result of eugenol exposure. Figure 58B shows 
the expression profiles of CD86 and CD54 for Donor 4 following treatment of 
moDCs with eugenol. 
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Eugenol is weakly sensitising and requires enzymatic conversion to become 
reactive (Karlberg et al., 2008). It is reasonable not to expect profound effects 
for eugenol in vitro due to the absence of mechanisms for its activation. 
 
Figure 58. moDC phenotypic analysis following exposure to eugenol. 
A. 250µM eugenol induced slight increase in CD86 expression in Donors 1 and 4. No response 
was observed for Donors 2 and 3. Expression of CD54 was not affected by eugenol for any of 
the donors tested. B. Dot plots from phenotypic analysis of moDCs from Donor 4 following 
eugenol treatment. 
The analysis of moDCs from 4 donors after treatment with the non-sensitiser, 
SLS, is shown in Figure 59. The graphs in A show that the expression of CD86 
and CD54 was not affected by exposure to SLS. The dot plots in B show the 
expression profile of CD86 and CD54 by moDCs for Donor 2. 
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It was reassuring that SLS did not affect the expression of CD86 or CD54 as it 
is not a sensitiser and is often used as a negative control for in vitro and in vivo 
sensitisation studies. 
 
Figure 59. Phenotypic analysis of SLS-treated moDCs. 
A. SLS did not affect expression of CD86 or CD54 for any of the 4 donors tested. B. Dot plots 
from the analysis of CD86 and CD54 expression for Donor 2 after treatment with SLS. 
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Dendritic Cell Responses to Sensitisers on the ECM 
Platform 
Sensitiser-induced moDC maturation in the context of 
collagen hydrogels 
In-keeping with the theme of this thesis, moDC exposure to sensitisers was 
performed in the context of collagen hydrogels and compared with responses 
from TCP cultures. 
Figure 60 shows the phenotypic analysis from these experiments of one of the 
donors. These results were representative of those obtained from 3 individuals 
tested under the same conditions. In the analysis, the phenotypic response to 
DNCB, eugenol and SLS in collagen hydrogel cultures was compared to that in 
TCP. 
There was a reproducible increase in CD86 expression in response to 25µM 
DNCB. The intensity of the increase in CD86 expression was lower on 
collagen hydrogels, compared to TCP. DNCB did not cause any change in 
CD54 expression in collagen cultures. 
Concentrations of 250µM eugenol induced a slight increase in CD86 
expression in collagen cultures. The magnitude of the response was lower in 
collagen hydrogel cultures than TCP. No response to eugenol was seen based 
on CD54 expression. 
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Finally, as expected, the non-sensitiser control, SLS, did not have an effect on 
CD86 or CD54 expression in collagen cultures. 
Compared to TCP, the collagen hydrogel impaired the intensity of the 
phenotypic response to sensitisers. This was surprising since ‘danger’ signals 
derived from other ECM components, such as hyaluronic acid, have been 
linked with the induction of innate immunity in sensitisation (Esser et al., 
2012). It was anticipated that collagen fragments, generated as a result of 
oxidation by sensitiser-dependent ROS, may have enhanced moDC maturation 
(Esser et al., 2012, Chen and Nuñez, 2010, Monboisse and Borel, 1992, 
Hawkins and Davies, 1997).  
Certain collagen peptides have been shown to activate innate immunity 
(Thomas et al., 2007). However, in the same study, different collagen 
fragments were demonstrated to have anti-inflammatory functions. This 
suggests collagen peptides may have complex immune-modulatory properties. 
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Figure 60. moDC phenotypic responses to sensitisers in collagen hydrogel and TCP 
cultures. 
DNCB. 25µM caused up-regulation of CD86, the magnitude of response was decreased in the 
presence of collagen. There was no change in CD54 expression. Eugenol. 250µM induced 
increased CD86 expression, levels of CD86 expression in collagen cultures were lower. CD54 
expression remained unchanged. SLS. No effect on CD86 or CD54 expression in TCP and 
collagen cultures. Data shown from one donor but represents analysis of 3 donors. 
Sensitiser-Specific T Cell Activation on the ECM Platform 
Activation of T cells by DNCB-pulsed moDCs  
To investigate the functional implications of pulsing moDCs with the strong 
sensitiser, DNCB, their ability to elicit a T cell response was investigated. In 
keeping with the topic of this chapter, T cell responses to DNCB-treated 
moDCs were investigated in both in TCP and collagen hydrogel cultures. 
Co-culture assays were performed with autologous T cells under similar 
experimental conditions to those described in Chapter 4 of this thesis and T cell 
activation was measured by IFN-γ production. moDCs were pulsed with 10µM 
of the strong sensitiser, DNCB, prior to co-culture with T cells. This 
concentration was chosen since the level of cytotoxicity caused by higher 
concentrations resulted in poor cell retrieval. 
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These experiments were performed with 3 donors, the results for each 
individual are presented in Figure 61. Out of the three donors, one (Donor 2) 
mounted a T cell response to DNCB-treated moDCs. For this donor, there was 
increased production of IFN-γ in TCP cultures with DNCB-pulsed moDCs 
(1875.6pg/mL), compared to 88.34pg/mL detected in the untreated conditions. 
For the other two donors (Donors 1 and 3), levels of IFN-γ production were 
low with no specific effect of sensitiser treatment. On the collagen hydrogel 
platform, a DNCB-specific T cell response was also detected for Donor 2 
based on the raised levels of IFN-γ (1443.04pg/mL). Sensitiser-specific 
responses were not found for Donors 1 and 3 on collagen hydrogels. 
 
Figure 61. T cell activation by DNCB-modified moDCs. 
One out of three donors responded to DNCB. TCP. Donor 2 mounted a T cell response towards 
DNCB-pulsed moDCs due to the increased levels of IFN-γ detected in these cultures. Collagen. 
DNCB-specific T cell activation was also observed for Donor2 as IFN-γ production was 
increased in this condition. T cell activation was not detected for Donors 1 or 3 in either TCP 
or collagen hydrogel cultures. (nd = not detected). 
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The possible reasons for the low frequency of T cell responses to DNCB-
modified moDCs observed in this investigation are numerous. First, the 
phenotypic analysis of moDCs pulsed with 10µM DNCB had previously 
revealed that they did not have increased expression of CD86 or CD54, 
therefore, they probably would not have had the capacity to activate T cells 
efficiently. 
The presence of memory T cell populations may have influenced T cell 
activation in this assay. This depends on the individual’s prior exposure to 
sensitiser. The occurrence of exposure to DNCB is expected to be low in the 
general population. Therefore DNCB-specific memory T cells are expected to 
be very rare. 
Third, the balance of effector and regulatory T cells has important implications 
in terms of the outcome of T cell responses. Since regulatory T cell populations 
were not depleted in these assays, they may have contributed to the suppression 
of T cell activation in response to DNCB-modified moDCs. 
Finally, antigen-specific TCR frequency is another factor for consideration. T 
cells isolated from blood samples only represent a fraction of the total in vivo 
population. This limits the number of TCRs available and therefore the 
probability of T cell activation, compared to whole-organism studies. 
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5.4. Conclusions and Further Work 
This chapter has described the investigation of moDC maturation and T cell 
activation in response to chemical sensitisers in the context of a collagen 
hydrogel platform. To the best of our knowledge, this is the first time such 
assays have been conducted in the presence of ECM. 
Sensitiser-induced moDC maturation on the ECM platform 
On the ECM platform, moDC maturation in response to sensitisers was evident 
based on the increased expression of CD86. The trend in moDC maturation by 
sensitisers was similar in the presence of collagen hydrogel compared with 
TCP. However, in collagen hydrogel cultures, the magnitude of the phenotypic 
response to sensitisers was dampened. 
It was postulated that collagen may enhance the immunogenic effects of 
sensitisers, since DAMPs (derived from the ECM) have been found to have a 
role in the activation of innate immunity during sensitisation (Esser et al., 
2012). This is due to the oxidative effects of the sensitisers on the ECM, which 
results in degradation and release of ECM fragments. 
With regards to collagen fragmentation, certain collagen peptides have also 
been shown to have anti-inflammatory properties on the innate immune 
system, which could have contributed to the dampened phenotypic response 
(Thomas et al., 2007). However, since the release of collagen peptides was not 
quantified here, the implications of this are difficult to assess. 
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Analysis of two cell-surface markers was not likely to be sufficient to capture 
the biological and functional effects of the collagen hydrogel on moDCs in the 
context of sensitiser exposure. Increasing the range of readouts would give a 
more detailed insight into moDC responses to sensitisers and the role of the 
ECM. Alternative measures, such as analysis of different phenotypic markers, 
such as programmed death-ligand 1 (PD-1), DC immunoreceptor and 
neutrophil-activating protein-2 (DCIR) (Hitzler et al., 2013); cytokine 
production, including IL-1β, IL-6 and IL-8; or functional assays, such as 
endocytosis, could be investigated to this end (dos Santos et al., 2009). 
Sensitiser-specific T cell activation on the ECM platform 
DNCB-specific T cell activation was elicited by one out of 3 individuals tested. 
T cell activation is dependent on co-stimulation by DCs, duration of activation, 
the balance between effector and regulatory T cells, peptide immunogenicity 
and the frequency of antigen-specific receptors. The impacts of these factors on 
the outcome of these experiments are considered as follows. 
The concentration of DNCB used to pulse moDCs prior to T cell co-culture 
was not found to induce a mature phenotype. Facilitating the increase in co-
stimulatory molecule expression by sensitiser-exposed moDCS could 
potentially enhance their ability activate T cells. This may be achieved by 
using higher concentrations of the sensitising agent. 
In vivo, T cell priming by chemical sensitisers lasts 10 – 15 days in humans 
(Vocanson et al., 2009). However, little is known about the kinetics of 
sensitiser-induced T cell activation in vitro. Therefore, the day 6 end point of 
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this assay may not be optimal for the detection of T cell priming by sensitisers. 
Further investigation into this aspect of T cell activation would help establish 
the most appropriate time point at which to monitor the T cell response to 
sensitisers. 
Modifications to the experimental method could be implemented to improve 
the detection of sensitiser-specific T cell priming. For example, adding a recall 
response following the initial priming phase would allow for the expansion of 
sensitiser-specific T cells and re-stimulation would elicit a stronger, specific T 
cell response. 
By directly applying chemicals to cell cultures there was no control over the 
formation of haptenated peptides (Martin et al., 2010). Other application 
methods, such as prior formation using a dedicated carrier, such as human 
serum albumin, could be used to give more control over sensitiser-peptide 
modification. 
This work has outlined the first attempt made at studying immune responses to 
sensitisers on an ECM platform. The results were encouraging since both 
innate and adaptive immune responses were mounted in response to sensitisers 
on the collagen hydrogel. 
Overall, it was difficult to quantify the effect of the collagen hydrogel on 
sensitiser-induced moDC maturation and T cell activation due to suboptimal 
responses to sensitisers and the high levels of biological variation. 
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The outcomes of this work reflect the complexity of the molecular and cellular 
mechanisms involved in the induction of sensitisation. This highlights the 
complications faced in the development of alternative methods for identifying 
chemical sensitisers. 
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Chapter 6 
Conclusions 
6.1. Summary 
This thesis has shown how tissue engineering technologies can be used to 
develop biomimetic platforms for in vitro immunological studies. This was 
achieved by the development of ECM and flow platforms in order to simulate 
the extra-cellular microenvironment to which cells are exposed in natural 
tissues. 
Conclusions from studies on the ECM platform 
Characterisation of biomaterials to provide a biologically relevant substrate for 
immune cell culture was important in order to overcome the limitations of 
conventional methods, which are mostly carried out the absence of ECM. 
Synthetic biomaterials, thermo-responsive particulate gel and electrospun 
scaffolds, and naturally-derived biomaterials, GelMA and collagen hydrogels, 
were tested in this work. 
Collagen hydrogel was determined to be a suitable ECM platform for immune 
cell culture since it supported a high level of cell viability (>75%), did not 
directly induce inflammatory immune responses and supported the induction of 
appropriate innate and adaptive immune responses. 
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Collagen is ubiquitous in all tissues of the body (Parenteau-Bareil et al., 2010). 
There are several of types of collagen and it can form a variety of 3D matrices, 
such as sponges, lattices and hydrogels (Glowacki and Mizuno, 2008).  
In the lymph node, networks of collagen fibres provide structural support and 
facilitate the attachment of stromal cells and DCs. It also has an important role 
in regulating cell adhesion and motility (Wolf et al., 2003). Collagen hydrogels 
have been used previously for immune cell culture, for example in a study of 
DC-T cell interactions in 3D reported by Gunzer et al (Gunzer et al., 2000). 
In Chapter 4, antigen-specific immunity, elicited in response to the model 
antigen PPD, was investigated in the context of the collagen hydrogel ECM 
platform. Compared with conventional methods, which are conducted without 
ECM, the collagen hydrogel appeared to increase the sensitivity and specificity 
of antigen-specific immune responses. 
Successful T cell activation requires the antigen-specific interaction between 
MHC-peptide and TCR, engagement of co-stimulatory molecules and 
inflammatory cytokines (Murphy et al., 2008). More recently, it has become 
clear that ECM components, namely laminin, fibronectin and collagen, also 
have important modulatory effects on T cell activation. This is reflected in a 
number of studies in the literature which reported that the ECM profoundly 
influenced the outcome of DC-T cell interactions (Gunzer et al., 2000, Garcia-
Nieto et al., 2010, Dustin et al., 2001). 
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Gunzer et al. demonstrated that collagen promotes the motility of DCs and T 
cells and supports T cell activation. They showed that in suspension, i.e. 
without ECM, cells formed large clusters dependent on MCH-peptide 
interactions with TCR. In the presence of a collagen matrix, they found that 
cells formed smaller clusters while retaining the capability for efficient T cell 
activation (Gunzer et al., 2000). These observations were similar in terms of 
the cell distribution, organisation and immune response observed in the 
experiments described in this work. 
The findings from this study and reports by others give rise to the possibility 
that a collagen ECM determines the threshold for T cell activation (Dustin and 
de Fougerolles, 2001). This may increase the sensitivity of antigen-specific T 
cell responses by preventing T cell activation as a result of sub-optimal APC-T 
cell interactions, according to the strength of the antigen-specific interaction or 
antigen-presenting efficiency of the DC. 
In Chapter 5, an investigation of immune responses to the chemical sensitisers 
DNCB and eugenol was carried out in the context of the ECM platform. DC 
maturation following treatment with sensitisers was observed in the presence of 
the collagen hydrogel. Also, sensitiser-specific T cell activation was detected in 
conventional cultures and on the ECM platform. 
Unlike PPD, no notable difference was found between immune responses to 
sensitisers on the ECM platform compared with conventional culture methods. 
This is probably due to the limited sample size, since there was a high level of 
variation and not all donors mounted a response towards the sensitisers tested. 
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It is also likely to be a reflection of the complexity of the mechanisms involved 
in the elicitation of immune responses by sensitisers. 
Conclusions from work on the fluidic platform 
Chapter 3 describes the development of a fluidic device with a paper-based 
scaffold for the incorporation of flow into cultures of immune cells. This was 
done in order to mimic interstitial flow, which cells experience in vivo but is 
not a feature of conventional in vitro methods.  
The collagen hydrogel-coated paper, which provided the scaffold for cell 
culture on the fluidic platform, was found to induce moDC maturation based 
on the expression of cell surface markers. This was the first time this type of 
scaffold has been used for immunological studies. Hydrogel-coated paper-
based scaffolds have recently been described for other cell culture applications, 
including the generation of an air-liquid interface and investigation of lung 
tumour cell interactions with fibroblasts (Rahim et al., 2015, Camci-Unal et al., 
2016). 
Under flow conditions, moDCs cultured on the fluidic platform exhibited high 
viability, maintained a less-mature phenotype (compared to static) and were 
responsive to immunological stimulation by LPS. 
The fluidic device was implemented in Chapter 4 to study the effect of flow on 
antigen-specific T cell responses to PPD. Despite the apparent reduction in the 
intensity of the immune response under flow conditions based on the level of 
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IFN-γ detected, the sensitivity of antigen-specific T cell activation was higher 
compared with the static counterpart. 
Based on the findings from this work and recent publications, it is clear that 
shear flow has crucial immune-modulatory effects (Previtera, 2014, Li et al., 
2010, Swartz et al., 2008). Elucidation of the mechanisms by which flow 
regulates inflammatory responses is in the early stages. To date, cell surface 
receptors and intracellular proteins, particularly those associated with the 
cytoskeleton, have been implicated in the transduction of flow induced changes 
in gene expression in immune cells (Makino et al., 2005, Makino et al., 2007). 
It has been suggested that under homeostatic conditions, physiological stimuli 
such as flow suppress inflammatory responses. This may explain the less 
mature moDC phenotype observed on the fluidic platform under the flow 
conditions. 
It is well-established that the maturation state of DCs is critical for the 
induction of T cell activation. moDCs cultured on the platform under static 
conditions exhibited a mature phenotype, which would have promoted non-
specific T cell activation and exaggerated antigen-specific responses. The 
effect of flow on moDC maturation state may have increased the threshold for 
T cell activation, thereby causing antigen-specific T cell activation to be more 
sensitive under flow conditions. 
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Future Work 
Future work will focus on the applications of ECM and fluidic platforms for 
the study of cellular immunology. This will include elucidating the 
mechanisms through which immune cells sense their extracellular environment 
and how this impacts their behaviour. A better understanding of how 
environmental factors modulate immune responses will be valuable for the 
advancement of immune-competent in vitro assays which are routinely used for 
research purposes in academia and industry. 
It is anticipated that through enhancing the physiological relevance of in vitro 
cell culture, it will be possible to generate more realistic immune responses, 
thus improving the reliability of the prediction of immune responses. This will 
have numerous implications for, but not limited to, optimising strategies for 
vaccine delivery, identifying novel therapeutic targets for the treatment of 
cancer and autoimmune diseases, and increasing the efficacy of safety testing. 
Finally, the ability to produce representative immune responses without 
resorting to animal models will make a huge contribution to the reduction in 
the numbers of animals used for research and safety testing. 
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Appendix I 
Supplementary data for TNF-alpha PCR 
 
A. Measurement of TNF-α gene 
expression by conventional 
ethidium gel-based RT PCR for 
donor 1. After 30 minutes, band 
intensity shows up-regulation of 
TNF-α in TC and GelMA LPS-
stimulations. At 4 hours, TNF-α 
expression is reduced in the 
stimulated GelMA conditions but 
up-regulation of expression is 
maintained in the LPS stimulated 
TC condition.  
B. Analysis of TNF-α expression 
by real time quantitative PCR 
for donor 2.TNF-α expression is 
up-regulated within 30 minutes of 
stimulation by LPS in both TC 
and GelMA cultures. After 4 
hours, expression is maintained in 
stimulated TC cultures, however, 
in the LPS-stimulated GelMA 
cultures expression is diminished. 
 
Melt curves from TNF-α and 
GAPDH quantitative real-time 
PCR. For each, the single peak is 
indicative of a specific PCR 
product. 
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Appendix II 
Microfabrication Technique 
Micro-patterning techniques provide a useful way to generate a variety of 
surface topographies, which can be used for cell culture applications. The 
advantage of micro-patterning techniques is that they are inexpensive and 
convenient, whilst giving a fine degree of control over dimensions and a high 
level of precision over the geometric features. 
Micro-scale wells (microwells) produced using micro-patterning methods have 
previously been used to investigate the effect of well size on cell behaviour. 
The research in this area concentrated on embryonic stem cell body 
homogeneity and differentiation (Hwang et al., 2009, Choi et al., 2010). 
In relation to the research presented in this thesis, microwell platforms have 
been identified as potentially valuable tools for studying the effect of well 
depth and diameter on DC-T cell interactions and subsequent T cell activation. 
The data presented in Chapter 4 of this thesis suggested that differences in the 
distribution of cells between the U-bottom TCP wells and the collagen 
hydrogel affected the outcome of the T cell response. 
A customised array of microwells of varying diameter and depth was produced. 
Microwells were fabricated from poly(ethylene glycol) diacrylate (PEGDA), 
using a photolithography micro-patterning method as illustrated in Figure i. 
PEGDA is cell-repellent, thus reducing the cell interactions with the substrate 
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in order to focus on the effect of the geometry of the microenvironment on cell 
behaviour. 
 
Figure i. Schematic representation of microwell fabrication by photolithography. 
A drop of pre-polymer solution is applied to a TMSPMA-functionalised glass slide. A PDMS 
mould is put on top of the polymer solution and exposed to UV to photo-cross link the polymer 
giving rise to a micropatterned surface. 
To investigate the precision of the fabrication technique and examine the 
integrity of the microwell structures, samples were analysed by environmental 
scanning electron microscopy (eSEM). eSEM is useful as it does not require 
sample dehydration, thereby allowing one to obtain high resolution images of 
hydrated structures, such as micro-patterned hydrogels.  
Figure ii shows representative micrographs taken by eSEM. The microwell 
patterns were robust and consistent. This demonstrated the reproducibility of 
the technique for the fabrication of precisely micro-patterned platforms. 
Overall, the microwells showed great promise for cell culture applications as a 
vast range of dimensions can be produced depending on the application. They 
can provide a defined microenvironment with precise dimensions which gives 
a high level of experimental control. 
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Figure ii. Microwell characterisation by eSEM. 
Analysis of microwell structures demonstrated a robust and consistent microwell pattern 
generated using a photolithography micro-patterning method. eSEM was performed using a 
FEI Quanta 650 ESEM system. 
Microwell Fabrication – Materials and Method 
The method for microwell fabrication has been described previously (Karp et 
al., 2007, Hwang et al., 2009, Moeller et al., 2008). PDMS stamps were used to 
mould the microwells, the stamps were made by pouring a mixture (10:1) of 
Sylgard 184 silicone elastomer base solution and curing agent (purchased from 
Dow Corning) onto a negative template in a petri dish. This was then put into a 
vacuum chamber for 1 hours to remove air bubbles. Finally, it was transferred 
to an oven, set at 80°C, for 2 hours to cure. 
Hydrogel microwells were fabricated from Poly(ethylene glycol 1000 Dimeth-
acrylate) (purchased from polysciences). A 0.5% w/v photoinitiator solution 
(Irgacure 2959) was prepared in PBS. Then a 10% w/v PEGDA solution was 
made in the 0.5% photoinitiator solution. A 15µL drop of PEGDA monomer 
solution was dispensed onto a TMSPMA-functionalised glass slide, a PDMS 
stamp was then placed on top. The PEGDA was photo cross-linked by 
exposure to UV light (180 seconds, 850mW, 8.5cm). Finally, slides were 
submerged in PBS to wash away excess un-polymerised solution and allow 
gels to swell to a uniform shape. 
